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Abstract
In Chapter 1, the first enantioselective cross-coupling reactions of racemic secondary
benzylic halides are described (eq 1). This method was applied to the syntheses of
intermediates employed by other groups in the generation of bioactive compounds, e.g., an
androgen receptor agonist (1.1) and two members of the trikentrin family of natural
products (1.2 and 1.3).
Br 10% NiBr2 diglyme) BrZn-Bu 13% (R)-(i-Pr)-Pybox
DMA, 0 C
racemic
Bu
oF3t
O N N
H H
r 1.1
(RXi-Pr)-Pybox LG 121071
rIH Me
Et
Me
1.2 1.3
trans-trikentrin A Iso-trans-trikentrin B
In Chapter 2, the first method for the kinetic resolution of indolines through catalytic N-
acylation is described (eq 2). To improve the selectivity factor, a new planar-chiral PPY-
derived catalyst (2.1) was prepared, wherein the chiral environment had been modified. The
method was applied to the resolution of an intermediate prepared by K. Tsuji in the synthesis
of a series of novel antibiotics of core structure 2.2. This work provides a rare example of a
nonenzyme-based acylation catalyst for the kinetic resolution of amines.
Me t-Bu •P~
H Ph
racemic 0.65 equiv
5% (+)-2.1
0.75 equiv 18-crown-6
1.5 equiv LiBrMe
[l/Me (2)
toluene, 0 °C
Ac
-Me
R F~e R
RýýR
R CO 2H
(+)-2.1: Ar = (3,5-dimethyl)phenyl 2.2: R1, R2 = amine or H
Finally, in Chapter 3, the first examples of catalyzed, enantioselective insertion of
carbenoid fragments into C-N sigma bonds are described (eq 3). The system uses
commercially-available catalyst components and gives highly enantioselective
rearrangements of benzylamine-, allylamine-, and x(-aminocarbonyl-containing substrates.
The method represents a new way to access 1,4-benzoxazinones, a subunit present in several
pharmaceutical targets and chiral natural products.
10% CuOTf
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DMA, 40 °C
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Abbreviations
cod 1,4-cyclooctadiene
Boc t-butoxycarbonyl
DIPEA N,N-diisopropylethylamine
DMA N,N-dimethylacetamide
DMAP N,N-4-dimethylaminopyridine
DMI N,N-dimethylimidazolidinone
DMF N,N-dimethylformamide
DOSP N-(p-dodecylphenylsulfonyl)prolinato
DPPP 1,3-bis(diphenylphosphino)propane
LHMDS lithium bis(trimethylsilyl)amide
MOM methoxymethyl
PPA polyphosphoric acid
PPY 4-(pyrrolidin-l -yl)pyridine
Py pyridine
TBA tetra-N-butylammonium
TBAT tetra-N-butylammonium triphenyldifluorosilicate
TBS tert-butyldimethylsilyl
THF tetrahydrofuran
TMEDA N,N,N',N'-tetramethylethylenediamine
Chapter 1
Catalytic Enantioselective Negishi Reactions
of Racemic Secondary Benzylic Halides
1.1 Background
Metal-catalyzed cross-coupling reactions are broadly defined as a set of reactions in
which a new C-C bond (R'-R2; eq 1.1) is formed by union of an organometallic reagent (Rl-
M) and an organic electrophile (R2-X; X = halide, tosylate, etc.), through the agency of a
transition-metal catalyst.1
catalyst
R1-M R2-X c l RI-R2 M-Xý (1.1)M-X
The fundamental steps of a conventional, catalyzed cross-coupling are shown in
Figure 1.1. The cycle initiates when the metal catalyst (LnM 1) undergoes oxidative addition
into the organic halide, producing an intermediate metal halide (L~M'R2X). Then, in a
transmetallation step, the metal halide and organometallic species transpose, producing a
substituted metal intermediate (LnM 1R'R 2) and a second, terminal metal halide (M-X).
Finally, the C-C bond is formed via reductive elimination of the substituted metal
intermediate, and the metal catalyst is concomitantly regenerated. For differing cross-
coupling systems, the precise mechanistic pathways of these fundamental steps can vary
widely.2
For reviews of metal-catalyzed cross-coupling reactions, see: (a) Metal-catalyzed Cross-coupling Reactions,
2nd ed.; de Meijere, A., Diederich, F., Eds.; Wiley-VCH: Weinheim, 2004. (b) Handbook of Organopalladium
Chemistry for Organic Synthesis; Negishi, E.-I., Ed. Wiley Interscience: New York, 2002.
2 For leading discussions and references on the fundamental steps of cross-couplings, see ref 1, and: Principles
and Applications of Organotransition Metal Chemistry Collman, J. P.; Hegedus, L. S.; Norton, J. R.; Finke, R.
G., Eds.; University Science Books: Sausalito, 1987.
R1-R2
LnM 1
reductive
elimination
LnM1-R2
R1
oxidative
addition
Ln'-R 2
X
M-X M-R1
transmetallation
Figure 1.1. Conventional cross-coupling cycle.
Cross-coupling reactions are often called by common names, according to the family
of organometallic nucleophile (Table 1.1). For the majority of this chapter, we will discuss
reactions of organozinc nucleophiles, i.e., Negishi reactions.
Table 1.1. Named cross-coupling reactions.
Organometallic reagent
R-BX2
R-MgX
R-SnX3
R-SiX3
R-ZnX
R-AIX2
R-ZrXCp 2
Reaction name
Suzuki (Suzuki-Miyaura)
Kumada (Kumada-Corriu)
Stille (Migita-Kosugi-Stille)
Hiyama
Negishi
For decades, cross-coupling reactions have been a powerful way of synthesizing C-C
bonds. Despite their utility, these reactions were seldom used for coupling P-hydride-
containing substrates, owing to a general limitation that those substrates tended to
preferentially undergo 3-hydride elimination, rather than leading to coupling product
formation (Figure 1.2). However, over the past several years, many nickel- and palladium-
based systems have emerged that are capable of circumventing the P-hydride elimination
process and forming coupling products of alkyl fragments in useful yields. 3
Me Me
Ralkyl Me Br Me
LnM
Me Me fl-hydride
SLelimination LnMH Me
LnM LnM - - LNM
RalkyI H X H X
M'-Br M1-Ralkyl
Figure 1.2. A conventional alkyl-alkyl cross-coupling cycle.
In 2003, Fu and Zhou reported the first nickel-based system that allowed coupling of
primary nucleophiles with secondary electrophiles in good yield (91%, eq 1.2). 4 One salient
feature of this system is the use of an enantiopure ligand, raising the question of whether
enantioselective cross-couplings of chiral, secondary electrophiles are possible.
4% Ni(cod) 2Me 8% (s-Bu)-Pybox Me
n-nonyl-ZnBr Br -- n-nonyl (1.2)
Me r.t. Me NN
s-Bu s-Bu
91% yield (s-Bu)-Pybox
Prior to 2005, no enantioselective cross-couplings of P-hydride containing
electrophiles were known, although many enantioselective cross-couplings with aryl and
vinyl electrophiles had been reported.5 For example, in 1983, Hayashi and Kumada
3 Metal-catalyzed cross-coupling reactions of alkyl halides: (a) Frisch, A. C.; Beller, M. Angew. Chem., Int. Ed.
2005, 44, 674-688. (b) Netherton, M. R.; Fu, G. C. Adv. Synth. Catal. 2004, 346, 1525-1532.
4 Zhou, J.; Fu, G. C. J. Am. Chem. Soc. 2003, 125, 14726-14727.
5 Enantioselective cross-couplings of aryl and vinyl electrophiles: (a) Hayahi, T. In Comprehensive Asymmetric
Catalysis, Supplement 1; Jacobsen, E. N., Pfaltz, A., Yamamoto, H. Eds.: Springer-Verlag: Berlin, Heidelberg,
2004; Chapter 25. (b) Tietze, L. F.; Ila, H.; Bell, H. P. Chem. Rev. 2004, 104, 3453-3516. For a specific
demonstrated the use of NiCl2 with a valine-derived phosphine to couple vinyl bromide
fragments with benzylic Grignard nucleophiles in good enantioselectivities (83% ee, eq
1.3).5c
MgBr 0.5% NiCI 2  i -Pr
Me Br,, 0.5% (S)-Valphos M (1.3)
0 "C Me2N PPh2
rapidly 83% ee, 94% yield (S)-Valphos
epimerizing
We felt that expanding the scope of enantioselective cross-couplings to include 3-
hydride-bearing alkyl coupling partners could ultimately be a valuable step forward in the
methodology. In principle, it could be a highly convergent way to produce a wide variety of
optically enriched stereocenters containing C-C bonds. In pursuit of that goal, Zhou
obtained promising selectivities with the original Ni(cod) 2/Pybox system and racemic 1-
bromoethylbenzene electrophile (70% ee, eq 1.4).6 The reaction initially gave low yields of
product, but with recovery of racemic starting material, indicating that the reaction may be
exhibiting stereoconvergent product formation. This result marked the beginning of my
studies in cross-coupling chemistry.
r 4% Ni(cod)2  n-Bu r8% (s-Bu)-Pybox
Me BrZn-n-Bu r.t. Me + Me (1.4)
racemic 70% ee, 25% yield racemic
starting material
Concurrently with the studies of benzylic halides, Dr. Christian Fischer discovered
high selectivities in cross-couplings of a-bromoamides (eq 1.5). 7 This reaction was certainly
stereoconvergent (96% ee, 90% yield), and, if run to partial conversion, also gave racemic
example, see: (c) Hayashi, T., Konishi, M., Fukushima, M.; Kanehira, K.; Hioki, T.; Kumada, M. J. Org. Chem.
1983, 48, 2195-2202.6 Zhou, J. Ph. D. Thesis, Massachusetts Institute of Technology, Cambridge, MA, September 2005.
7 Fischer, C.; Fu, G. C. J. Am. Chem. Soc. 2005, 127, 4594-4595
recovered starting material. The catalyst is composed of commercially available ligands and
NiC12-glyme, which is more stable to heat and light and is less toxic than Ni(cod)2.
10% NiCI2*glyme
BnN Et BrZn-n-Hex 13% (R)-(i-Pr)-Pybox BnN EtEtly BrZn-n-Hex ( 0
Ph Br DMI/THF (7:1), 0 °C Ph n-Hex
racemic 96% ee, 90% yield
N
00
N N
i-Pr i-Pr
(R)-(i-Pr)-Pybox
(1.5)
1.2 Results and Discussion
Initial efforts to improve the yields and enantioselectivities of benzyl halide cross-
couplings gave limited success. As with the a-bromoamide system, a Ni(II)-source could be
incorporated, but we could not bolster enantioselectivities beyond moderate levels (75% ee,
eq 1.6).
On exploration of substrate scope (Table 1.2), we found that electronic perturbations
on the aryl ring did not improve selectivities (entries 1 and 2). Increased hindrance on the
aryl ring or on the alkyl chain gave much lower product yields (entries 3 and 4). However,
employing indane-based electrophiles resulted in higher enantioselectivities and yields of
product (92% ee, 80% yield; entry 6). Other fused-ring systems were less effective in terms
of both chemical yield and enantioselectivity.
r
S Me
racemic
Table 1.2. Early substrate screening.
4% NiBr 2(diglyme) n-Bu
8% (i-Pr)-Pybox
BrZn-n-Bu > Me
1.6 equiv DMA, r.t, 16-24 h
75% ee, 50% yield
(1.6)
entry substrate yield ee
r
1 60 40
Me
MeO
2
entry substrate yield ee
Br5 I 68 16
41 48
3 <5 -
Me
4 Me 8 64
7 10 33
8 9 42
K-
The optimized indane system (eq 1.7) gives high enantioselectivities across a range of
indane coupling reactions (Table 1.3). As in the a-bromoamide-based system, the nickel-
source and both enantiomers of ligand are commercially available. Additionally, the system
does not appear to be highly air- or moisture-sensitive. The final entries were set up in air
with untreated glassware, and the reaction vessels were purged with an inert gas (nitrogen or
argon) prior to the reaction initiation.
Table 1.3. Catalytic enantioselective Negishi reactions of racemic bromoindanes.a
10% NiBr2*diglyme
13% (S)-(i-Pr)-Pybox
BrZn-R DMA, 0 =C, 24 h
R1-X
1 Br
Br
3 NC,, IB
Br
c5 Me
Br
Br
6 7
8b
R2-ZnBr
BrZnl CN
BrZn " CIl
BrZn- "O
BrZn-n-Hex
BrZn Ph
BrZn-n-Bu
BrZn
BrZn/ N3O
a All data are the average of two experiments. b The coupling was
performed at room temperature.
Br
racemic
entry
R2
R( ' (1.7)
yield (%)
64
69
ee (%)
91
94
47 91
82 91
89 96
76 98
72 98
39 96
41 99
Organozinc reagents bearing a cyano, chloro, or acetal functional group cross-couple
with high enantioselectivities (entries 1-4), as do those with alkyl branching at the n-carbon
or with imines (entries 8 and 9), albeit with more modest chemical yield. Incorporation of a
second fused benzo-ring bolsters enantioselectivities further (entries 6-9). In those cases, we
may be benefiting from an enhanced substrate-ligand n-n interaction.
Although nickel-based cross-couplings of aryl and alkyl chlorides are known,8 we did
not observe the corresponding aryl- or alkyl-chloride coupling products in our system (entries
2-4). 1-Chloroindanes were suitable coupling partners in these systems (Figure 1.3). In
comparison with 1-chloroindane and 1-bromoethylbenzene, the open-chain 1-
chloroethylbenzene was repeatedly shown to give poor chemical yields and comparatively
low conversion (ca. 33% recovered starting material).
89% yield, 94% ee ca. 8% yield, 63% ee
Figure 1.3. Racemic benzylic chlorides, with yields and enantioselectivities resulting
from cross-coupling reactions with n-Bu-ZnBr (eq 1.6).
We demonstrated two chloroindane couplings under our finalized conditions (eq 1.7;
Table 1.4). As with the parent chloroindane system used in preliminary studies (Figure 1.3),
these chloroindane substrates coupled in comparable yield and enantioselectivity to their
bromoindane counterparts.
8 Nickel-based systems that cross-couple aryl chlorides: (a) Tamao, K.; Sumitani, K.; Kumada, M. J. Am. Chem.
Soc. 1972, 94, 4374-4376. (b) Wolfe, J. P.; Buchwald, S. L. J. Am. Chem. Soc. 1997, 119, 6054-6058. A
nickel-based system that cross-couples alkyl chlorides: (c) Gonzilez-Bobes, F.; Fu, G. C. J. Am. Chem. Soc.
2006, 128, 5360-5361.
Cl
Cb
Table 1.4. Final 1-chloroindane couplings.
entry R'-X R2-ZnBr yield (%) ee (%)
CI
1 BrZn CN 56 91
2 MeO BrZn OMe 61 932
Some electrophiles containing a 6,5-fused ring architecture were not suitable reaction
partners in our final system (Figure 1.4). cis-1,3-Dibromoindane (1.4) underwent full
conversion, but produced 68% indene side product under the reaction conditions, with no
other detectable products. The indene may arise from a decomposing benzylic radical
intermediate (see Section 1.3). Bromoindene (1.5) also underwent full conversion, producing
traces of product (<5% yield, <10% ee), with ca. 30% electrophile homocoupling side
products detected. Coumaranone 1.6 and oxindole 1.7 both gave low conversion, with no
detectable product.
Br Br
Csn0
Br
Me
1.4 1.5 1.6 1.7
Figure 1.4. Electrophiles with a 6,5-fused ring framework that perform inefficiently in
cross-coupling reactions.
It is notable in the above context that control reactions run in the presence of a full
equivalent of indene gave ca. 43% recovery of that indene, after the course of the reaction (eq
1.8). One explanation for the consumption of indene is its adventitious polymerization,
possibly mediated by nickel. 9
1.6 equiv Bu-ZnBr
10% NiBr 2*diglyme
13% (S)-(i-Pr)-Pybox
DMA, 0 °C
Bu
89% yield
95% ee
(1.8)
43% recovered
Figure 1.5 shows nucleophiles inefficient in bromoindane coupling systems. Poor
yields were observed with phenylzinc, benzylzinc, and cyclohexylzinc reagents.
Dimethylzinc did produce moderate amounts of product, but in decreased enantioselectivity.
Bn-ZnBr
< 5% yield
Ph-ZnBr Ph-Znl
12% yield, <10% ee 23% yield, <10% ee
ZnMe 2
50% yield, 77% ee
ZnPh2
5% yield, 38% ee
Figure 1.5. Organozinc nucleophiles that perform inefficiently in cross-coupling reactions.
Although our final system was highly enantioselective only in the case of indane
electrophiles, we found several instances in the literature where the method could be
employed in the formation of useful products. For example, compound 1.8 could be prepared
in high ee's and moderate yields in only two steps from commercially available starting
materials (eq 1.9).
9 For a review of nickel-catalyzed ethylene polymerization, including systems using oxazoline-based ligands,
see: Speiser, F.; Braunstein, P.; Saussine, L. Acc. Chem. Res. 2005, 38, 784-793.
1.0 equivracemic
Cy-Znl
<10% yield
Br Et
01-/6 Nimr2"uiglyme
13% (R)-(i-Pr)-PyboxBrZn-Et D (1.9)DMA, 0 °C
o
racemic 1.892% ee
56% yield
This compound had previously been used by Ligand Pharmaceuticals en route to
target LG 121071 (1.1; Scheme 1.1), the first orally active non-steroidal androgen receptor
agonist. 1' 0 Their route proceeded in a four-step sequence that generated the benzylic
stereocenter though a Cu-catalyzed hydrosilylation." The 5-membered ring was formed by
acid-mediated condensation, and then expanded to the 6-membered ring through a Beckman
rearrangement.
Scheme 1.1. Synthesis of LG 121071 by Ligand Pharmaceuticals (1.1).a
a CO 2Et b CO 2 Et c,d
propiophenone e, --k- -
86% ee, 83% yield
e,f
F3 6t EE
O h-j 9
H 1.1 H EtO2C F3 H N-OMs
LG 121071 1.9
a Reagents and conditions: (a) triethylphosphonoacetate, NaH; (b) (R)-p-tol-BINAP, CuCI, NaOt-Bu, PMHS; (c) NaOH; (d)
PPA; (e) NH 2 OH.HCI, KOH; (f) MsC1, TEA; (g) DIBAL-H; (h) HNO3, H2SO 4 ; (i) H2, Pd/C; (j) 1.9, ZnC12.
We also synthesized the enantioenriched compound (-)-1.10 in a five-step sequence,
wherein our coupling methodology was used twice to set the two stereocenters (Scheme 1.2).
o0 (a) Hamann, L. G.; Mani, N. S.; Davis, R. L.; Wang, X.-N.; Marschke, K. B.; Jones, T. K.; J. Med. Chem.
1999, 42, 210-212. (b) Mani, N. S.; Wu, M. Tetrahedron: Asymmetry 2000, 11, 4687-4691.
I1 Appella, D. H.; Moritani, Y.; Shintani, R.; Ferreira, E. M.; Buchwald, S. L. J. Am. Chem. Soc. 1999, 121,
9473-9474.
Scheme 1.2. Synthesis of enantioenriched dimethylindane (-)-1.10.
CH3Zni
1.6 equiv
10% NiBr2-diglyme
13% (S)-i-Pr-Pybox
-15 OC, 48 h, DMA
Me
0
67% yield, 90% ee
Me
Me(-)-1.10
85% yield, 94% ee
>30:1 trans:cis
1.6 eq CH3ZnI
10% NiBr2-diglyme
13% (S)-i-Pr-Pybox
-15 OC, 48 h, DMA
(a) NaBH 4, 97%;(b) PBr 3, 93%.
Me
Br
-2:1 trans:cis
This sequence also afforded us an opportunity to test whether the final methylation
was occurring under catalyst or substrate control. Thus, in eq 1.10, when the opposite
enantiomer of Pybox ligand was employed under otherwise identical conditions, we still
obtained ca. 30:1 selectivity favoring trans-(-)-1.10, indicating that the second stereocenter is
set under substrate control.
opposite enantiomer of ligand
I A eniiv MA7Znl
10% NiBr2-diglyme
13% (R)-i-Pr-Pybox
-15 OC, DMA, 48 h
Me
(1.10)
Br Me
(-)-1.10
-2:1 trans:cis (-)-1.1085% yield, 92% ee
>30:1 trans:cis
To our knowledge this was the first instance of an enantioselective preparation of
1.10. However, racemic 1.10 had previously been used by MacLeod in the syntheses of
trans-trikentrin Al2 and iso-trans-trikentrin B.13
12 Monahan, L. C.; MacLeod, J. K. Aust. J. Chem. 1990, 43, 329-337.
13 MacLeod, J. K.; Ward, A.; Willis, A. C. Aust. J. Chem. 1998, 51, 177-187.
r
racemic
20.0 mmole
The synthesis of trans-trikentrin A (Scheme 1.3) begins with Bu3SnH-mediated
radical ring-closure to produce the 6,5-fused core. After screening several reaction conditions,
it was discovered that alkaline W4 Raney nickel reduction gave the target trans-(+)-1.10
product in a 9:1 ratio versus cis-(±)-1.10. Friedel-Crafts acylation, followed by C-Haryl
nitrene insertion produced the trikentrin core, and subsequent saponification-decarboxylation
yielded the final natural product.
Scheme 1.3. Synthesis of (±)-trans-trikentrin A by MacLeod.a
Me
B a,b 
c
IMe 
(1!I *
0 HOMe
Me
d-f Et 
Me
9:1 trans:cis (not separated)
All other attempted reductions gave
predominantly cis-(±)-1.10, including
neutral W4 Raney Ni.
Me
u.uA u
trans-Trikentrin A
a Reagents and conditions: (a) allylmagnesium bromide; (b) Bu3SnH; (c) alkaline W4 Raney Ni, H2; (d) AcCI, AIC13; (e)
NaBH4; (f) H2, Pd/C; (g) dichloromethyl methyl ether, TiC14, then H20; (h) ethyl 2-azidoacetate, base; (i) toluene, reflux;
(j) KOH, 1,4-dioxane, reflux; (k) flash vacuum pyrolysis.
Iso-trans-trikentrin B (1.3) was also prepared from the intermediate (+)-1.10 (Scheme
1.4). This sequence proceeded first through installation of a MOM ether fragment, and then
indole formation through nitrene insertion. The MOM ether was eliminated with dimethyl
bromoborane, producing the final (E)-but-1-enyl side chain, and target 1.3.
j,kNo- i
e
Scheme 1.4. Synthesis of Iso-trans-trikentrin B by MacLeod.a
mOM Me
a-d n-Pr
Br M
Me
MOM Me
e,f n-Pr
E O Me
Et02C N3
Me MUM Me
(E)-but-l-enyl k n-Pr h-j
IH Me H Me
(±)-1.3 EtO 2C
Iso-trans-Trikentrn B
a Reagents and conditions: (a) butyryl chloride, AICI 3; (b) NaBH4; (c) n-BuLi, CBr4; (d) DMAP, DIPEA,
MOM-Cl; (e) n-BuLi, DMF; (f) ethyl azidoacetate, Nao, EtOH; (g) 135 OC; (h) DIBAL-H; (i) MnO2; (j)
RhCI(CO)(PPh),, DPPP; (k) BMe,Br.
We were also able to access an open-chain target (+)-1.11 in a two-step sequence,
albeit with more modest enantioselectivity (eq 1.11). This molecule had previously been used
by Takano in the syntheses of a series of natural products.
r10% NiBr2*diglyme
Ný Me BrZn ,/-NOBn 13% (R)-(i-PryPybox
DMA, 0 "C
racemic
Me
Me'
(+)-1.11
75% ee, 63% yield
Takano previously synthesized fragment (+)-1.11 through a 9-step sequence from
trans-2-butene-1,4-diol (Scheme 1.5).14 The route features a Sharpless asymmetric
epoxidation, base-mediated epoxide opening, and a Claisen rearrangement to set the benzylic
stereocenter. After deprotection and oxidation, they access aldehyde intermediate 1.12, which
is used to prepare three natural products: (+)-nuciferol, (+)-nuciferal, (+)-a-curcumene.
14 Takano, S.; Sugihara, T.; Samuzi, K.; Akiyama, M.; Ogasawara, K. Chem. Lett. 1989, 1781-1784. Previously,
(+)-1.11 had been synthesized in a 13-step route from mannitol: Takano, S.; Goto, E.; Ogasawara, K.
Tetrahedron Lett. 1982, 23, 5567-5570.
(1.11)
~··rr·
Scheme 1.5. Synthesis of three natural products from (+)-1.11, by Takano.a
OBn COBn Cl, , 0L O BnC I.. OBn
Li
••O2Et
p-tol
OEt
p-tol j
f OH d'e OBn
p-tol
g-i
- CHO
j,k
p-tol Me
1.12
1.12
1.12
I,m
n ON-
o
HO
Me
p-tol Me
(+)-nuciferol
CHO
Me
p-tol Me
(+)-nuciferal
Me
- Me
p-tol Me
(+)-a-cu rcu mene
a Reagents and conditions: (a) Sharpless AE; (b) PPh3, CC14; (c) n-BuLi; (d)p-tol-I, cat. PdC12(PPh3) 2, cat. Cul, TEA; (e)
LiAIH 4; (f) MeC(OEt)3, cat. pivalic acid; (g) cat. Hg(I)(OAc) 2, ethyl vinyl ether; (h) H2, Pd/C; (i) (PPh3)3RhC1; (j) H2, Pd/C;(k) Swern; (1) Ph3P=CHMe; (m) n-BuLi; CH20; (n) EtCH=Nt-Bu, LDA; H30'; (o) Ph3P=CH(i-Pr).
Recent Work
In 2008, Sestelo and Sarandeses reported a closely related Ni/pybox system that is
capable of coupling alkynylindium nucleophiles with benzylic bromides in good
enantioselectivities (eq 1.12).15
10% NiBr2.diglyme
In R) 13% (S)-(i-Pr)-Pybox
3 DMAITHF (1:1), r.t
0.40 equiv
Me
01 R
Within the Fu group, Sunghee Son reported a pybox-based system capable of
coupling allylic chloride substrates with organozinc reagents in high enantioselectivities (eq
1.13) in 2008.16 Other group members have observed excellent selectivities for Ni/pybox-
based systems that couple a-bromoketones and propargylic halide substrates.
R'N R3
R2a
racemic
BrZn-R
1.2 equiv
5.0% NiBr2*diglyme
5.5% (S)-BnCH 2-Pybox
4.0 equiv NaCI
DMA/DM F (1:1), -10 "C
R
RI' R3
R
2
(S)-BnCH 2-Pybox
In 2006, Dr. Francisco Gonzalez-Bobes reported that aminoalcohol ligands are
suitable components in systems that mediate the couplings of arylboronic acids and alkyl
halides (non-asymmetric).8c Soon thereafter, Dr. Bunnai Saito applied diamine ligands to
cross-couplings of alkyl-9-BBN nucleophiles, 17 and then he demonstrated asymmetric
couplings of 9-BBN nucleophiles with unactivated homobenzylic bromides (eq 1.14).18
's Caeiro, J.; Sestelo, J. P.; Sarandeses, L. A. Chem. Euro. J. 2008, 14, 741-746.
16 Son, S.; Fu, G. C. J. Am. Chem. Soc. 2008, 130, 2756-2757.
17 Saito, B.; Fu, G. C. J. Am. Chem. Soc. 2007, 129, 9602-9603.
's Saito, B.; Fu, G. C. J. Am. Chem. Soc. 2008, 130, 6694-6695.
r
Me
racemic
(1.12)
(1.13)
(9-BBN)-alkyll
1.5 equiv
10% Ni(cod)212% (R,R)-1.13
1.2 equiv KOt-Bu
2.0 equiv i-BuOH
dioxane, 5 "C or r.t.
Ar alkyI F3C CF3 (1.14)
alkylI
MeHN NHMe
(R,R)-1.13
Earlier in 2008, Drs. Xing Dai and Neil Strotman had demonstrated that diamine
ligands could also be used in asymmetric couplings of Hiyama couplings of a-bromoester
electrophiles (eq 1.15).19 Additionally, our group has obtained preliminary high selectivities
in couplings of a-bromoketones using Ni/bisoxazoline systems.
BHTO ,
Br
racemic
10% NiCI 2*glyme O
12% (S,S)-1.14 ) alkyl
2.0 equiv TBAT R1.3 equv dioxane, r.t.1.3 equiv
Ph Ph
MeHN NHMe
(S,S)-1.14
'9 Dai, X.; Strotman, N. A.; Fu, G. C. J. Am. Chem. Soc. 2008, 130, 3302-3303.
Arl'ý alkyl
Br
racemic
(1.15)
1.3 Mechanistic Discussion
In the two-year interim between the achiral secondary cross-coupling by Zhou and the
2005 reports of enantioselective couplings, the Vicic lab advanced a mechanistic hypothesis
for alkyl-alkyl cross-couplings.20
They initially believed, on the basis of stoichiometric control experiments, that the
active catalyst was an alkylated Ni(I) species (1.15), which was produced through ligand
exchange of the dialkylated Ni(II) precursor, along with concomitant expulsion of a free
methyl radical that homocouples in situ to form ethane (eq 1.16).
tpy
2 x (TMEDA)Ni"Me 2  t 2 x (tpy)Ni'-Me Me-Me
-TMEDA
(1.16)
1.15 tpy
Vicic went on to propose that the active catalytic cycle proceeded via a Ni(I)/Ni(II)
shuttle (Figure 1.6), wherein two free alkyl radical fragments were expelled during
successive steps, and that final C-C bond formation was a result of free radical coupling (eq
1.17), as opposed to classic reductive elimination. Vicic isolated complex 1.15, characterized
it by X-ray crystallography, and demonstrated its chemical competence as a catalyst for
alkyl-alkyl cross-coupling reactions.
20 Anderson, T. J.; Jones, G. D.; Vicic, D. A. J. Am. Chem. Soc. 2004, 126, 8100-8101.
[Zn 12]
[IZn-Me]
(tpy)Ni'-I
(tpy)Ni -Me
1.15
I-0
(tpy)Ni"-I
Me
Me*
Figure 1.6. The first mechanistic proposal regarding alkyl-alkyl cross-couplings by Vicic.
Me- .O -- Me-- (1.17)
In 2005, Vicic issued a revised mechanism, on the basis of updated stoichiometric
control experiments. 21 The revised mechanism is thought to initiate via ligand-initiated loss
of ethane, and then comproportionation of the resulting Ni(II) and Ni(0) species to generate
the proposed active catalyst, 1.15 (eq 1.18).
2 x (TMEDA)Ni"Me 2 2 x tpy LnNi'-Me LAliO
N Me
Me-Me
2 x (tpy)Nii-Me
1.15
2 x TMEDA
The revised catalytic cycle proceeds through a Ni(I)/Ni(III) shuttle, wherein the final
C-C bond is produced through a classic reductive elimination (Figure 1.7). This Ni(I)/(III)
cycle was evaluated computationally, and the mechanism was deemed feasible for primary
2 1 (a) Jones, G. D.; McFarland, C.; Anderson, T. J.; Vicic, D. A. Chem. Comm. 2005, 4211-4213. (b) Jones, G.
D.; Martin, J. L.; McFarland, C.; Allen, O. R.; Hall, R. E.; Haley, A. D.; Brandon, R. J.; Konovalova, T.;
Desrochers, P. J.; Pulay, P.; Vicic, D. A. J. Am. Chem. Soc. 2006, 128, 13175-13183.
(1.18)
alkyl halides, but less likely for secondary alkyl halides, due to an unfavorable reductive
elimination step.22'23
Me-ZnBr
(tpy)Ni'-I
(tpy)NillLMe I®
ICy
(tpy)Ni -Me
(tpy)NiLMe I
Figure 1. 7. The revised catalytic cycle by Vicic.
Both of these mechanisms propose that oxidative addition proceeds first through
radical formation at the formerly halogenated carbon, and then combination of alkyl radical
and metal center, to generate the Ni-C bond. This is notable in that it provides a rationale for
stereoconvergence, i.e., that a free alkyl radical, having a rapidly-inverting geometry, could
lose its stereoinformation during the oxidative addition step.
Kochi has studied oxidative additions of Ni(O) complexes into aryl halides (Figure
1.8).24 Through a fairly rigorous investigation, Kochi concluded that the Ni(O) species likely
forms a n-complex with the aryl halide (1.16), and then transfers a single electron into that
aryl halide, producing a close radical-ion pair (1.17). Then, C-X bond fragmentation and Ni-
Br bond formation occur, through either concerted or stepwise processes, resulting in a
neutral radical pair that undergoes collapse within a solvent cage to afford the Ni(II) adduct.
22 Lin, X.; Phillips, D. L. J. Org. Chem. 2008, 73, 3680-3688.
23 Kochi has proposed a Ni(I)/(III) cycles in the past for nickel-mediated aryl-aryl couplings: Tsou, T. T.; Kochi,
J. K. J. Am. Chem. Soc. 1979, 101, 7547-7560.
24 Tsou, T. T.; Kochi, J. K. J. Am. Chem. Soc. 1979, 101, 6319-6332
0
N ioL electron N ilL C-Br fragmentation BNi'Ln radical pair
Br transfer and Ni-Br formation Br collapse BrNL-Ph
solvent cage
1.16 1.17
Figure 1.8. The proposed mechanism for Ni(0) insertion into an Ar-X bond, by Kochi.
Although he did not undertake in-depth studies on the corresponding alkyl
electrophiles, Kochi speculates that those species are more likely to pre-coordinate to the
Ni(0) in an end-on l '-complex, and that electron transfer proceeds through an inner-sphere
route, as opposed to an 112 7c-complex with outer-sphere electron transfer as in the case of Ar-
X.
2 5
Our lab has also obtained other preliminary evidence, pointing to the possibility of
alkyl radical intermediates. In two nickel-based systems for Suzuki couplings of arylboronic
acids and alkyl electrophiles, we have observed that endo- and exo-2-bromonorbornane both
convert to the same exo-cross-coupling product, each in greater than 20:1 selectivity over the
endo-product (Figure 1.9).26,8c
B•lr Ni-based Ph
Suzuki couplings
H H
exo exoA B Ni-based Ph
Suzuki couplings
Br H
endo exo
Figure 1.9. Convergent product formation in Ni-based Suzuki cross-couplings.
Additionally, in a study of nickel/bipyridine-mediated Stille couplings of secondary
alkylbromides 1.18 and 1.19, we observe formation of the corresponding 5-exo-trig
cyclization products (1.20 and 1.21; eq 1.19), where the cis/trans ratios of cross-coupling
25 For a discussion on inner-sphere vs. outer-sphere electron transfer, see: Principles and Applications of
Organotransition Metal Chemistry Collman, J. P.; Hegedus, L. S.; Norton, J. R.; Finke, R. G., Eds.; University
Science Books: Sausalito, 1987; pp 308-309.26 Zhou, J.; Fu, G. C. J. Am. Chem. Soc. 2004, 126, 1340-1341.
products correlate with the ratios of previous radical cyclization studies of these substrates. 27
The same phenomenon was observed in nickel-mediated Suzuki couplings of arylboronic
acids and alkyl halides,8c and in a study by Cdrdenas of alkyl-alkyl Negishi cross-couplings. 28
,Br
X
1.18, X = CH21.19, X = O
10% NiCI215% 2,2'-bipyridine
CI3Sn-Ph u7.0 equiv KOt-Bu
f-RllBuHi-RBuOCH (7:3\
Another possible explanation for our observed stereoconvergence, apart from radical
formation during oxidative addition, is spontaneous in situ Ni-C bond homolysis. Ni-C bond
homolysis has long been discussed as a route to observed side products in cross-couplings,
and in 2003 Schofield and Halpern reported an empirical bond-dissociation energy for the
homolysis of Ni(tmc) species (AH = 19 kcal/mol; eq 1.20).29 This process was facile at room
temperature.
(tmc)Ni--Bn
spontaneous
homolysis
- ý (tmc)Ni l t  "Bn
recombination
BDE: 19±1 kcal/mol
-NH N
NH HN
tmc
(1.20)
27 Powell, D. A.; Maki, T.; Fu, G. C. J. Am. Chem. Soc. 2004, 127, 510-511.28 Cirdenas also observed instances of cyclopropyl ring-opening cross-coupling products: Phapale, V. B.;
Bufluel, E.; Garcia-Iglesias, M.; Cirdenas, D. J. Angew. Chem., Int. Ed. 2007, 46, 8790-8795.
29 Schofield, M. H.; Halpern, J. Inorg. Chim. Acta 2003, 345, 353-358.
1.19)
1.20, X = CH2; 67% (2:1 endo:exo)
1.21, X = 0; 57% (>20:1 endo:exo)
1.4 Conclusion
The first enantioselective cross-coupling reactions of racemic secondary benzylic
halides have been described, and the method was applied to the syntheses of intermediates
used by other groups in the generation of bioactive compounds. 30
30 Arp, F. O.; Fu, G. C. J Am. Chem. Soc. 2005, 127, 10482-10483.
1.5 Experimental Section
I. General
N,N-Dimethylacetamide (DMA; anhydrous in a Sure-Seal® bottle; Fluka),
NiBr2.diglyme (Aldrich), I-(i-Pr)-Pybox (Aldrich), (S)-(i-Pr)-Pybox (Fluka), and pyridine
(anhydrous in a Sure-Seal® bottle; Fluka) were used as received. CH 2C12 was dried by
passage through a neutral alumina column under argon pressure prior to use. All other
chemicals were reagent-grade and used as received.
Note: Although NiBr 2.diglyme and (i-Pr)-Pybox can be left in the air without any
impact on cross-coupling efficiency, we recommend that, for long-term storage, they be kept
under an inert atmosphere.
HPLC analyses were carried out on an Agilent 1100 Series system with Daicel
Chiralpak@ columns in hexanes/isopropanol mixtures. GC analyses were performed on a
Hewlett-Packard HP 6850 Series apparatus with a Chrompack capillary column 'CP Chirasil-
Dex CB' (25 m x 0.25 mm x 0.25 mm), unless otherwise noted.
II. Preparation of Substrates
The yields in this section have not been optimized.
NaBH 4 Reduction Procedure. A 250-mL round-bottomed flask was charged with
the indanone and a mixture of 1,2-dichloroethane/methanol (1:1; 50 mL). NaBH 4 (2 equiv)
was then added to the stirred mixture, and the resulting clear, colorless solution was allowed
to stir open to the air for 30 min. Then, the reaction mixture was transferred to a separatory
funnel with the aid of water (50 mL), and the aqueous layer was extracted with CH2C12 (3 x
50 mL). The combined organic layers were dried (Na2SO4) and concentrated under
vacuum to furnish the product as either a white solid or a clear, colorless oil.
5-Chloro-l-indanol [33781-38-3]. This compound was reduced according to the
Reduction Procedure using 5-chloro-l-indanone (2.08 g, 12.5 mmol) and NaBH 4 (946 mg,
25.0 mmol). The product was obtained as a white solid (2.01 g, 95%).
1H NMR (CDC13, 400 MHz): 8 7.33-7.20 (m, 1H), 7.23-7.20 (m, 2H), 5.20 (t, J= 6.0
Hz, 1H), 3.07-2.99 (m, 1H), 2.84-2.76 (m, 1H), 2.54-2.46 (m, 1H), 2.00-1.91 (m, 2H);
13C NMR (CDC13, 100 MHz): 8 145.3, 143.4, 134.0, 126.9, 125.3, 125.0, 75.7, 36.1,
29.6.
Me
6-Methyl-l-indanol [200425-63-4]. This compound was reduced according to the
Reduction Procedure using 6-methyl-l-indanone (0.989 g, 6.77 mmol) and NaBH 4 (500 mg,
13 mmol). The product was obtained as a clear, colorless oil (0.947 mg, 94%).
'H NMR (CDCl3, 400 MHz): 8 7.25 (s, 1H), 7.17-7.15 (m, 1H), 7.11-7.09 (m, 1H),
5.24-5.19 (m, 1H), 3.06-2.99 (m, 1H), 2.83-2.75 (m, 1H), 2.53-2.45 (m, 1H), 2.38 (s, 3H),
1.99-1.89 (m, 2H);
13C NMR (CDCl3, 100 MHz): 8 145.1, 140.2, 136.3, 129.1, 124.7, 124.6, 76.4, 36.2,
29.3, 21.2.
NI
5-Cyano-1-indanol [125114-88-7]. This compound was reduced according to the
Reduction Procedure using 5-cyano-1-indanone 31 (540 mg, 3.44 mmol) and NaBH 4 (260 mg,
6.87 mmol). The product was obtained as a white solid (498 mg, 91%).
1H NMR (CDCl3, 500 MHz): 8 7.55-7.51 (m, 3H), 5.31-5.26 (m, 1H), 3.10-3.04 (m,
1H), 2.89-2.83 (m, 1H), 2.60-2.53 (m, 1H), 2.09 (br s, 1H), 2.02-1.95 (m, 1H);
13C NMR (CDCl3, 125 MHz): 6 150.3, 144.1, 130.7, 128.4, 124.9, 119.1, 111.3, 75.5,
35.5, 29.4.
1-Benz[f]indanol [123332-18-3]. This compound was reduced according to the
Reduction Procedure using benz[f]indanone32 (499 mg, 2.74 mmol) and NaBH 4 (200 mg, 5.3
mmol). The product was obtained as a white solid (503 mg, 100%).
1H NMR (CDC13, 500 MHz): 8 7.87-7.84 (m, 2H), 7.81-7.79 (m, 1H), 7.70 (s, 1H),
31 Arnold, D. R.; Du, X.; Chen, J. Can. J. Chem. 1995, 73, 307-318.
32 (a) Becker, C. L.; McLaughlin, M. L. Synlett 1991, 642. (b) Jones, D. W.; Marmon, R. J. J. Chem. Soc.,
Perkin Trans. 1 1990, 3271-3275.
7.48-7.41 (m, 2H), 5.39 (dd, J= 6.0, 6.1 Hz, 1H), 3.26-3.19 (m, 1H), 3.02-2.94 (m, 1H),
2.60-2.52 (m, 1H), 2.09-2.01 (m, 1H), 1.81 (d, J= 6.6 Hz, 1H);
13C NMR (CDC13, 125 MHz): 6 144.2, 141.5, 133.9, 132.9, 128.1, 127.6, 125.8,
125.2, 122.9, 122.6, 75.9, 36.7, 29.3.
H
MeO
6-Methoxy-l-indanol [3469-09-8]. This compound was reduced according to the
Reduction Procedure using 6-methoxy-1-indanone (2.23 g, 13.7 mmol) and NaBH 4 (1.04 g,
27.5 mmol). The product was obtained as a white solid (2.18 g, 97%).
1H NMR (CDC13, 500 MHz): 6 7.15 (d, J= 8.2 Hz, 1H), 6.97 (d, J= 2.4 Hz, 1H),
6.83 (dd, J= 2.5, 8.3 Hz, 1H), 5.22-5.21 (m, 1H), 3.82 (s, 3H), 3.02-2.95 (m, 1H), 2.80-2.72
(m, 1H), 2.57-2.48 (m, 1H), 1.99-1.91 (m, 1H), 1.81 (br s, 1H).
13C NMR (CDC13, 125 MHz): 8 159.0, 146.3, 135.0, 125.5, 115.0, 108.7, 76.6, 55.5,
36.6, 28.9.
PBr 3/PCI3 Halogenation Procedure. A dry 250-mL round-bottomed flask was
charged with the benzylic alcohol and then placed under a nitrogen atmosphere. Dry CH2C12
(- 50 mL) and dry pyridine (0.1 mL) were added, and then the reaction mixture was cooled to
-10 TC in an iso-propanol/ice bath. PBr3 (0.5 equiv) was dissolved separately in dry CH 2C12
(5 mL), and the resulting solution was added portionwise over a period of 10 min to the
solution of the alcohol. The mixture was allowed to stir for an additional 20 min, and then
the solution was transferred to a separatory funnel with the aid of 5% aqueous Na2CO 3 (50
mL) and extracted with CH 2C12 (3 x 50 mL). The combined organic layers were dried
(Na2SO 4) and concentrated under vacuum to give a yellow residue that was taken up in ether
(10 mL), passed through an Acrodisc®, and then concentrated, furnishing the desired
benzylic halide as either a clear, colorless oil or a white solid.
Br
C"
1-Bromo-5-chloroindane [192702-71-9]. This compound was prepared according to
the Halogenation Procedure using 5-chloro-1-indanol (2.01 g, 11.9 mmol), PBr3 (1.61 g, 5.95
mmol), and dry pyridine (0.1 mL). The product was obtained as a clear, light-pink oil (1.57 g,
57%).
'H NMR (CDC13, 500 MHz): 8 7.36-7.34 (m, 1H), 7.26 (s, 1H), 7.23-7.21 (m, 1H),
5.54 (dd, J= 2.2, 6.2 Hz, 1H), 3.25-3.23 (m, 1H), 2.88 (ddd, J= 2.6, 7.6, 16.3 Hz, 1H), 2.67-
2.59 (m, 1H), 2.58-2.50 (m, 1H);
13C NMR (CDCl3, 125 MHz): 6 145.5, 142.4, 134.7, 127.4, 126.1, 125.0, 53.4, 37.8,
30.5.
Br
Me
6-Methyl-l-bromoindane. This compound was prepared according to the
Halogenation Procedure using 6-methyl-l-indanol (0.920 g, 6.21 mmol), PBr 3 (870 mg, 3.2
mmol), and dry pyridine (0.1 mL). The product was obtained as a clear, colorless oil (1.03 g,
79%).
H NMR (CDC13, 400 MHz): 8 7.26 (s, 1H), 7.18-7.16 (m, 1H), 7.10-7.08 (m, 1H),
5.58 (dd, J= 2.3, 6.0 Hz, 1H), 3.20-3.12 (m, 1H), 2.89-2.82 (m, 1H), 2.64-2.50 (m, 2H), 2.37
(s, 3H);
13C NMR (CDC13, 100 MHz): 8 143.9, 140.6, 136.8, 129.9, 125.5, 124.5, 55.2, 37.9,
30.6, 21.2;
IR (film) 3011, 2976, 2945, 2916, 2846, 1493, 1442, 1184, 1162, 861, 812 cmi;
EIMS (70 eV) m/z: M +210, 208, 130, 115, 102, 89.
Br
1-Bromoindane [24373-98-6]. This compound was prepared according to the
Halogenation Procedure using 1-indanol (4.00 g, 29.8 mmol), PBr3 (4.03 g, 14.9 mmol), and
dry pyridine (0.1 mL). The product was obtained as a clear, colorless oil (5.47 g, 93%) that
contained -5% 1-indene according to 'H NMR.
'H NMR (CDC13, 500 MHz): 8 7.48-7.46 (m, 1H), 7.31-7.25 (m, 3H), 5.63 (dd, J=
2.4, 6.1 Hz, 1H), 3.27-3.19 (m, 1H), 2.96-2.89 (m, 1H), 2.67-2.53 (m, 2H);
'
3C NMR (CDC13, 125 MHz): 8 143.8, 143.6, 128.8, 127.1, 125.1, 124.8, 54.8, 37.7,
30.6.
Br
NC
1-Bromo-5-cyanoindane [475475-78-6]. This compound was prepared according to
the Halogenation Procedure using 5-cyano-l-indanol (498 mg, 3.13 mmol), PBr3 (425 mg,
1.57 mmol), and dry pyridine (0.1 mL). The product was obtained as a white solid (472 mg,
68%).
'H NMR (CDCl 3, 500 MHz): 8 7.56-7.51 (m, 3H), 5.51 (dd, J= 2.5, 6.5 Hz, 1H),
3.25-3.17 (m, 1H), 2.98-2.92 (m, 1H), 2.70-2.60 (m, 1H), 2.58-2.51 (m, 1H);
13C NMR (CDCl3, 125 MHz): 8 148.8, 144.3, 131.0, 128.4, 125.7, 118.7, 112.1, 51.8,
37.1, 30.2.
Bromoacenaphthene [24171-73-1]. This compound was prepared according to the
Halogenation Procedure using 1-acenaphthenol (1.00 g, 5.88 mmol), PBr3 (796 mg, 2.94
mmol), and dry pyridine (0.1 mL). The resulting yellow solid was further purified by
recrystallization from benzene/hexanes (1:5; 6 mL) to give the desired product as a lustrous,
white crystalline solid (0.925 g, 68%).
1H NMR (CDC13, 500 MHz): 8 7.77-7.75 (m, 1H), 7.70-7.69 (m, 1H), 7.60-7.56 (m,
2H), 7.55-7.52 (m, 1H), 7.36-7.34 (m, 1H), 5.95 (dd, J= 2.1, 7.3 Hz, IH), 4.14 (dd, J= 7.3,
18.4 Hz, 1H), 3.84 (d, J= 18.5 Hz, 1H);
'
3C NMR (CDC13, 125 MHz): 8 144.7, 140.6, 136.5, 131.1, 128.3, 128.2, 125.2,
123.1, 121.6, 120.0, 47.6, 43.6.
Br
Bromobenz[f]indane [146000-51-3]. This compound was prepared according to the
Halogenation Procedure using 1-benz[f]indanol (503 mg, 2.73 mmol), PBr3 (371 mg, 1.37
mmol), and dry pyridine (0.1 mL). The product was obtained as a white solid (598 mg, 89%).
'H NMR (CDC13, 500 MHz): 8 7.92 (s, 1H), 7.85-7.79 (m, 2H), 7.72 (s, 1H), 7.49-
7.42 (m, 2H), 5.74 (dd, J= 3.1, 5.1 Hz, 1H), 3.42-3.33 (m, 1H), 3.10-3.03 (m, 1H), 2.65-2.59
(m, 2H);
'
3C NMR (CDC13, 125 MHz): 8 142.8, 141.3, 134.0, 132.9, 128.3, 127.6, 126.3,
125.4, 124.0, 123.0, 53.9, 38.4, 30.1.
Me
1-(l-Bromoethyl)-4-methylbenzene [69150-78-3]. This compound was prepared
according to the Halogenation Procedure using 1-(4-methylphenyl)ethanol (1.50 g, 11.0
mmol), PBr3 (1.49 g, 5.50 mmol), and dry pyridine (0.1 mL). The product was obtained as a
clear, colorless oil (1.93 g, 88%).
1H NMR (CDC13, 400 MHz): 6 7.35 (d, J= 8.2 Hz, 2H), 7.16 (d, J= 7.9 Hz, 2H),
5.23 (q, J= 6.9 Hz, 1H), 2.35 (s, 3H), 2.05 (d, J= 6.9 Hz, 3H);
13C NMR (CDC13, 100 MHz): 6 140.3, 138.3, 129.3, 126.7, 49.8, 26.8, 21.2.
CI
Chloroindane [35275-62-8]. This compound was prepared according to the
Halogenation Procedure using 1-indanol (1.00 g, 7.45 mmol), PC13 (512 mg, 3.73 mmol), and
dry pyridine (0.1 mL). The product was obtained as a clear, colorless oil (0.866 g, 76%).
H NMR (CDC13, 500 MHz): 8 7.44-7.43 (m, 1H), 7.29-7.24 (m, 3H), 5.44 (dd, J
3.3, 6.7 Hz, 1H), 3.23-3.16 (m, 1H), 2.93-2.87 (m, 1H), 2.64-2.57 (m, 1H), 2.42-2.36 (m,
1H);
13 C NMR (CDC13, 125 MHz): 8 143.3, 143.0, 128.8, 127.0, 124.9, 124.7, 63.2, 36.9,
30.3.
MeO
I-
Chloro-6-methoxyindane [128226-43-7]. This compound was prepared according
to the Halogenation Procedure using 6-methoxy-1-indanol (651 mg, 3.96 mmol), PC13 (272
mg, 1.98 mmol), and dry pyridine (0.1 mL). The product was obtained as a clear, colorless
oil (510 mg, 70%).
1H NMR (CDC13, 500 MHz): 8 7.18-7.16 (m, 1H), 6.97-6.96 (m, 1H), 6.86-6.84 (m,
1H), 5.40 (dd, J= 3.4, 6.7 Hz, 1H), 3.82 (s, 3H), 3.15-3.09 (m, 1H), 2.87-2.81 (m, 1H), 2.67-
2.59 (m, 1H), 2.42-2.37 (m, 1H);
13C NMR (CDC13, 125 MHz): 8 159.1, 144.3, 135.2, 125.4, 115.8, 109.3, 63.4, 55.5,
37.4, 29.5.
Preparation of the Organozinec Reagents.33 A 25-mL Schlenck tube was charged
with zinc powder (1.47 g, 22.5 mmol) and heated to 70 oC under high vacuum for 30 min.
After back-filling with argon, iodine (0.19 g, 0.75 mmol) and DMA (to give a total volume of
10 mL) were added, and the resulting heterogeneous red mixture was allowed to stir until the
red color of the iodine had faded (typically 1-2 min). Then, the alkyl halide (16 mmol;
freshly distilled) was added. The colorless reaction mixture was allowed to stir for 12 h at
70 'C (exceptions: For Mel, the reaction was not heated; for cyclohexylmethylbromide, the
reaction was heated for 24 h at 85 'C; for EtBr the reaction was not heated and it was
allowed to stir for 48 h), then the mixture was allowed to cool to room temperature (the
disappearance of the starting material and the formation of the organozinc reagent can readily
be monitored by no-D NMR). The gray solution (-~1.6 M) was passed through an Acrodisc®
and stored under argon in a dry container with a pierceable septum.
These organozinc solutions can be stored at room temperature for several weeks
without deterioration.
33 This is based on the work of Huo: Huo, S. Org. Lett. 2003, 5, 423-425.
III. Negishi Cross-Coupling Reactions
General Procedure. In the air (no special precautions are necessary), a 4-mL glass
vial was charged with NiBr 2.diglyme (35.3 mg, 0.100 mmol), I-(i-Pr)-Pybox (39.2 mg, 0.130
mmol), and the benzylic halide (1.00 mmol). The vial was fitted with a septum cap and
purged with argon for 15 min. DMA (1.75 mL) was then added, and the resulting orange
mixture was allowed to equilibrate for 15 min under argon in an isopropanol bath cooled to 0
oC. The organozinc solution (-1.6 M in DMA; 1.0 mL, 1.6 mmol) was then added in a single
portion to the heterogeneous mixture, which rapidly became a clear, red-brown solution. The
reaction mixture was allowed to stir for 24 h at 0 oC. Then, the excess organozinc reagent
was quenched by the addition of ethanol (0.3 mL), and the resulting orange liquid was
purified directly by flash chromatography.
The ee was determined on Chirasil® DEX-CB or Daicel Chiralpak® columns.
The second runs were conducted with (S)-(i-Pr)-Pybox.
"CN
4-Indan-1-yl-butyronitrile (Table 1.3, entry 1). This compound was prepared
according to the General Procedure using (+)-l-bromoindane (197 mg, 1.00 mmol) and the
appropriate organozinc reagent (-1.6 M in DMA; 1.0 mL, 1.6 mmol). After purification by
column chromatography (6% EtOAc in hexanes), the title compound was isolated as a clear,
colorless oil.
1st run: 122 mg (66%; 92% ee); 2nd run: 116 mg (63%; 91% ee).
The ee's were determined via HPLC on an OD-H column (eluent: 1.0% isopropanol
in hexanes; flow rate: 1.0 mL/min) with tr (major): 20.8 min, t, (minor): 26.7 min.
[a]23D = -4.2 (c = 0.56, CHC13);
'H NMR (CDC13, 500 MHz): 8 7.25-7.23 (m, 1H), 7.21-7.17 (m, 3H), 3.17-3.15 (m,
1H), 2.95-2.93 (m, 1H), 2.90-2.85 (m, 1H), 2.41 (t, J= 7.0 Hz, 2H), 2.34-2.29 (m, 1H), 2.02-
1.98 (m, 1H), 1.83-1.58 (m, 4H);
13C NMR (CDC13, 125 MHz): 8 146.3, 143.8, 126.6, 126.2, 124.6, 123.5, 119.7, 44.0,
33.9, 31.8, 31.3, 23.5, 17.4;
IR (film) 3068, 3019, 2942, 2850, 2245, 1477, 1457, 1424, 747 cm';
EIMS (70 eV) m/z: M ÷ 185, 117, 91.
GCI
1-(6-Chlorohexyl)indane (Table 1.3, entry 2) [361541-11-9]. This compound was
prepared according to the General Procedure using (+)-l-bromoindane (197 mg, 1.00 mmol)
and the appropriate organozinc reagent (-1.6 M in DMA; 1.0 mL, 1.6 mmol). After
purification by column chromatography (pentane), the title compound was isolated as a clear,
colorless oil.
1st run: 163 mg (69%; 95% ee); 2nd run: 166 mg (70%; 94% ee).
The ee's were determined via HPLC on an OD-H column (eluent: 0.5% isopropanol
in hexanes; flow rate: 1.0 mL/min) with tr (major): 5.1 min, t, (minor): 5.6 min.
[a]23D = -11 (c = 0.79, CHCl3);
'H NMR (CDC13, 500 MHz): 8 7.24-7.14 (m, 4H), 3.56 (t, J= 6.7 Hz, 2H), 3.13-3.07
(m, 1H), 2.93 (ddd, J= 4.6, 8.5, 15.5 Hz, 1H), 2.87-2.81 (m, 1H), 2.32-2.26 (m, 1H), 1.88-
1.78 (m, 3H), 1.72-1.64 (m, 1H), 1.51-1.34 (m, 7H);
13C NMR (CDC13, 125 MHz): 8 147.6, 144.0, 126.2, 125.9, 124.4, 123.5, 45.2, 44.8,
34.9, 32.6, 32.1, 31.4, 29.1, 27.5, 26.9;
IR (film) 2930, 2852, 2359, 2336, 1698, 1648, 1558,1474, 1457, 1312, 752 cm';
EIMS (70 eV) m/z: M+ 236, 128, 117, 91.
IkIf•
IM,
1-(6-Chlorohexyl)indan-5-carbonitrile (Table 1.3, entry 3). This compound was
prepared according to the General Procedure using (+)-l-bromo-5-cyanoindane (222 mg,
1.00 mmol) and the appropriate organozinc reagent (-1.6 M in DMA; 1.0 mL, 1.6 mmol).
After purification by column chromatography (5% EtOAc in hexanes), the title compound
was isolated as a clear, colorless oil.
1st run: 128 mg (49%; 91% ee); 2nd run: 120 mg (46%; 90% ee).
The ee's were determined via HPLC on an AS-H column (eluent: 0.5% isopropanol
in hexanes; flow rate: 1.0 mL/min) with tr (major): 24.6 min, t, (minor): 28.1 min.
[a] 23D = +3.8 (c = 0.54, CHCl3);
'H NMR (CDCl3, 500 MHz): 8 7.47-7.25 (m, 2H), 7.25 (s, 1H), 3.54 (t, J= 6.7 Hz,
2H), 3.15-3.07 (m, 1H), 2.98-2.92 (m, 1H), 2.88-2.82 (m, 1H), 2.35-2.28 (m, 1H), 1.85-1.68
(m, 4H), 1.49-1.34 (m, 7H);
13C NMR (CDC13, 125 MHz): 6 153.4, 145.2, 130.4, 128.0, 124.3, 119.6, 109.8, 45.1,
45.1, 34.4, 32.5, 31.8, 31.1, 29.0, 27.3, 26.8;
IR (film) 3380, 2930, 2856, 2226, 1608, 1483, 1442, 827 cm 1';
EIMS (70 eV) m/z: M+ 261, 142, 115.
2-[2-(5-Chloroindan-1-yl)ethyl]-[1,3]dioxolane (Table 1.3, entry 4). This
compound was prepared according to the General Procedure using (±)-1-bromo-5-
chloroindane (232 mg, 1.00 mmol) and the appropriate organozinc reagent (-1.6 M in DMA;
1.0 mL, 1.6 mmol). After purification by column chromatography (8% EtOAc in hexanes),
the title compound was isolated as a clear, colorless oil.
1st run: 210 mg (83%; 91% ee); 2 nd run: 204 mg (81%; 91% ee).
The ee's were determined via HPLC on an OD-H column (eluent: 0.5% isopropanol
in hexanes; flow rate: 1.0 mL/min) with t, (major): 16.3 min, t, (minor): 15.3 min.
[a]23D = -2.0 (c = 0.83, CHCl3);
1H NMR (CDC13, 500 MHz): 8 7.18 (s, 1H), 7.12 (s, 2H), 4.90 (t, J= 4.7 Hz, 1H),
4.00-3.98 (m, 2H), 3.89-3.86 (m, 2H), 3.13-3.07 (m, 1H), 2.91 (ddd, J= 4.8, 8.6, 15.9 Hz,
1H), 2.85-2.78 (m, 1H), 2.34-2.27 (m, 1H), 1.98-1.92 (m, 1H), 1.82-1.67 (m, 3H), 1.58-1.49
(m, 1 H);
13C NMR (CDCl3, 125 MHz): 6 146.0, 145.6, 131.9, 126.1, 124.6, 124.6, 104.5, 64.9,
44.0, 32.1, 31.7, 31.2, 28.9;
IR (film) 2949, 2883, 2860, 1600, 1474, 1410, 1131, 1034, 875, 813 cm';
EIMS (70 eV) m/z: M+ 252, 190, 164, 151, 129, 115, 73, 45.
e
Me
1-Hexyl-6-methylindane (Table 1.3, entry 5). This compound was prepared
according to the General Procedure using (A)-6-methyl-1-bromoindane (211 mg, 1.00 mmol)
and the appropriate organozinc reagent (-1.6 M in DMA; 1.0 mL, 1.6 mmol). After
purification by column chromatography (pentane), the title compound was isolated as a clear,
colorless oil.
1st run: 188 mg (87%; 96% ee); 2nd run: 196 mg (91%; 95% ee).
The ee's were determined by chiral GC: CP Chirasil-Dex CB, t, (major) 33.8 min, tr
(minor) 33.3 min; heating program: 125 "C; flow: 1.0 mL/min.
[a] 23D = -23 (c = 0.99, CHC13);
'H NMR (CDC13, 500 MHz): 8 7.13-7.11 (m, 1H), 7.04 (s, 1H), 6.99-6.97 (m, 1H),
3.10-3.05 (m, 1H), 2.93-2.75 (m, 2H), 2.36 (s, 3H), 2.33-2.25 (m, 1H), 1.89-1.82 (m, 1H),
1.72-1.63 (m, 1H), 1.48-1.29 (m, 9H), 0.93 (t, J= 6.8 Hz, 3H);
13C NMR (CDCl 3, 125 MHz): 8 148.1, 141.0, 135.5, 126.9, 124.3, 124.1, 44.8, 35.1,
32.5, 31.9, 31.0, 29.6, 27.7, 22.7, 21.4, 14.2;
IR (film) 3005, 2954, 2924, 2854, 1614, 1491, 1377, 1457, 877, 808, 723 cm ';
EIMS (70 eV) m/z: M + 216, 131, 91.
Ph
1-(3-Phenylpropyl)benz[findane (entry 1.3, entry 6). This compound was
prepared according to the General Procedure using (±)-l-bromobenz[f]indane (247 mg, 1.00
mmol) and the appropriate organozinc reagent (-1.6 M in DMA; 1.0 mL, 1.6 mmol). After
purification by column chromatography (2% EtOAc in hexanes), the title compound was
isolated as a white solid.
1st run: 211 mg (74%; 97% ee); 2nd run: 227 mg (79%; 99% ee).
The ee's were determined via HPLC on an OD-H column (eluent: 2% isopropanol in
hexanes; flow rate: 0.9 mL/min) with tr (major): 11.8 min, t, (minor): 10.8 min.
[a]23D = -47 (c = 0.80, CHC13);
'H NMR (CDC13, 500 MHz): 6 7.79-7.75 (m, 2H), 7.65 (s, 1H), 7.59 (s, 1H), 7.41-
7.37 (m, 2H), 7.33-7.30 (m, 2H), 7.24-7.20 (m, 3H), 3.28-3.23 (m, 1H), 3.10-3.04 (m, 1H),
3.01-2.94 (m, 1H), 2.78-2.66 (m, 2H), 2.40-2.34 (m, 1H), 2.08-2.01 (m, 1H), 1.86-1.71 (m,
3H), 1.61-1.54 (m, 1H);
13C NMR (CDC13, 125 MHz): 8 146.8, 143.3, 142.6, 133.0, 132.8, 128.4, 128.3,
127.6, 127.4, 125.7, 124.9, 124.8, 122.1, 121.4, 44.3, 36.2, 34.4, 32.8, 31.1, 29.5;
IR (CDC13 solution) 3155, 2984, 2254, 1794, 1647, 1472, 1382, 911 cm-1;
EIMS (70 eV) m/z: M+ 286, 167, 152, 91;
mp 117-119 'C.
1-Butylacenaphthene (Table 1.3, entry 7). This compound was prepared according
to the General Procedure using (+)-1-bromoacenaphthene (233 mg, 1.00 mmol) and the
appropriate organozinc reagent (-1.6 M in DMA; 1.0 mL, 1.6 mmol). After purification by
column chromatography (pentane), the title compound was isolated as a clear, colorless oil.
1st run: 148 mg (70%; 98% ee); 2nd run: 154 mg (73%; 98% ee).
The ee's were determined via HPLC on an OD-H column (eluent: 0.5% isopropanol
in hexanes; flow rate: 0.7 mL/min) with tr (major): 7.6 min, tr (minor): 8.9 min.
[a] 23D = -15 (c = 0.80, CHC13);
'H NMR (CDC13, 500 MHz): 6 7.63-7.61 (m, 2H), 7.50-7.45 (m, 2H), 7.30-7.27 (m,
2H), 3.71-3.66 (m, 1H), 3.59 (dd, J= 8.0, 17.1 Hz, 1H), 3.08 (dd, J= 3.4, 17.1 Hz, 1H),
1.99-1.92 (m, 1H), 1.69-1.61 (m, 1H), 1.54-1.39 (m, 4H), 0.96 (t, J= 7.1 Hz, 3H);
13C NMR (CDCl 3, 125 MHz): 8 149.8, 144.8, 138.6, 131.4, 127.8, 127.7, 122.5,
122.2, 119.1, 118.7, 43.4, 37.5, 36.3, 29.7, 22.9, 14.1;
IR (film) 3036, 2955, 2926, 2856, 1604, 1496, 1466, 1368, 796, 774 cm-;
EIMS (70 eV) m/z: M' 210, 167, 153.
1-Cyclohexylmethyl-acenaphthene (Table 1.3, entry 8). This compound was
prepared according to the General Procedure at room temperature using (±)-1-bromo-
acenaphthene (233 mg, 1.00 mmol) and the appropriate organozinc reagent (-1.6 M in DMA;
1.0 mL, 1.6 mmol). After purification by column chromatography (pentane), the title
compound was isolated as a clear, colorless oil.
1st run: 96 mg (38%; 97% ee); 2 nd run: 98 mg (39%; 96% ee).
The ee's were determined via HPLC on an OD-H column (eluent: 1.0% isopropanol
in hexanes; flow rate: 0.7 mL/min) with tr (major): 8.6 min, tr (minor): 9.7 min.
[a]23D = -24 (c = 0.60, CHC13);
1H NMR (CDC13, 500 MHz): 8 7.62-7.61 (m, 2H), 7.49-7.44 (m, 2H), 7.28-7.25 (m,
2H), 3.81-3.76 (m, 1H), 3.59 (dd, J= 7.9, 17.2 Hz, 1H), 3.05 (dd, J= 3.2, 17.5 Hz, 1H),
1.96-1.93 (m, 1H), 1.82-1.72 (m, 5H), 1.66-1.50 (m, 2H), 1.38-1.19 (m, 3H), 1.10-0.99 (m,
2H);
13C NMR (CDC13, 125 MHz): 8 150.3, 144.8, 138.5, 131.5, 127.8, 127.7, 122.4,
122.2, 119.1, 118.7, 45.0, 40.6, 38.0, 35.9, 34.2, 32.9, 26.7, 26.5, 26.4;
IR (film) 3036, 2920, 2849, 1604, 1448, 1369, 795, 771 cm- ;
EIMS (70 eV) m/z: M+ 250, 165, 153, 55.
2-(4-Acenaphthen-1-yl-butyl)isoindole-1,3-dione (Table 1.3, entry 9). This
compound was prepared according to the General Procedure at room temperature using
(±)-l-bromoacenaphthene (233 mg, 1.00 mmol), 0.75 mL (rather than 1.75 mL) of DMA,
and the appropriate organozinc reagent (~0.80 M in DMA; 2.0 mL, 1.6 mmol). After
purification by column chromatography (12% EtOAc in hexanes), the title compound was
isolated as a clear, colorless oil, which solidified after a period of time.
1st run: 138 mg (39%; 99% ee); 2 nd run: 151 mg (42%; 99% ee).
The ee's were determined via HPLC on an OD-H column (eluent: 10% isopropanol in
hexanes; flow rate: 1.0 mL/min) with tr (major): 18.0 min, tr (minor): 16.9 min.
[a]23D = +6.0 (c = 0.45, CHCl3);
'H NMR (CDC13, 500 MHz): 8 7.87-7.85 (m, 2H), 7.74-7.72 (m, 2H), 7.61-7.59 (m,
2H), 7.47-7.43 (m, 2H), 7.27-7.26 (m, 2H), 3.73 (t, J= 7.3 Hz, 2H), 3.70-3.65 (m, 1H), 3.58
(dd, J= 8.0, 17.1 Hz, 1H), 3.05 (dd, J= 3.4, 17.1 Hz, 1H), 2.02-1.95 (m, 1H), 1.83-1.65 (m,
3H), 1.61-1.52 (m, 2H);
13C NMR (CDC13, 125 MHz): 8 168.4, 149.3, 144.6, 138.5, 133.9, 132.1, 131.4,
127.8, 127.7, 123.2, 122.6, 122.2, 119.1, 118.8, 43.3, 37.9, 37.5, 36.1, 28.8, 24.8;
IR (CDC13 solution) 3155, 2936, 2254, 1772, 1712, 1469, 1398, 1096 cm';
EIMS (70 eV) m/z: M + 355, 207, 165, 153, 133, 104, 71;
mp 80-83 oC.
CN
4-Indan-1-yl-butyronitrile (Table 1.4, entry 1). This compound was prepared
(using (+)-1-chloroindane (153 mg, 1.00 mmol)) and assayed as described for Table 1.3,
entry 1.
1st run: 99 mg (53%; 91% ee); 2 nd run: 108 mg (58%; 91% ee).
[] 23D = -4.4 (c = 0.54, CHC13).
Me
4-(6-Methoxy-indan-1-yl)butyric acid methyl ester (Table 1.4, entry 2) [102062-
86-2]. This compound was prepared according to the General Procedure using (+)-1-chloro-
6-methoxyindane (182 mg, 1.00 mmol) and the appropriate organozinc reagent (-1.6 M in
DMA; 1.0 mL, 1.6 mmol). After purification by column chromatography (4% - 6% EtOAc
in hexanes), the title compound was isolated as a clear, colorless oil.
1st run: 152 mg (61%; 94% ee); 2nd run: 153 mg (62%; 92% ee).
The ee's were determined via HPLC on an OD-H column (eluent: 0.75% isopropanol
in hexanes; flow rate: 1.0 mL/min) with tr (major): 17.2 min, tr (minor): 20.1 min.
[a]23D = -19 (c = 0.60, CHC13);
IH NMR (CDC13, 400 MHz): 6 7.13-7.11 (m, 1H), 6.75-6.70 (m, 2H), 3.80 (s, 3H),
3.69 (s, 3H), 3.12-3.05 (m, 1H), 2.89-2.73 (m, 2H), 2.42-2.26 (m, 3H), 1.90-1.65 (m, 4H),
1.48-1.39 (m, 1H);
13C NMR (CDC13, 100 MHz): 8 174.1, 158.6, 148.7, 135.9, 124.8, 111.9, 109.3, 55.4,
51.5, 44.7, 34.4, 34.2, 32.5, 30.5, 23.0;
IR (film) 2948, 2846, 1738, 1608, 1583, 1490, 1436, 1246, 1169, 1034, 808 cm-1;
EIMS (70 eV) m/z: M+ 248, 160, 147, 115, 91.
r
3-Bromo-1-indanone [40774-41-21. A dry 500-mL round-bottomed flask was
charged with 1-indanone (11.0 g, 83.2 mmol), N-bromosuccinimide (17.8 g, 100 mmol), and
benzoyl peroxide (1.0 g, 4.1 mmol), and then it was equipped with a reflux condenser and
placed under a nitrogen atmosphere. Dry benzene (200 mL) was added, and the solution was
brought to reflux. After 2 h at reflux, the heterogeneous red mixture was allowed to cool to
room temperature, and then it was concentrated under vacuum, and passed through Florisil
(eluent: benzene). The resulting orange solution was concentrated and stirred under high
vacuum for 2 h. Then, hexanes (100 mL) were added, and the resulting mixture was stirred
(-3 rotations per min) at 0 OC, leading to the formation of small, dark-orange, granular
crystals. The crystals were separated from the brown, gummy residue and resubmitted to the
same crystallization conditions. After the second crystallization, pure product was obtained
as yellow, granular crystals (4.7 g, 27%).
1H NMR (CDC13, 300 MHz): 8 7.78-7.71 (m, 3H), 7.52-7.47 (m, 1H), 5.62 (dd, J=
2.7, 7.2 Hz, 1H), 3.38 (dd, J= 7.2, 19.8 Hz, 1H), 3.07 (dd, J = 2.7, 19.8 Hz, 1H);
13C NMR (CDC13, 75 MHz): 8 201.5, 154.2, 136.0, 135.6, 129.6, 127.5, 123.4, 48.1,
40.6.
(-)-(R)-3-Ethylindan-1-one (eq 1.9) [16460-88-1]. This compound was prepared
according to the General Procedure using (+)-3-bromo-l-indanone (211 mg, 1.00 mmol) and
EtZnBr (-1.6 M in DMA; 1.0 mL, 1.6 mmol). After purification by column chromatography
(1 -- 2% EtOAc in hexanes), the title compound was isolated as a clear, colorless oil.
1st run: 93 mg (58%; 92% ee); 2 nd run: 88 mg (55%; 93% ee).
The ee's were determined by chiral GC: CP Chirasil-Dex CB, t, (major) 22.0 min, tr
(minor) 21.5 min; heating program: 75 'C -- 175 OC @ 3 OC/min; flow: 1.0 mL/min.
[X]23D = -27 (c = 2.8, CHC13) {lit.34 []X25D = -15.5 (c = 0.67, EtOH); I};
IH NMR (CDC13, 300 MHz): 8 7.75-7.73 (m, 1H), 7.64-7.58 (m, 1H), 7.52-7.50 (m,
1H), 7.40-7.35 (m, 1H), 3.37-3.29 (m, 1H), 2.86 (dd, J= 7.5, 19.1 Hz, 1H), 2.37 (dd, J= 3.3,
19.1 Hz, 1H), 2.05-1.92 (m, 1H), 1.63-1.48 (m, 1H), 0.99 (t, J= 7.4 Hz, 3H);
13C NMR (CDC13, 75 MHz): 8 206.5, 158.7, 136.9, 134.6, 127.4, 125.6, 123.5, 42.6,
39.6, 28.7, 11.6;
IR (film) 2969, 2936, 1703, 1600, 1464, 1331, 1292, 1245, 765 cm-1;
EIMS (70 eV) m/z: M+ 160, 145, 132, 115, 103, 91, 77.
(-)-(R)-3-Methylindan-1-one (Scheme 1.2, 1st step) [769-14-21. In the air (no
special precautions are necessary), a dry 50-mL Schlenck tube was charged with
NiBr 2.diglyme (705 mg, 2.00 mmol), I-(i-Pr)-Pybox (784 mg, 2.60 mmol), and (+)-3-bromo-
1-indanone (4.22 g, 20.0 mmol). The tube was fitted with a septum cap and purged with
argon for 15 min. DMA (25 mL) was then added, and the resulting heterogeneous orange
mixture was allowed to equilibrate for 15 min under argon in an isopropanol bath cooled to 0
'C. The MeZnI solution (1.6 M in DMA; 20 mL, 32 mmol) was then added in a single
34 Mani, N. S.; Wu, M. Tetrahedron: Asymmetry 2000, 11, 4687-4691.
portion to the heterogeneous mixture, which rapidly became a clear, brown solution. The
reaction mixture was allowed to stir for 48 h at -15 oC. Then, the excess organozinc reagent
was quenched by the addition of ethanol (6.0 mL), and the resulting brown-orange liquid was
passed through a large pad of silica gel (5% EtOAc in hexanes) to remove the inorganic salts
and much of the DMA. The clear, bright-yellow washings were concentrated and further
purified by flash chromatography (1% -- 2% EtOAc in hexanes), which afforded the title
compound as a clear, colorless oil.
1st run: 1.87 g (64%; 90% ee); 2nd run: 2.04 g (70%; 90% ee).
The ee's were determined by chiral GC: CP Chirasil-Dex CB, tr (major) 18.7 min, t,
(minor) 18.0 min; heating program: 75 OC -- 175 OC @ 3 TC/min; flow: 1.0 mL/min.
The second run was conducted with (S)-(i-Pr)-Pybox.
[C]23D = -7.6 (c = 0.63, EtOH) {lit.35 [a]D = -6.67 (c = 1.05, EtOH); I};
'H NMR (CDC13, 300 MHz): 8 7.75-7.73 (m, 1H), 7.65-7.59 (m, 1H), 7.53-7.51 (m,
1H), 7.41-7.36 (m, 1H), 3.51-3.40 (m, 1H), 2.95 (dd, J= 7.5, 19.1 Hz, 1H), 2.29 (dd, J= 3.5,
19.1 Hz, 1H), 1.42 (d, J= 7.1 Hz, 3H);
13C NMR (CDC13, 75 MHz): 6 206.5, 159.9, 136.4, 134.7, 127.4, 125.3, 123.4, 45.3,
32.8, 21.3;
IR (film) 2961, 1713, 1606, 1464, 1464, 1326, 1281, 1239, 1041, 760 cm';
EIMS (70 eV) m/z: M ÷ 146, 131, 117, 103, 91, 77, 63, 51.
MVe
OH
(3R)-cis,trans-3-Methyl-l-indanol (Scheme 1.2, 2 nd step) [1006-18-41. This
compound was reduced according to the Reduction Procedure using I-3-methyl-1-indanone
(1.85 g, 12.7 mmol) and NaBH 4 (960 mg, 25.4 mmol). The product was obtained as a white
35 Yun, J.; Buchwald, S. L. J. Org. Chem. 2000, 65, 767-774.
solid (1.82 g, 97%) as a mixture of cis and trans isomers (-20: 1). A second run was
performed with (S)-3-methyl-1-indanone, and the product was obtained as a white solid (1.80
g, 96%) as a mixture of cis and trans isomers (-20:1).
H NMR (CDC13, 500 MHz; cis isomer): 8 7.42-7.39 (m, 1H), 7.33-7.22 (m, 3H),
5.22-5.14 (m, 1H), 3.10-3.03 (m, 1H), 2.81-2.73 (m, 1H), 1.91 (d, J= 13.0 Hz, 1H), 1.53-
1.43 (m, 1H), 1.37 (d, J= 11 Hz, 3H);
13C NMR (CDC13, 125 MHz; cis isomer): 6 147.3, 145.0, 128.1, 126.8, 123.6, 123.3,
75.1, 45.7, 36.2, 20.1;
IR (film) 3340, 2958, 2924, 2870, 1645, 1442, 1342, 1211, 1089, 1056, 759 cm';
EIMS (70 eV) m/z: M + 148, 129, 105, 77, 51;
mp 74-76 TC.
Me
Br
(3R)-cis,trans-1-Bromo-3-methylindane (Scheme 1.2, 3 rd step). This compound
was prepared according to the Halogenation Procedure using (3R)-cis,trans-3-methyl-1-
indanol (20:1 mixture; 1.76 g, 11.9 mmol), PBr3 (1.61 g, 5.95 mmol), and dry pyridine (0.1
mL). The product was obtained as a clear, colorless oil (2.34 g, 93%) as a mixture of trans
and cis isomers (-2:1).
A second run was conducted, and the product was obtained as a clear, colorless oil
(2.41 g, 96%) as a mixture of trans and cis isomers (-2:1).
1H NMR (CDC13, 400 MHz; trans isomer): 8 7.41-7.39 (m, 1H), 7.32-7.20 (m, 3H),
5.56 (d, J= 6.1 Hz, 1H), 3.54-3.45 (m, 1H), 2.69 (dd, J= 6.4, 14.2 Hz, 1H), 2.10 (ddd, J=
6.2, 8.9, 14.2 Hz, 1H), 1.35 (d, J= 6.9 Hz, 3H);
cis isomer: 8 7.41-7.39 (m, 1H), 7.32-7.20 (m, 3H), 5.46 (dd, J= 6.2, 6.7 Hz, 1H),
3.33-3.24 (m, 1H), 3.04-2.97 (m, 1H), 2.24-2.18 (m, 1H), 1.42 (d, J= 7.0 Hz, 3H);
13C NMR (CDC13, 100 MHz; trans isomer): 6 148.4, 143.6, 129.1, 127.1, 124.9, 123.4,
53.8, 46.8, 36.9, 17.8;
cis isomer: 8 147.3, 143.0, 128.7, 127.2, 125.6, 123.5, 51.2, 45.5, 38.5, 20.4;
IR (film) 2958, 2919, 2868, 2364, 2331, 1650, 1634, 1454, 753 cmn';
EIMS (70 eV) m/z: M+ 210, 208, 193, 129, 115, 103, 77.
Me
Me
(+)-(R,R)-trans-1,3-Dimethylindane (Scheme 1.2, 4th step) [4175-53-5]. In the air
(no special precautions are necessary), a dry 50-mL Schlenk tube was charged with
NiBr2.diglyme (368 mg, 1.04 mmol), I-(i-Pr)-Pybox (409 mg, 1.36 mmol), and (3R)-1-
bromo-3-methylindane (2.20 g, 10.4 mmol). The tube was fitted with a septum cap and
purged with argon for 15 min. DMA (15 mL) was then added, and the resulting
heterogeneous orange mixture was allowed to equilibrate for 15 min under argon in an
isopropanol bath cooled to 0 OC. The MeZnI solution (1.6 M in DMA; 10.4 mL, 16.6 mmol)
was then added in a single portion, and the resulting homogeneous brown solution was
allowed to stir for 48 h at -15 OC. Then, the excess organozinc reagent was quenched by the
addition of ethanol (6.0 mL), and the resulting brown-orange liquid was passed through a
large pad of silica gel (pentanes) to remove the inorganic salts and much of the DMA. The
solution was then concentrated and further purified by flash chromatography (pentanes),
which afforded the title compound as a clear, colorless oil.
1st run: 1.27 g (83%; 93% ee); 2nd run: 1.32 g (87%; 94% ee).
The ee's were determined by chiral GC: CP Chirasil-Dex CB, tr (major) 45.7 min, tr
(minor) 45.1 min; heating program: 70 oC ; flow: 0.9 mL/min.
The second run was conducted with (S)-(i-Pr)-Pybox.
[a]23D = +2.75 (c = 1.92, CHC13);
'H NMR (CDC13, 500 MHz): 8 7.20 (s, 4H), 3.31-3.27 (m, 2H), 1.93-1.90 (m, 2H),
1.26 (d, J= 7.0 Hz, 6H);
13C NMR (CDC13, 125 MHz): 8 148.3, 126.3, 123.4, 42.9, 37.6, 20.5;
IR (film) 3068, 3019, 2956, 2925, 2866, 1476, 1453, 1373, 1330, 1019, 750 cm';
EIMS (70 eV) m/z: M÷ 146, 131, 115, 91.
. .OBn
M Me
(S)-O-Benzyl-4-(p-tolyl)pentan-l-ol (eq 1.11) [85758-06-1]. This compound was
prepared according to the General Procedure using (+)-1-(1-bromoethyl)-4-methylbenzene
(199 mg, 1.00 mmol) and the appropriate organozinc reagent (-1.6 M in DMA; 1.0 mL, 1.6
mmol). After careful purification by column chromatography (0% -- 2% EtOAc in hexanes),
the title compound was isolated as a clear, colorless oil.
1st run: 170 mg (63%; 76% ee); 2 nd run: 166 mg (62%; 74% ee).
The ee's were determined via HPLC on an OJ-H column (eluent: 1.0% isopropanol in
hexanes; flow rate: 1.0 mL/min) with tr (major): 15.7 min, tr (minor): 22.6 min.
[a]23D = +12 (c = 0.59, EtOH) {lit.36 [025D = +12.3 (c = 0.91, EtOH); (S)};
1H NMR (CDCl3, 400 MHz): 8 7.39-7.28 (m, 5H), 7.12-7.06 (m, 4H), 4.47 (s, 2H),
3.45-3.42 (m, 2H), 2.70-2.62 (m, 1H), 2.33 (s, 3H), 1.70-1.44 (m, 4H), 1.24 (d, J= 6.9 Hz,
3H);
13C NMR (CDC13, 100 MHz): 8 144.4, 138.6, 135.3, 129.0, 128.3, 127.6, 127.4,
126.8, 72.8, 70.5, 39.3, 34.8, 28.0, 22.4, 21.0;
IR (film) 3025, 2924, 2854, 1510, 1491, 1454, 1362, 1101, 816, 733, 697 cm-;
EIMS (70 eV) m/z: M+ 268, 177, 159, 119, 91.
36 Takano, S.; Sugihara, T.; Samizu, K.; Akiyama, M.; Ogasawara, K. Chem. Lett. 1989, 1781-1784.
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Chapter 2
Kinetic Resolution of Indolines
with a Ferrocene-based Acylation Catalyst
2.1 Background
A kinetic resolution is a process in which a racemic mixture of material undergoes a
process of enantioenrichment (i.e., becomes resolved) by means of reaction with another
enantioenriched substance. 37 It is based on the principle that a given enantiomer of substrate
(e.g., (S)-SM; Figure 2.1) could have a lower kinetic barrier to reaction with a chiral
substance than the barrier of the antipode of substrate ((R)-SM, where AGSs < AGSR).
Therefore, given a half-equivalent of the chiral reactant, the faster-reacting enantiomer of
substrate could be preferentially "funneled out" of the mixture, leaving the remaining
mixture enriched in the slower-reacting enantiomer (enriched in (R)-SM).
.. ]'AAAG G
AGts
(R)-SM (S)-SM
(R)-PDT (S)-PDT
Figure 2.1. Comparative energies of starting materials and products in an example kinetic
resolution.
The above definition can include processes in which a chiral catalyst performs an
operation preferentially on one enantiomer of a racemic mixture. As a practical matter, in
both stoichiometric and catalytic cases, the final mixture of enantioenriched starting material
and product is often easier to separate (e.g., by chromatography) than the initial racemic
mixture of starting material.
One commonly accepted metric for evaluating the efficiency of kinetic resolutions is
to discuss them in terms of their selectivity factor (denoted: s). The selectivity factor is the
37 Reviews on kinetic resolution: (a) Kagan, H. B.; Fiaud, J. C. Top. Stereochem. 1988, 18, 249-330. (b) Keith,
J. M.; Larrow, J. F.; Jacobsen, E. N. Adv. Synth. Catal. 2001, 1, 5-26. (c) Robinson, D. E. J. E.; Bull, S. D.
Tetrahedron: Asymmetry 2003, 14, 1407-1446. (d) Vedejs, E.; Jure, M. Angew. Chem., Int. Ed. 2005, 44, 3974-
4001.
ratio of the two rate constants of reaction, with the higher rate constant over the lower (s =
kret = kR/ks or ks/kR). Selectivity factors and reaction conversion (c) can be calculated from
the enantiomeric excesses of product (e%dt) and recovered starting material (eesm), through
eqs 2.1 and 2.2, as described by Kagan. 37a
c= ees (2.1)
eesm + eepdt
ln[l - c(1 + eepdt)]
s = (2.2)ln[1 - c(1 - eepdt)]
In the current literature, enantioselective acylations of chiral alcohols by nucleophilic
catalysts represent a frequently explored example of catalyzed kinetic resolution (eq 2.3).
Although the field of enzyme-based catalysts is well developed,38 significant effort has also
been directed toward the development of synthetic (i.e., non-enzymatic) catalysts. 39 Synthetic
catalysts are often preparable in both enantiomeric forms, and can undergo more rational or
systematic modification of their structure as compared with enzyme-based catalysts.
OH OH OAc
chiral
Me nucleophilic catalyst Me Me (2.3)
'-0.5 equiv
acylating agent
racemic kinetic resolution
A simplified catalytic cycle for alcohol resolution is shown in Figure 2.2. The chiral
nucleophilic catalyst (denoted Nuc*) obtains an acyl group from the acylating agent, and
transfers it preferentially to one enantiomer of alcohol, thus regenerating free catalyst.
38 Enzyme-based kinetic resolutions of amine: van Rantwijk, F.; Sheldon, R. A. Tetrahedron 2004, 60, 501-519.
39 Kinetic resolutions of alcohols: Jarvo, E. R.; Miller, S. J. In Comprehensive Asymmetric Catalysis,
Supplement 1; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.: Springer-Verlag: Berlin, 2004; Chapter 43.
OAc OH
Ph Me Ph M Nuc* Ac-X
Ph Me Nuc*-dc
racemic eX
Figure 2.2. Cycle for Nuc*-catalyzed alcohol resolutions.
Several chiral variants of the DMAP nucleophile have been successfully employed in
alcohol resolutions (Figure 2.3).40 In many cases, the molecules do not bear alkyl-substitution
at the 2-position of the pyridine ring, due to a general observation that hindrance at this
position significantly diminishes catalyst reactivity.
Fuji (1997) Fu (1999) Spivey (2000)
Me-NMe
-n aph thyl) N
Ph Fe Ph
-CNDk±>
Ph
uumirrn 5
exhibits planar chirality exhibits axial chirality
Figure 2.3. Chiral DMAP-variants used in catalytic kinetic resolutions of alcohols.
Literature pertaining to catalytic amine resolutions is far more scant. Before the
present results, there were only two examples of catalyzed amine resolutions with synthetic
catalysts, although the use of enzyme-based catalysts has also been reported.41
In 2001, our lab published a kinetic resolution of benzylamines using oxazole-based
acylating agents (eq 2.4).42 The system was based on a previous report from our lab, wherein
40 Reviews of enantioselective catalysis, based on chiral DMAP derivatives: Wurz, R. P. Chem. Rev. 2007, 107,
5570-5595.
41 Amine resolutions with enzyme-based catalysts: van Rantwijk, F.; Sheldon, R. A. Tetrahedron 2004, 60,
501-51942 Arai, S.; Bellemin-Laponnaz, S.; Fu, G. C. Angew. Chem., Int. Ed. 2001, 40, 234-236.
stoichiometric amounts of acylated-variants of DMAP-Ph 5 were shown to resolve benzylic
amines.43 In order to allow for catalyst-mediated acyl transfer, oxazole 2.3 was employed,
which was adapted from those used in a previous series of rearrangement studies.44
10%
NH2
Me
racemic
t-Bu
2-Napht
Me Fe Me
Me . Me NH2Me
-50 C j Me
HN OMe
Me
(2.4)
s = 12
In 2005, Vladamir Birman published a resolution of 2-aryl-oxazolidinones with
outstanding selectivities (eq 2.5). 45 This system features a commercially available acylating
agent and a heterocyclic catalyst, 2.4, that is prepared in two steps from phenylglycinol.
i-Pr ,0 i-Pr 2.4
(i-Pr)2NEt, r.t.
0 NH
Ph
i-Pr
Ph
s = 200
The existing catalytic, enzyme-based systems are usually limited to resolutions of
primary, benzylic amines.40 In one notable case, Blickvall demonstrated that the enzyme
catalyst Candida antarctica lipase B (CALB or Novozyme 435) can mediate enantioselective
acyl transfer onto benzylic amines in the presence of a dimeric Ru-based catalyst (2.5) which
racemizes the chiral amine starting material.46 Thus, they were able to demonstrate a very
efficient dynamic kinetic resolution (eq 2.6), i.e., a kinetic resolution in which the
enantiomers of starting material are interconverting, allowing for full conversion to product.
43 le, Y.; Fu, G. C. Chem. Comm. 2000, 119-120.
44 Ruble, J. C.; Fu, G. C. J. Am. Chem. Soc. 1998, 120, 11532-11533.45 Birman, V. B.; Jiang, H.; Li, X.; Guo, L.; Uffmian, E. W. J. Am. Chem. Soc. 2006, 128, 6536-6537.46 Paetzold, J.; Bickvall, J. E. J. Am. Chem. Soc. 2005, 127, 17620-17621.
Q(NH
Ph
racemic
(2.5)
ht l
y '3
4% 2.5
CALB, Na2CO3
toluene, 90 *C
racemic O -H0
Ar Ar Ar Ar
Ar / Ar
Ar Ru-H-Ru Ar2\ I-
OC CO OC CO
2.5: Ar = 4-(MeO)-C 6H4
90% yield, 98% ee
It is also notable, in the context of Section 2.3, that enzyme-based kinetic resolutions
of indolines are currently not possible through N-acylation. However, enzyme-based
hydrolysis of Boc-protected methyl indoline-2-carboxylate with immobilized Candida
antarctica lipase (Chirazyme L-2) is extremely efficient (eq 2.7). 47
Chirazyme L-2
CO2Me
oNc phosphate bufferBoc
racemic
C Ný CO 2H
Boc
[ON? "'CO2Me (2.7)
Boc
s-12,000
Enantioenriched indolines may also be prepared by catalytic hydrogenation of the
corresponding N-protected indole, using the bisferrocene ligand, 2.6 (eq 2.8).48 The reaction
proceeds in good enantioselectivities for 2-substituted indoles and 3-substituted indoles, but
not 2,3-disubstituted indoles.
47 Kurokawa, M.; Sugai, T. Bull. Chem. Soc. Jpn. 2004, 77, 1021-1022.
48 Ru-catalyzed hydrogenation of N-protected indolines: (a) Kuwano, R.; Sato, K.; Kurokawa, T.; Karube, D.;
Ito, Y. J. Am. Chem. Soc. 2000, 122, 7614-7615. (b) Kuwano, R.; Kashiwabara, M.; Sato, K.; Ito, T.; Kaneda,
K., Ito, Y. Tetrahedron: Asymmetry 2006, 17, 521-535. (c) Kuwano, R.; Kashiwabara, M. Org. Lett. 2006, 8,
2653-2655.
NH2
Me i-PrOAc
HN AcHN
\ Me
(2.6)
1.0% RuCl2(p-cymene)CI * 2.6
10% CS2CO 3
H2, i-PrOH, 60 TC
.Me
Ph2P
CpFe PPh2FeCp
Me H
2.6
Me
Boc
99% yield, 95% ee
Meo
N
Boc
(2.8)
2.2 Results and Discussion
We began our studies with the goal of expanding the scope of catalytic amine
resolutions, to improve their efficiency in the resolution of secondary amines (i.e.,
disubstituted amines). To help meet that goal, we prepared a series of acylated DMAP-based
catalysts, and tested their efficiencies as stoichiometric resolving agents. Although indolines
were resolved in modest selectivity, open-chain aniline analogues were unreactive in the
tested systems (eq 2.9).
0.4 equivCl@
AcPh Fe Ph
Phý Ph
Me Ph Me "Me (2.9)
N 0.5 equiv Cy2NMe "N C NH H Ac
ra cemic s = krel 
= 2.4
PhNH MNe NH
Me Me
no N-acylation product observed
At the same time, we were pursuing a catalyzed version of the resolution. We
anticipated that this would be a more difficult problem to solve because it introduced the
possibility of a competitive, non-catalyzed background reaction between the amine and the
acylating agent. Nevertheless, we screened several systems, both with oxazole-based
acylating agents and other families of acylating agent.
The majority of prospective acyl-transfer reagents were either unreactive in catalytic
systems, or showed fast reactions with the racemic amine in both catalyzed and non-
catalyzed systems (all giving s < 1.1). However, four reagents were capable of undergoing
fast, catalyzed acyl transfer, while limiting the extent of the undesired background reaction
with the amine substrate (Table 2.1).
Table 2.1. Comparison of acylating agents that allow catalyzed acyl
C -Ný M e
H
racemic
5% PPY-Me 5 or PPY-Phs0.40 equiv Acyl-X
toluene, r.t. K·N Me N 'MeH Acyl
kinetic
resolution
transfer to indolines.
R Fe R
~-~
R
PPY-Mes: R = Me;
PPY-Phs: R = Ph
entry acylating agent catalyst kcatk noncat s
1 PPY-Me 5  2.3 1.0
O0 CF3
2a  C OMe PPY-Me s  >11 1.9
3 PPY-Me 5  >25 2.1
F3C O CF3
4 Ac PPY-Phs >35 1.1
i-Pr
N(
Ph
2.7
a Reaction performed with 0.50 equiv NMeCy 2.
The low selectivities deriving from systems with acylating agent 2.7 struck us as
interesting. Whereas in the stoichiometric reaction, the acyl pyridinium chloride 2.8 produced
low selectivities, its catalytically active counterpart, 2.9, gave essentially no selectivity
(Figure 2.4).
/ I
Ac Ph Fe Ph
PhýýPh
Ph
AC •Ph r" r"
Ph hIPh
Ph
2.8 2.9
stoichiometric reagent catalytically active species
s = 2.4 s = 1.1
Figure 2.4. Two distinct acylating species.
We reasoned that kinetic resolution systems involving oxazole 2.7 might therefore
benefit from added chloride counteranion. Indeed, the addition of 1.5 equiv TBAC1 to
catalyzed systems gave a small boost in resolution efficiency (Table 2.2).49 Further screening
would reveal that the use of lithium chloride and 18-crown-6, a traditionally "mismatched"
crown ether, gave a larger boost to selectivities.50 Lower temperatures and use of lithium
bromide gave us our first double-digit selectivity factors.
Table 2.2. Effect of halide additives and temperature on resolution efficiency
I5% PPY-Ph 5  "- '7"'Me
Me 0.40 equiv 2.7 N 'Me
H 1.50 equiv halide additive H Ac
racemic 0 oC kinetic
resolution
entry halide additive (1.5 equiv) temp s
1 NBu4CI r.t. 1.7
2 LiCI 18-crown-6 r.t. 4.4
3 LiCI 18-crown-6 0 OC 8.2
4 LiBr -18-crown-6 0 "C 10
Through further optimization, we found that systems using the 4-tert-butyl-oxazole,
2.10, gave more efficient catalyzed acyl transfer to indolines than systems with 2.7 (eq
2.10).51,52 Additionally, exploration showed several other Lewis acidic additives that
improved selectivity of the resolution (Table 2.3). Although none of them were superior to
the lithium/crown-ether systems, it is notable that all additives tested, which gave any degree
of selectivity, also gave the same absolute sense of selectivity in the products.
49 Salt additives have previously been shown to improve selectivities of benzylamine resolution by
stoichiometric resolving agents: Arseniyadis, S.; Subhash, P. V.; Valleix, A.; Mathew, S. P.; Blackmond, D. G.;
Wagner, A.; Mioskowski, C. J. Am. Chem. Soc. 2005, 127, 6138-6139.
50 Crystal structures have been obtained for LiC1 * 18-crown-6 adducts, and show a coordinatively unsaturated
lithium: Chang, T.-L.; Zhao, M.; Hu, N.-H.; Jin, Z.-S. Rev. Chim. Min. 1987, 24, 382-390.
51 The 4-iso-propyl-bearing oxazole 2.7 underwent catalyzed acylation of its 4-carbon, to varying degrees (see
ref 45).
52 The analogous oxazoles transferring Ac = COEt or COPh gave a dramatic drop in the selectivity of resolution.
Table 2.3. Other salt-additives that improve resolution selectivities.
QCNMe
H
racemic
Ac
t-Bu
Ph
2.10
0.40 equiv
5% (+-PPY-Ph50.5 equiv additive
0 0C
xN M eA
H
"'Me (2.10)
Ac
entry additive s
1 MgCI2  2.4
2 Mg(OTf)2  1.2
3 AI(Ot-Bu) 3  3.4
4 CeCI 3 1.9
We found that the selectivity could be increased by incorporating structurally
modified catalysts (Table 2.4). On changing the aryl substitution of the cyclopentadiene
fragment, we learned that 3,5-dimethyl-substitution on each aryl ring nearly doubled the
selectivity of the system. Larger bottom rings did not provide a more efficient system,
however. In terms of reaction rate, preliminary studies also showed that the 3,5-dialkyl
substituted catalysts produced nearly identical reaction rates with one another over a 7-day
period of time, but that rate is about half as fast as the parent pentaphenyl catalyst (catalyst
reaction rates: 3,5-H > Me ~ Et - i-Pr).
Table 2.4. Screens of structurally modified catalysts.
AAc 5% catalyst
1.5 equiv LiBr
Me t-Bu 0 0.75 equiv 18-crown-6 Me "'Me (2.11)
N'--N 0 OC C CNý NýH Ph H Ac
racemic 2.10
0.65 equiv
R Fe R
R R
R
entry R s
1 phenyl 10
2 (+)-2.1: 3,5-dimethyl-phenyl 23
3 3,5-diethyl-phenyl 19
4 3,5-di(isopropyl)-phenyl 8.4
5 methyl <2
The optimized system is shown in eq 2.12, and the effect of parameter changes are
shown in Table 2.5. Systems with 15-crown-5 were comparably selective, but systems with
12-crown-4 gave very poor selectivities (entries 2 and 3). The exclusion of crown ether gives
a system with very poor turnover rate and selectivity, whereas exclusion of lithium salt gives
good turnover rate, with poor selectivity (entries 4 and 5). Other salt additives, such as
TBABr, LiC1, or LiI, gave lower selectivity, as did lower temperature (entries 7-10).
Table 2.5. Effect of reaction parameters of the resolution efficiency.
Ac
t-Bu ••
Ph
5% (+)-2.1
1.5 equiv LiBr
0.75 equiv 18-crown-6
toluene, 0 OC, 5 days
2.10
0.65 equiv
(2.12)
Ac
kinetic resolution
entry racemic indoline % conversion s
1 none 54 23
2 15-crown-5 instead of 18-crown-6 54 20
3 12-crown-4 instead of 18-crown-6 43 3
4 no 18-crown-6 16 6
5 no LiBr 55 <2
6 no LiBr or 18-crown-6 43 <2
7 TBA-Br instead of LiBr/18-crown-6 49 2
8 LiCI instead of LiBr 43 14
9 Lil instead of LiBr 12 12
10 room temperature instead of 0 OC (2 days) 49 11
The indoline scope is shown in Table 2.6. As the size of the 2-substituent increases,
the selectivities of the reaction steadily drop (entries 1-5). Tying back the alkyl side chain
into a second 6-membered ring gives a selectivity factor of 9.8, whereas a 7-membered ring
produces the highest selectivity encountered in the system (entries 6 and 7). 2,3-
Disubstitution with a cis-configuration gives high selectivity, whereas trans-configuration
gives low selectivity (entries 8 and 9).53 Electronic perturbations are tolerated by the system
(entries 10-12), although electron-poor aryl rings give a very slow rate of reaction.
53 Notably, substrates without 2-alkyl substitution, but with 3-alkyl substitution, give selectivity factors of ca. 2-
3 (cf. Figure 2.5, vide infra).
*>-M e
H
racemic
Table 2.6. Scope of Indoline Resolution.
Ac
t-Bu 0
NK
Ph
2.10
0.65 equiv
5% 2.1
1.5 equiv LiBr
0.75 equiv 18-crown-6
toluene, 0 C
R
R
N R
Ac
kinetic resolution
entry racemic indoline s ee of resolved indoline
H
H
H
Me
H
Me
0Me
H
XMe
H
R = Me
n-Pr
2-phenylethyl
CH20TBS
i-Pr
25
26
18
14
8.2
94%
90%
98%
94%
78%
(55%
(53%(60%(56%
(58%
conversion)
conversion)
conversion)
conversion)
conversion)
9.8 91% ee (64% conversion)
31 91% ee (51% conversion)
18 91% ee (55% conversion)
9.5 94% ee (64% conversion)
X=OMe 13
Br 11
92% ee (60% conversion)
90% ee (60% conversion)
19 95% ee (58% conversion)
Me
Several aniline-based substrates were not suitable for resolution by this system
(Figure 2.5). Low selectivities, with moderate rates of acylation, were observed for those
racemic
C il
U2t :
substrates with 3-substitution rather than 2-substitution, as well as substrates with 2-
substitution containing sp2-hybridization. Both slow conversion and poor selectivity were
observed for substrates with 2-tert-butyl substitution, a tetrahydroisoquinoline framework, or
for racemic BINAP-diamine, which primarily underwent mono-N-acylation in our final
system.
Me
H
s =2.3
i-Pr
H
s =2.5
C >-N t-Bu
H
s =2.3
C--N Ph
H
s < 1.1
N Me
H
s =2.3
-N C02Et
H
s <1.1
s < 1.1
Figure 2.5. Racemic, aniline-based substrates that undergo inefficient resolution.
We were interested in applying the resolution to intermediates used en route to
bioactive compounds. Thus, we resolved difluorinated indoline 2.11, which had been used
previously by Tsuji and Miyamoto in the synthesis of Floxin-based antibiotics (eq 2.13). 54,55
The racemic indoline is available through a one-step reduction from the commercially
available indole, and it can be resolved with moderate levels of selectivity at room
temperature.
54 (a) Tsuji, K.; Ishikawa, H. Synth. Comm. 1994, 24, 2943-2953. (b) Tsuji, K.; Tsubouchi, H.; Ishikawa, H.
Chem. Pharm. Bull. 1995, 43, 1678-1682.
55 Ishikawa, H.; Uno, T.; Miyamoto, H.; Ueda, H.; Tamaoka, H.; Tominaga, M.; Nakagawa, K. Chem. Pharm.
Bull. 1990, 38, 2459-2462.
Ac
t-Bu j
Ph
2.10
0.65 equiv
5% (+)-2.1
0.75 equiv 18-crown-6
1.5 equiv LiBr
toluene, rt
F
F,..F•, M•
N
H
(-)-2.11
80% ee at 65% conv.
s = 7.5
The synthesis of the Floxin analogues is outlined in Scheme 2.1. Onto amino alcohol
2.12,56 was installed a proline-based chiral auxiliary, and then through a reduction/oxidation
sequence, preferentially generated mesylate 2.13. 54 The core indoline ring was generated
through base-mediated cyclization, which also set the 2-methyl stereocenter, and the chiral
auxiliary was removed, affording free (-)-2.11. This indoline was further annulated with
ethoxymethylenemalonate, producing the Floxin core structure, and nucleophilic aromatic
substitutions then produced a range of bioactive analogs. 55
56 Parikh, V. D.; Fray, A. H.; Kleinman, E. F. J. Heterocycl. Chem. 1988, 25, 1567-1569.
H
racemic
(2.13)II ' "IVI
Scheme 2.1. Synthesis of Floxin analogs by Tsuji and Miyamoto.a
OH
a-d F e
-NO 2  / \ FHH NNF NH2 F- No
F
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F N
CO02H
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CO2H
15 analogs
I f-h
.OMs
Me
FF NHRAux
2.13
NH2
F .
n,o F' "'Me
F N
O
CO2H
I R2NH
NH2
F, "'Me
R2N N
CO2H
6 analogs
a Reagents and conditions: (a), ethyl acetoacetate, NaH; (b) HCI/HOAc; (c) NaBH4; (d) H2, Raney-Ni; (e) (R)-
N-(p-tolylsulfonyl)prolinyl chloride, Py; (f) CrO3, H2SO4; (g) LiAIH 4; (h) MsC1, TEA; (i) K2CO 3, acetone;
(j) KOH; (k) ethoxymethylenemalonate; (1) PPA; (m) HCI; (n) KNO 3; (o) H2, Pd/C.
We also made some preliminary progress on pyrrolidine resolutions, using a similar
system to that employed in the benzylamine resolutions (eq 2.14). This system did not benefit
F
F
L.12A
from the addition of lithium salt and crown ether, nor did the original benzylic amine
resolution (from eq 2.4) during later control experiments.
OC0 2Mee
t-Bu 0
N _ H N
Me 2-naphthyl
racemic 2.3
0.50 equiv
5% PPY-Me 5
-50 OC
Recent Work
Over the past two years, new reports of stoichiometric benzylamine resolving agents
have surfaced, 57 as well as a catalyzed resolution of secondary diamine, 2.14, employing
oxazole 2.3 with various DMAP-based catalysts (s = ca. 2-3; eq 2.15).58
5-20% cat*
1.0 equiv 2.3
HMe,, N
N Me
H
2.14
racemic
9O 2Me
M e l, , N
N Me
H
kinetic resolution
Me2N
Fe
Ph Ph
Ph Ph
Ph
DMAP-Ph s
57 For example: (a) Sabot, C.; Subhash, P. V.; Valleix, A.; Arseniyadis, S.; Mioskowski, C. Synlett 2008, 268-
272. (b) Karnik, A. V.; Kamath, S. S. Tetrahedron: Asymmetry 2008, 19, 45-48.
58 Anstiss, M.; Nelson, A. Org. Biomol. Chem. 2006, 4, 4135-4143.
(2.14)
2Me
IVIU
kinetic resolution
toluene: s = 4.2
CH 2CI 2: S = 2.6
(2.15)
2.3 Mechanistic Discussion
The kinetic resolution of benzylic amines, reported in 2001, is believed to possess a
reaction-coordinate diagram similar to that shown in Figure 2.6 (See eq 2.4; TLS = turnover-
limiting step). 42 The resting state of the catalytic cycle is the acylated catalyst, and the
reaction is zero order in acylating agent, and first order in catalyst and amine. In a simplified,
two-step cycle the second step is believed to be both turnover-limiting, and, of course,
stereochemistry-determining.
TLS
benzy
acylati
Ac+-cat* amide product
cat*
Figure 2.6. Simplified, two-transformation energy diagram for the catalyzed benzylic amine
resolution (eq 2.4). Some components have not been listed, for clarity (e.g., base and solvent).
For the indoline resolution, NMR studies show that catalyst and acylating agent rest
as separate species, under the finalized reaction conditions (eq 2.12). Additionally, we
observe dramatically higher rates of product formation for electron-rich indolines versus
electron-poor indolines. This seems to suggest that the indoline resolution also proceeds with
the turnover-limiting and stereochemistry-determining step being the second one (in a
simplified cycle), but that the corresponding energies of the pre-equilibrium are inverted
compared to the benzylic amine resolution (Figure 2.7).
TLS
indoline
Ac+-cat*
ind
acvlati
Scat* amide product
cat*
Figure 2.7. Simplified, two-step energy diagram for the catalyzed indoline resolution. Some
components have not been listed, for clarity (e.g., additives and solvent).
Moving into an area of greater speculation, an expanded catalytic cycle for the
additive-containing indoline resolution is proposed in Figure 2.8, which explicitly illustrates
the orthoamidate intermediates."
This cycle proceeds via an orthoamidate intermediate to the acylated catalyst (step 1).
The turnover-limiting step (step 2, which may actually be a composite of several more-
fundamental steps) is proposed to require indoline association with carbonyl center and
deprotonation by the aryl-alkoxide, forming a high-order intermediate 2.15. In step 3, the
intermediate decomposes into a second orthoamidate, which is presumed to be the rate-
limiting step for many types of DMAP-catalyzed alcohol acylations.59 Finally, the second
orthoamidate decomposes into amide product and regenerated catalyst.
59 Spivey, A. C.; Arseniyadis, S. Angew. Chem., Int. Ed. 2004, 43, 5436-5441.
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Figure 2.8. Expanded proposal for the catalytic cycle of the metal-containing indoline
resolution.
Kinetically, this cycle could "short-circuit" the lithium-free cycle (e.g., the
unselective cycle in Table 2.5, entry 6), and thus metal-containing and metal-free cycles may
have little overlap with one another, despite the unremarkable difference in their reaction
rates.
This speculative rate-limiting step also rationalizes the observation that electron-rich
indolines produce product more quickly than electron-poor indolines, and the observation
that substrates with hindered N-centers are slower reacting than those with small 2-
substitution.
(a
7J
_,__
2.4 Conclusion
We have demonstrated the first method, enzymatic or non-enzymatic, for the kinetic
resolution of indolines through N-acylation. The final system incorporates salt additives and
a new planar-chiral catalyst, and it presents a rare example of non-enzymatic, catalytic amine
resolution.60
60 Arp, F. O.; Fu, G. G. J. Am. Chem. Soc. 2006, 128, 14264-14265.
2.5 Experimental Section
I. General
Lithium bromide (Alfa Aesar; ultra dry, 99.998%) was crushed into a fine powder
under nitrogen, and 2-methylindoline (Aldrich) was purified by distillation from calcium
hydride. Toluene was dried by passage through an activated alumina column. All other
chemicals were reagent grade and used as received.
HPLC analyses were performed on an Agilent 1100 Series system with Daicel
Chiralpak@ columns in hexanes/isopropanol solvent mixtures.
All reactions were conducted under nitrogen, unless otherwise noted.
II. Preparation of Materials
The yields in this section have not been optimized.
N R = 3,5-dimethylphenyl
R Fe R
R R
R
Catalyst 2.1. n-Butyllithium (1.6 M in hexanes; 2.1 mL, 3.4 mmol) was added to a solution
of penta(3,5-dimethylphenyl)cyclopentadiene (2.00 g, 3.41 mmol) in dry THF (20 mL).
A suspension of crushed FeC12 (433 mg, 3.42 mmol) in dry THF (250 mL) was
prepared in a 500-mL round-bottomed flask. The flask was fitted with a rubber septum,
equipped with a nitrogen-inlet needle, and then cooled to 0 oC in an ice bath. Next, the
cyclopentadienyllithium solution was added by cannula into the FeC12 solution, and the
resulting green mixture was stirred at 0 oC for 15 min.
In a separate flask, 4-dimethylaminopyridine 6 1 (0.529 g, 2.84 mmol) was dissolved in
dry THF (15 mL) and then treated with n-butyllithium (1.6 M in hexanes; 1.8 mL, 2.9 mmol).
The mixture was stirred at r.t. for 10 min, and then it was transferred by cannula into the cold
mixture that contained the iron complex (previous paragraph). The resulting dark-yellow
solution was placed into an oil bath preheated to 60 OC and stirred for 3 h. During that time,
the solution turned dark red.
The solvents were removed by rotary evaporation, and the residue was purified by
flash chromatography (CH 2C12 and then ethyl acetate). The dark-purple fractions were
concentrated to provide the product as a glassy, dark-purple solid (1.68 g, 72%).
Catalyst 1 is air-stable (for months).
61 Ruble, J. C.; Fu, G. C. J. Am. Chem. Soc. 1998, 120, 11532-11533.
'H NMR (CDC13, 400 MHz): 8 8.11 (d, J= 5.4 Hz, 1H), 6.72 (s, 5H), 6.57 (s, 10H),
5.73 (d, J= 5.4 Hz, 1H), 4.97-4.91 (m, 2H), 4.16 (t, J= 2.8 Hz, 1H), 3.53-3.42 (br, 4H), 2.09
(s, 30H), 1.94-1.88 (br, 4H);
'
3C NMR (CDC13, 100 MHz): 6 156.5, 152.6, 149.6, 135.3, 135.1, 130.3, 127.2, 96.5,
85.2, 77.9, 77.0, 69.0, 65.1, 49.7, 25.3, 21.2;
IR (film) 3434, 2918, 1642, 1600, 1536, 1485, 1462, 1401, 1339, 1025, 904, 848, 759,
706 cm-;
HRMS calculated for C57H58FeN 2 826.3949, found 826.3945;
mp 154-157 TC.
The enantiomers of catalyst 2.1 were separated by semi-preparative chiral HPLC:
Regis (R,R)-Whelk-O 2 10/100, 25 cm x 10 mm; diethylamine/CH 2Cl 2/hexanes, 0.4:20:80;
2.50 mL/min flow rate; 25.0 mg catalyst in 0.5 mL per injection. Enantiomer (+)-2.1 ([a] 23 D
= +1100 (c = 0.021, CHC13)) was collected from 8.8 min to 11.1 min, and (-)-2.1 was
collected from 11.8 min to 16.0 min.
The absolute configuration of (+)-2.1 was assigned by X-ray crystallography (see
Section IV).
O
t-Bu
Ph
4-tert-Butyl-2-phenyloxazol-5(4H)-one [71953-55-41. NaOH (3.4 g, 85 mmol) and
then benzoyl chloride (4.9 mL, 42 mmol) were added to a solution of tert-leucine (5.03 g,
38.3 mmol) in water (200 mL) in a large Erlenmeyer flask. This heterogeneous mixture was
stirred overnight, during which time it became homogeneous. The product amide was then
precipitated by the slow addition of aqueous HC1 (2 M), isolated by filtration, and dried
thoroughly under high vacuum. This chalky white solid was dissolved in CH2C12 (50 mL),
and then 1,3-dicyclohexylcarbodiimide (8.05 g, 39.0 mmol) was added. The resulting
heterogeneous mixture was stirred open to air at r.t. overnight. The solution was filtered, and
then the filtrate was washed with aqueous HCI (2 M; 100 mL), dried (Na2SO4), and
concentrated. The desired product was purified by flash chromatography through a short pad
of silica gel (5% ethyl acetate in hexanes), which afforded a white solid (6.95 g, 84%, two
steps).
'H NMR (CDC13, 400 MHz): 6 8.03-8.01 (m, 2H), 7.59-7.55 (m, 1H), 7.50-7.47 (m,
2H), 4.09 (s, 1H), 1.15 (s, 9H);
13C NMR (CDCl3, 125 MHz): 8 176.9, 161.2, 132.6, 128.7, 127.8, 125.9, 74.0, 35.9,
26.1.
OAc
t-Bu _ o
Ph
4-tert-Butyl-2-phenyloxazol-5-yl acetate. A 500-mL round-bottomed flask was
capped with a rubber septum, flushed with nitrogen, and charged with sodium hydride (845
mg, 35.2 mmol) and 4-tert-butyl-2-phenyloxazol-5(4H)-one (6.95 g, 32.0 mmol). Dry THF
(250 mL) was added, and the resulting heterogeneous mixture was cooled to -15 oC. 15-
Crown-5 (7.75 g, 35.2 mmol) was added, and the resulting canary yellow, bubbling solution
was stirred at -15 'C for 15 min. Then, acetyl chloride (2.76 g, 35.2 mmol) was added, and
the resulting colorless solution was stirred for 20 min. The reaction mixture was then
concentrated and purified by flash chromatography (5% ethyl acetate in hexanes) to remove
most of the crown ether and sodium salts. The residue was further purified by flash
chromatography (2.5% ethyl acetate in hexanes) to afford the product as a white solid (6.74 g,
81%).
'H NMR (CDCl3, 400 MHz): 8 7.97-7.95 (m, 2H), 7.43-7.41 (m, 3H), 2.35 (s, 3H),
1.33 (s, 9H);
13C NMR (CDC13, 100 MHz): 8 168.1, 154.4, 143.4, 132.1, 129.9, 128.5, 127.5,
125.8, 31.0, 28.9, 20.3;
IR (film) 2959, 2870, 1798, 1636, 1556, 1486, 1450, 1371, 1322, 1170, 1093, 1075,
1007, 873, 776, 724, 691 cm1 ;
EIMS (70 eV) m/z: M+ (calculated for C15H17N0 3: 259) 259, 218, 203, 174, 156, 133,
106, 84, 51;
mp 76-78 OC.
Reduction by Sodium Cyanoborohydride: General Procedure.62 Sodium
cyanoborohydride (3.0 equiv) was carefully dissolved in glacial acetic acid, and the resulting
bubbling clear solution was added by pipette to a stirred solution of the indole in glacial
acetic acid. This clear, colorless mixture was allowed to stir open to air for 12 h at r.t. Then,
the mixture was transferred to an Erlenmeyer flask, and a saturated aqueous K2C0 3 solution
was added until the solution had become basic. The resulting mixture was extracted with
diethyl ether (2 x 100 mL), and the combined organic phases were dried (K2CO3),
concentrated, and purified by flash chromatography.
n-Pr
H
2-Propylindoline [76916-57-9]. This indoline was prepared from 2-propylindole4
(906 mg, 5.69 mmol) and sodium cyanoborohydride (1.1 g, 18 mmol) via the general
reduction procedure. After flash chromatography (5% ethyl acetate in hexanes), the product
was obtained as a clear, colorless oil (508 mg, 55%).
1H NMR (CDC13, 300 MHz): 8 7.10-6.99 (m, 2H), 6.72-6.60 (m, 2H), 3.92-3.82 (m,
2H), 3.14 (dd, J= 8.6, 15.5 Hz, 1H), 2.69 (dd, J= 8.5, 15.5 Hz, 1H), 1.66-1.57 (m, 2H),
1.49-1.35 (m, 2H), 0.98 (t, J= 7.2 Hz, 3H);
13C NMR (CDC13, 75 MHz): 6 151.0, 128.9, 127.2, 124.6, 118.4, 109.0, 59.8, 39.0,
36.1, 19.7, 14.1.
Ph
NH2
2-(4-Phenylbut-1-ynyl)benzenamine [736184-66-0]. A 100-mL round-bottomed
flask was charged with 2-iodoaniline (2.30 g, 10.5 mmol), trans-
62 Gribble, G. W.; Hoffman, J. H. Synthesis 1977, 859-860.
dichlorobis(triphenylphosphine)palladium (73.7 mg, 0.105 mmol), and CuI (100 mg, 0.53
mmol).63 The flask was fitted with a rubber septum and purged with nitrogen for 5 min.
Triethylamine (20 mL) and then but-3-ynylbenzene (2.39 g, 18.4 mmol) were added by
syringe, and the resulting reaction mixture was stirred at r.t. for 24 h. Then, the triethylamine
was removed in vacuo, and the resulting brown residue was purified by flash
chromatography (5% ethyl acetate in hexanes), which afforded the product as an orange oil
(2.25 g, 97%).
1H NMR (CDC13, 400 MHz): 8 7.37-7.30 (m, 4H), 7.28-7.23 (m, 2H), 7.11-7.07 (m,
1H), 6.69-6.65 (m, 2H), 3.99 (br s, 2H), 2.96 (t, J= 7.3 Hz, 2H), 2.82 (t, J= 7.1 Hz, 2H);
13C NMR (CDC13, 125 MHz): 8 147.7, 140.6, 131.9, 128.9, 128.6, 128.4, 126.3,
117.7, 114.0, 108.5, 94.6, 77.9, 35.1, 21.7.
NPh
H
2-Phenethylindole [98055-06-2]. A 100-mL round-bottomed flask was charged with
2-(4-phenylbut-1-ynyl)benzenamine (2.25 g, 10.2 mmol), Cul (387 mg, 2.03 mmol), and
DMF (10 mL).xx (refbelow) The flask was fitted with a reflux condenser, and the system was
purged with nitrogen for 5 min. The heterogeneous reaction mixture was stirred at reflux for
12 h. Then, most of the DMF was removed in vacuo, and the residue was purified by flash
chromatography (5% ethyl acetate in hexanes), which furnished the product as an off-white
crystalline solid (643 mg, 29%).
'H NMR (CDC13, 400 MHz): 8 7.77 (br s, 1H), 7.56 (d, J= 7.6 Hz, 1H), 7.36-7.32 (m,
2H), 7.29-7.24 (m, 4H), 7.16-7.08 (m, 2H), 6.31 (s, 1H), 3.14-3.05 (m, 4H);
13C NMR (CDC13, 125 MHz): 8 141.2, 139.0, 135.8, 128.6, 128.5, 128.4, 126.3,
121.1, 119.8, 119.6, 110.3, 99.8, 35.6, 30.1.
63 Kuyper, L. F.; Baccanari, D. P.; Jones, M. L.; Hunter, R. N.; Tansik, R. L.; Joyner, S. S.; Boytos, C. M.;
Rudolph, S. K.; Knick, V.; Wilson, H. R.; Caddell, J. M.; Friedman, H. S.; Comley, J. C. W.; Stables, J. N. J.
Med. Chem. 1996, 39, 892-903.
Ph
H
2-Phenethylindoline. This indoline was prepared from 2-phenethylindole (643 mg,
2.91 mmol) and sodium cyanoborohydride (550 mg, 8.8 mmol) via the general reduction
procedure. After flash chromatography (5% ethyl acetate in hexanes), the product was
obtained as an off-white solid (643 mg, 84%).
'H NMR (CDCl 3, 400 MHz): 8 7.33-7.29 (m, 2H), 7.23-7.19 (m, 3H), 7.09 (d, J= 7.2
Hz, 1H), 7.02 (t, J= 7.4 Hz, 1H), 6.70 (t, J= 7.4 Hz, 1H), 6.61 (d, J= 7.7 Hz, 1H), 3.93-3.86
(m, 1H), 3.17 (dd, J= 8.7, 15.5 Hz, 1H), 2.79-2.68 (m, 3H), 2.00-1.94 (m, 2H), 1.58 (br s,
1H);
13C NMR (CDCl3, 125 MHz): 8 150.8, 141.7, 128.7, 128.4, 128.3, 127.2, 125.9,
124.6, 118.5, 109.1, 59.5, 38.4, 36.1, 32.9;
IR (film) 3368, 3022, 2922, 2848, 1607, 1484, 1466, 1454, 1319, 1246, 1017, 745
cm- ;
EIMS (70 eV) m/z: M÷ (calculated for C16H17N: 223) 223, 207, 130, 118, 91, 65;
mp 39-41 OC.
J -CH2OTBS
H
2-((tert-Butyldimethylsilyloxy)methyl)indoline [321744-15-4]. Lithium aluminum
hydride (1.0 M in THF; 37 mL, 37 mmol) was carefully added to a solution of (±)-indoline-
2-carboxylic acid (2.0 g, 12.3 mmol) in dry THF (100 mL). The mixture was stirred for 1 h
at r.t., and then the reaction was carefully quenched by the addition of aqueous sodium
potassium tartrate (10% by weight; 100 mL). The resulting mixture was stirred for an
additional hour, and then it was filtered. The filtrate was concentrated to a yellow oil, which
was purified by flash chromatography (CH2C12) to afford the aminoalcohol.
The aminoalcohol (1.00 g, 6.70 mmol) was dissolved in CH2C12 (100 mL), and then
imidazole (500 mg, 7.4 mmol) and tert-butyldimethylsilyl chloride (1.1 g, 7.4 mmol) were
added. The resulting mixture was stirred at r.t. for 2 h, and then it was filtered. The filtrate
was concentrated and then purified by flash chromatography (5% ethyl acetate in hexanes),
which afforded the product as a clear yellow oil (1.50 g, 46%, two steps).
'H NMR (CDC13, 500 MHz): 8 7.09-7.00 (m, 2H), 6.71-6.63 (m, 2H), 4.23 (br s, 1H),
3.98-3.91 (m, 1H), 3.62-3.52 (m, 2H), 3.11 (dd, J= 9.0, 15.7 Hz, 1H), 2.65 (dd, J= 5.7, 15.8
Hz, 1H), 0.92 (s, 9H), 0.07 (s, 6H);
13C NMR (CDCl3, 125 MHz): 8 150.5, 128.1, 127.3, 124.7, 118.4, 109.4, 66.6, 60.4,
32.0, 25.9, 18.3, -5.3.
(N+)
H
cis-5,6,7,8,8a,9-Hexahydro-4bH-carbazole [4828-96-01. This indoline was
prepared from 6,7,8,9-tetrahydrocarbazole (1.00 g, 5.84 mmol) and sodium
cyanoborohydride (1.1 g, 18 mmol) via the general reduction procedure. After flash
chromatography (5% ethyl acetate in hexanes), the product was obtained as a white solid
(779 mg, 78%).
'H NMR (CDC13, 300 MHz): 8 7.13-7.03 (m, 2H), 6.80-6.69 (m, 2H), 3.78-3.72 (m,
1H), 3.68 (br s, 1H), 3.13 (app q, J= 6.6 Hz, 1H), 1.83-1.77 (m, 2H), 1.83-1.53 (m, 3H),
1.47-1.35 (m, 3H);
13C NMR (CDC13, 75 MHz): 8 150.7, 133.5, 126.9, 123.1, 118.7, 110.1, 59.6, 40.8,
29.1, 26.9, 22.5, 21.6.
(±)
cis-5,5a,6,7,8,9,10,10a-Octahydrocyclohepta[b]indole [886024-65-31. This
indoline was prepared from 5,6,7,8,9,10-hexahydrocyclohepta[b]indole (Ryan Scientific; 650
mg, 3.51 mmol) and sodium cyanoborohydride (660 mg, 10.5 mmol) via the general
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reduction procedure. After flash chromatography (5% ethyl acetate in hexanes), an
inseparable mixture of the cis and trans isomers was obtained as a white solid (569 mg; -9:1).
To facilitate isolation of the cis isomer, the mixture was acylated (diethyl ether (25
mL), triethylamine (515 gL, 1.3 equiv), and acetyl chloride (222 glL, 1.1 equiv); 15 min at
r.t.) and purified by flash chromatography (10% -> 15% ethyl acetate in hexanes), which
furnished the isomerically pure N-acetylated cis diastereomer.
The title compound was then obtained by dissolving the N-acetylated cis isomer in
dioxane (10 mL), adding concentrated aqueous HCI (5.0 mL), and refluxing the reaction
mixture overnight. Then, the mixture was concentrated and purified by flash
chromatography (5% ethyl acetate in hexanes), which afforded the desired product as a
feathery white solid (482 mg, 73%, three steps).
'H NMR (CDCl 3, 300 MHz): 8 7.04-6.99 (m, 2H), 6.73-6.67 (m, 1H), 6.58-6.55 (m,
1H), 4.05 (dt, J= 5.5, 9.8 Hz, 1H), 3.65 (br s, 1H), 3.48 (dt, J= 3.8, 10.6 Hz, 1H), 2.03-1.68
(m, 7H), 1.47-1.29 (m, 3H);
13C NMR (CDCl 3, 125 MHz): 8 150.1, 133.5, 127.3, 124.1, 118.1, 108.4, 63.4, 46.7,
33.5, 31.31, 31.34, 28.7, 26.0.
Me Me
(+) Me (+) -, ,,,Me
H H
cis-2,3-Dimethylindoline [10276-90-1] and trans-2,3-dimethylindoline [7356-42-5].
These indolines were prepared from 2,3-dimethylindole (2.28 g, 15.7 mmol) and sodium
cyanoborohydride (3.0 g, 48 mmol) via the general reduction procedure. After flash
chromatography (3% -> 5% ethyl acetate in hexanes), cis-2,3-dimethylindoline (221 mg,
10%) and trans-2,3-dimethylindoline (1.09 g, 47%) were obtained as yellow oils.
cis-2,3-Dimethylindoline:
'H NMR (CDCl 3, 500 MHz): 6 7.09-7.01 (m, 2H), 6.76-6.72 (m, 1H), 6.63-6.62 (m,
1H), 3.99-3.93 (m, 1H), 3.65 (br s, 1H), 3.31-3.25 (m, 1H), 1.19 (d, J= 7.2 Hz, 3H), 1.15 (d,
J= 6.5 Hz, 3H);
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13C NMR (CDC13, 125 MHz): 8 150.1, 134.2, 127.2, 123.8, 118.7, 109.3, 58.3, 39.4,
16.3, 13.6.
trans-2,3-Dimethylindoline:
'H NMR (CDC13, 500 MHz): 8 7.24-7.21 (m, 2H), 6.95-6.91 (m, 1H), 6.77-6.76 (m,
1H), 3.96 (br s, 1H), 3.61-3.56 (m, 1H), 3.02-2.96 (m, 1H), 1.50-1.47 (m, 6H);
13C NMR (CDC13, 125 MHz): 8 150.3, 134.0, 127.0, 122.9, 118.2, 108.8, 63.6, 44.0,
20.2, 16.9.
C02Et
MeOMe
H
Ethyl 2-(5-methoxy-2-methyl-1H-indol-3-yl)acetate [17536-38-8]. A 50-mL
round-bottomed flask was charged with bis(2-oxo-3-oxazolidinyl)phosphinic chloride (1.38 g,
5.42 mmol) and 2-(5-methoxy-2-methyl-1H-indol-3-yl)acetic acid (Aldrich; 1.08 g, 4.93
mmol) and then flushed with nitrogen. Dry CH 2C12 (15 mL) and triethylamine (1.51 mL,
10.8 mmol) were added, and the solution was stirred at r.t. for 5 min. Then, dry ethanol (1.0
mL, 17 mmol) was added, and the mixture was stirred overnight. The solution was then
extracted with water (2 x 50 mL), and the organic layer was dried (Na2SO4), concentrated,
and purified by flash chromatography through a short pad of silica gel (33% ethyl acetate in
hexanes), which afforded the desired product as a viscous yellow oil (0.97 g, 86%).
1H NMR (CDCl3, 400 MHz): 8 7.77 (br s, 1H), 7.14 (d, J= 8.5 Hz, 1H), 7.02-7.01 (m,
1H), 6.79-6.77 (m, 1H), 4.14 (q, J= 7.1 Hz, 2H), 3.87 (s, 3H), 3.65 (s, 2H), 2.39 (s, 3H), 1.26
(t, J= 7.0 Hz, 3H);
13C NMR (CDC13, 125 MHz): 8 172.2, 153.9, 133.5, 130.1, 128.8, 110.9, 110.8,
104.3, 100.3, 60.6, 55.8, 30.5, 14.2, 11.6.
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cis-Ethyl 2-(5-methoxy-2-methylindolin-3-yl)acetate. A 25-mL round-bottomed
flask was charged with ethyl 2-(5-methoxy-2-methyl-1H-indol-3-yl)acetate (657 mg, 2.66
mmol), trifluoroacetic acid (8.0 mL), and triethylsilane (2.12 mL, 13.3 mmol).64 The flask
was fitted with a reflux condenser, heated to 70 OC, and stirred for 48 h. Then, additional
triethylsilane (2.12 mL, 13.3 mmol) was added, and the reaction was stirred for another 48 h.
Next, the mixture was carefully transferred by pipette into an aqueous K2CO 3 solution (5%
by weight; 150 mL) and extracted with diethyl ether (2 x 100 mL). The combined organic
layers were dried (K2CO3), concentrated, and purified by flash chromatography (15% -)
20% ethyl acetate in hexanes), which afforded the desired product as a yellow oil (401 mg,
60%; cis isomer), along with recovered starting material (43 mg, 7%).
'H NMR (CDCl 3, 400 MHz): 6 6.70 (s, 1H), 6.63-6.61 (m, 1H), 6.61-6.56 (m, 1H),
4.19 (q, J= 7.1 Hz, 2H), 4.06 (dq, J= 6.7, 6.5 Hz, 1H), 3.75 (s, 3H), 3.68-3.62 (m, 1H), 3.40
(br s, 1H), 2.65-2.53 (m, 2H), 1.28 (t, J= 7.1 Hz, 3H), 1.15 (d, J= 6.5 Hz, 3H);
13C NMR (CDCl3, 125 MHz): 8 172.6, 153.4, 144.0, 133.0, 112.6, 111.0, 110.0, 60.5,
58.2, 55.8, 41.6, 33.7, 16.2, 14.1;
IR (film) 3435, 2981, 2832, 2099, 1727, 1639, 1491, 1232, 1156, 1033 cml';
EIMS (70 eV) m/z: M+ (calculated for Cl4H19NO 3: 249) 249, 234, 222, 204, 178, 160,
142, 117.
MeOMe
H
5-Methoxy-2-methylindoline [41568-27-81. This indoline was prepared from 5-
methoxy-2-methylindole (500 mg, 3.10 mmol) and sodium cyanoborohydride (580 mg, 9.2
64 Lanzilotti, A. E.; Littell, R.; Fanshawe, W. J.; McKenzie, T. C.; Lovell, F. M. J. Org. Chem. 1979, 44, 4809-
4813.
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mmol) via the general reduction procedure. After flash chromatography (15% ethyl acetate
in hexanes), the product was obtained as a yellow oil (445 mg, 88%).
1H NMR (CDC13, 400 MHz): 6 6.73 (s, 1H), 6.61-6.54 (m, 2H), 4.01-3.95 (m, 1H),
3.75 (s, 3H), 3.59 (br s, 1H), 3.12 (dd, J= 8.4, 15.5 Hz, 1H), 2.63 (dd, J= 7.9, 15.5 Hz, 1H),
1.30 (d, J= 6.2 Hz, 3H);
13C NMR (CDC13, 125 MHz): 6 144.7, 130.7, 130.5, 112.0, 111.6, 109.8, 55.9, 55.7,
38.2, 22.2.
BrM e
H
5-Bromo-2-methylindoline [99847-70-8]. This indoline was prepared from 5-
bromo-2-methylindole (500 mg, 3.11 mmol) and sodium cyanoborohydride (450 mg, 7.2
mmol) via the general reduction procedure. After flash chromatography (15% ethyl acetate
in hexanes), the product was obtained as a clear, colorless oil (454 mg, 90%).
1H NMR (CDCl 3, 400 MHz): 8 7.17 (s, 1H), 7.10 (d, J = 8.2 Hz, 1H), 6.46 (d, J = 8.2
Hz, 1H), 4.05-3.96 (m, 1H), 3.78 (br s, 1H), 3.13 (dd, J= 8.6, 15.6 Hz, 1H), 2.63 (dd, J= 7.6,
15.7 Hz, 1H), 1.28 (d, J= 6.2 Hz, 3H);
13C NMR (CDC13 , 125 MHz): 8 149.7, 131.3, 129.8, 127.6, 110.4, 110.1, 55.6, 37.5,
22.1.
F
FI Me
H
2.11
4,5-Difluoro-2-methylindoline [85730-59-2]. This indoline was prepared according
to the reduction procedure from 4,5-difluoro-2-methylindole (832.1 mg; Astatech, Inc.) and
sodium cyanoborohydride (940 mg, 3.0 equiv). After silica chromatography (7% ethyl
acetate in hexanes) the product was obtained as a clear, colorless oil (438.0 mg, 52%).
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'H NMR (CDC13, 300 MHz): 8 6.84-6.75 (m, 1H), 6.26-6.22 (m, 1H), 4.07 (ddq, J
= 6.2, 7.6, 8.6 Hz, 1H), 3.75 (br s, 1H), 3.22 (dd, J= 8.6, 15.9 Hz, 1H), 2.72-2.63 (m, 1H),
1.30 (d, J= 6.2 Hz, 3H);
13C NMR (CDC13, 125 MHz): 6 148.5 (dd, JCF = 7.2, 1.3 Hz), 147.2 (dd, JCF = 246,
14.9 Hz), 144.1 (dd, JCF = 236, 12.8 Hz), 116.5 (d, JCF = 17.4 Hz), 115.1 (d, JCF = 18.9 Hz),
103.3 (dd, JCF = 6.3, 3.4 Hz), 56.1, 34.1 (d, JCF = 1.8 Hz), 21.8.
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III. Kinetic Resolutions
General Procedure. In a nitrogen-filled glovebox, an oven-dried 40-mL vial was
charged with catalyst (+)-1 (41 mg, 0.050 mmol), powdered LiBr (130 mg, 1.50 mmol), and
the indoline (1.00 mmol). Toluene (8.5 mL) was added, resulting in a light purple,
heterogeneous mixture. A solution of 18-crown-6 (0.375 M in toluene; 2.0 mL, 0.75 mmol)
was added slowly to the stirred suspension over the course of 1 min, during which time the
mixture turned darker. A solution of the acylating agent (0.325 M in toluene; 2.0 mL, 0.65
mmol) was then added. The vial was capped with a rubber septum, removed from the
glovebox, and placed into a cold bath. After the indicated time had elapsed, the remaining
acylating agent was quenched by the addition of propylamine (0.65 mmol), and the reaction
mixture was concentrated and purified by flash chromatography.
The second runs were conducted with catalyst (-)-1.
The ee values were determined on Chirasil® Dex-CB or Daicel Chiralpak® columns.
The catalyst can be recovered in good yield. For an example, see the kinetic resolution of 2-
propylindoline (Table 2, entry 2).
The absolute stereochemistry of the indolines resolved in entries 1, 4, and 8 of Table
2 was assigned by comparison with compounds reported in the literature. All other
assignments were made by analogy.
Note on reaction times: As indicated in Table 1 (entry 3 vs. entry 12), shorter reaction
times can be employed, at the expense of lower selectivity.
.... "Me
H
(-)-(S)-2-Methylindoline (Table 2.6, entry 1). This compound was resolved
according to the General Procedure using 133 mg (1.00 mmol) of racemic indoline (0 'C for
5 days). After quenching, the reaction mixture was passed through a short pad of silica gel
(10% isopropanol in hexanes) to remove the catalyst and LiBr. Purification by flash
chromatography (5% -+ 20% ethyl acetate in hexanes) furnished the indoline and the N-
acylated indoline.
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Recovered indoline: 56.8 mg (43% yield; 94% ee); [a] 23D= -11 (c = 0.11, benzene)
{lit.65 [a] 20D = +11 (c = 2.0, benzene); (R)}. The ee was determined by HPLC using a Daicel
Chiralpak OD-H column (eluent: 1% isopropanol in hexanes; flow rate: 1.0 mL/min).
Retention times: 11.1 min (major) and 9.6 min (minor).
Acylated product: 88.5 mg (51% yield; 76% ee; white, crystalline solid); [a] 23D = -45
(c = 0.65, benzene). The ee was determined by HPLC using a Daicel Chiralpak OD-H
column (eluent: 1% isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 23.7
min (major) and 19.2 min (minor).
Calculated conversion = 55%; s = 25.
Second run: conversion = 55%; s = 24 (indoline: 53.5 mg, 40% yield, 92% ee; N-acyl
indoline: 90.4 mg, 52% yield, 77% ee).
2-Propylindoline (Table 2.6, entry 2). This compound was resolved according to
the General Procedure using 161 mg (1.00 mmol) of racemic indoline (0 'C for 10 days).
After quenching, the reaction mixture was passed through a short pad of silica gel (10%
isopropanol in hexanes) to remove the catalyst and LiBr. Purification by flash
chromatography (10% -> 20% ethyl acetate in hexanes) furnished the indoline and the N-
acylated indoline.
Catalyst 1 was recovered by flushing the initial short pad of silica gel with a solution
of diethylamine/isopropanol/hexanes (10:10:80) and recovering the purple fractions, which
contain the catalyst. Purification by flash chromatography (3 column volumes of CH2C12,
then diethylamine/methyl tert-butyl ether/hexanes, 2.5:10:87.5) furnished the catalyst in
-80% yield (Run 1: 33.5 mg, 81%; Run 2: 35.3 mg, 85%).
Recovered indoline: 76.0 mg (47% yield; 82% ee); [a] 23D = +39 (c = 0.56, CHCl3).
The ee was determined by HPLC using a Daicel Chiralpak OJ-H column (eluent: 1%
isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 10.8 min (major) and 17.7
min (minor).
65 Krasnov, V. P.; Levit, G. L.; Bukrina, I. M.; Andreeva, I. N.; Sadretdinova, L. S.; Korolyova, M. A.; Kodess,
M. I.; Charushin, V. N.; Chupakhin, O. N. Tetrahedron: Asymmetry 2003, 14, 1985-1988.
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Acylated product: 97.2 mg (48% yield; 82% ee; white, crystalline solid); [a] 23D =-79
(c = 0.32, CHCl3). The ee was determined by HPLC using a Daicel Chiralpak OD-H column
(eluent: 1% isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 21.5 min
(major) and 15.3 min (minor).
Calculated conversion = 50%; s = 25.
Second run: conversion = 53%; s = 28 (indoline: 59.0 mg, 37% yield, 90% ee; N-acyl
indoline: 109 mg, 53% yield, 81% ee).
2-Phenethylindoline (Table 2.6, entry 3). This compound was resolved according
to the General Procedure using 223 mg (1.00 mmol) of racemic indoline (r.t. for 14 days).
After quenching, the reaction mixture was passed through a short pad of silica gel (10%
isopropanol in hexanes) to remove the catalyst and LiBr. Purification by flash
chromatography (5% - 20% ethyl acetate in hexanes) furnished the indoline and the N-
acylated indoline.
Recovered indoline: 67.7 mg (30% yield; 98% ee); [a] 23D = +12 (c = 0.17, CHC13).
The ee was determined by HPLC using a Daicel Chiralpak OD-H column (eluent: 1%
isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 24.9 min (major) and 17.0
min (minor).
Acylated product: 148 mg (56% yield; 64% ee; clear, colorless oil); [a] 23D= -46 (c =
0.38, CHC13). The ee was determined by HPLC using a Daicel Chiralpak AS-H column
(eluent: 1% isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 26.9 min
(major) and 35.9 min (minor).
Calculated conversion = 60%; s = 20.
Second run: conversion = 54%; s = 17 (indoline: 63.5 mg, 28% yield, 85% ee; N-acyl
indoline: 135 mg, 51% yield, 73% ee).
2-((tert-Butyldimethylsilyloxy)methyl)indoline (Table 2.6, entry 4). This
compound was resolved according to the General Procedure using 264 mg (1.00 mmol) of
racemic indoline (10 'C for 19 days). After quenching, the reaction mixture was passed
through a short pad of silica gel (10% isopropanol in hexanes) to remove the catalyst and
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LiBr. Purification by flash chromatography (5% -> 15% ethyl acetate in hexanes) furnished
the indoline and the N-acylated indoline.
Recovered indoline: 85.5 mg (32% yield; 84% ee); [a] 23D = -43 (c = 0.20, CHC13).
The ee was determined by HPLC using a Daicel Chiralpak OD-H column (eluent: 0.5%
isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 12.0 min (major) and 11.0
min (minor).
Acylated product: 159 mg (52% yield; 62% ee; clear, colorless oil); [a]23D= -34 (c =
0.30, CHCl3). The ee was determined by HPLC using a Daicel Chiralpak OD-H column
(eluent: 1% isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 13.8 min
(major) and 10.2 min (minor).
Calculated conversion = 57%; s = 11.
Second run: conversion = 56%; s = 17 (indoline: 97.1 mg, 37% yield, 90% ee; N-acyl
indoline: 160 mg, 52% yield, 71% ee).
N .... CH20H
H
(-)-(R)-2-Hydroxymethylindoline [77122-21-5]. This indoline was obtained by
stirring resolved 2-((tert-butyldimethylsilyloxy)methyl)indoline (263 mg, 1.00 mmol) with
tetrabutylammonium fluoride (1.0 M in THF; 0.65 mL, 0.65 mmol) in THF (5 mL) at r.t. for
30 min. The mixture was then concentrated and purified by flash chromatography (10%
isopropanol in hexanes), which afforded the product as a clear, colorless oil (45.2 mg, 93%).
[a]23D= -44 (c = 0.31, ethanol) {lit. 66 [a]D = +53.6 (c = 0.89, ethanol); (S)}.
cis-5,6,7,8,8a,9-Hexahydro-4bH-carbazole (Table 2.6, entry 6). This compound
was resolved according to the General Procedure using 173 mg (1.00 mmol) of racemic
indoline (0 'C for 6 days). After quenching, the reaction mixture was passed through a short
pad of silica gel (10% isopropanol in hexanes) to remove the catalyst and LiBr. Purification
66 Pasquier, C.; Naili, S.; Mortreux, A.; Agbossou, F.; PBlinski, L.; Brocard, J.; Eilers, J.; Reiners, I.; Peper, V.;
Martens, J. Organometallics 2000, 19, 5723-5732.
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by flash chromatography (5% -- 20% ethyl acetate in hexanes) furnished the indoline and
the N-acylated indoline.
Recovered indoline: 61.6 mg (36% yield; 84% ee); [a] 2 3 D =-20 (c = 0.25, CHCl3).
The ee was determined by HPLC using a Daicel Chiralpak OD-H column (eluent: 1%
isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 10.3 min (major) and 9.5
min (minor).
Acylated product: 108 mg (49% yield; 53% ee; white, crystalline solid); [a] 23D =-41
(c = 0.72, CHC13). The ee was determined by HPLC using a Daicel Chiralpak OD-H column
(eluent: 1% isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 25.6 min
(major) and 20.6 min (minor).
Calculated conversion = 58%; s = 10.2
Second run: conversion = 64%; s = 9.3 (indoline: 53.6 mg, 31% yield, 91% ee; N-acyl
indoline: 117 mg, 54% yield, 52% ee).
cis-5,5a,6,7,8,9,10,10a-Octahydrocyclohepta[b]indole (Table 2.6, entry 7). This
compound was resolved according to the General Procedure using 187 mg (1.00 mmol) of
racemic indoline (0 TC for 10 days). After quenching, the reaction mixture was passed
through a short pad of silica gel (10% isopropanol in hexanes) to remove the catalyst and
LiBr. Purification by flash chromatography (10% -> 20% ethyl acetate in hexanes) furnished
the indoline and the N-acylated indoline.
Recovered indoline: 89.3 mg (48% yield; 86% ee); [a] 23D = -30 (c = 0.52, CHC13).
The ee was determined by HPLC using a Daicel Chiralpak OD-H column (eluent: 1%
isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 13.0 min (major) and 10.2
min (minor).
Acylated product: 110 mg (48% yield; 80% ee; white, crystalline solid); [a] 2 3D = -93
(c = 0.48, CHCl3). The ee was determined by HPLC using a Daicel Chiralpak OD-H column
(eluent: 1% isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 28.2 min
(major) and 18.0 min (minor).
Calculated conversion = 52%; s = 24.
Second run: conversion = 51%; s = 39 (indoline: 85.6 mg, 46% yield, 91% ee; N-acyl
indoline: 104 mg, 45% yield, 85% ee).
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cis-2,3-Dimethylindoline (Table 2.6, entry 8). This compound was resolved
according to the General Procedure using 147 mg (1.00 mmol) of racemic indoline (0 °C for
7 days). After quenching, the reaction mixture was passed through a short pad of silica gel
(10% isopropanol in hexanes) to remove the catalyst and LiBr. Purification by flash
chromatography (10% -> 20% ethyl acetate in hexanes) furnished the indoline and the N-
acylated indoline.
Recovered indoline: 53.5 mg (36% yield; 91% ee); [a]23D= +41 (c = 0.060, CHC13).
The ee was determined by HPLC using a Daicel Chiralpak OD-H column (eluent: 0.5%
isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 34.6 min (major) and 30.5
min (minor).
Acylated product: 95.8 mg (51% yield; 74% ee; white, crystalline solid); [X] 23D = -66
(c = 0.51, CHCl3). The ee was determined by HPLC using a Daicel Chiralpak OD-H column
(eluent: 1% isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 25.5 min
(major) and 19.1 min (minor).
Calculated conversion = 55%; s = 21.
Second run: conversion = 55%; s = 16 (indoline: 51.7 mg, 35% yield, 85% ee; N-acyl
indoline: 87.3 mg, 46% yield, 71% ee).
Me
W1"'Me
H
(-)-(2S,3R)-trans-2,3-Dimethylindoline (Table 2.6, entry 9). This compound was
resolved according to the General Procedure using 147 mg (1.00 mmol) of racemic indoline
(r.t. for 20 days). After quenching, the reaction mixture was passed through a short pad of
silica gel (10% isopropanol in hexanes) to remove the catalyst and LiBr. Purification by
flash chromatography (7% -- 15% ethyl acetate in hexanes) furnished the indoline and the
N-acylated indoline.
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Recovered indoline: 37.2 mg (25% yield; 94% ee); [a]23D = -41 (c = 0.13, CC14)
{lit.67 [a]25D = -52.6 (c = 1.91, CCl4); (2S,3R)}. The ee was determined by HPLC using a
Daicel Chiralpak OD-H column (eluent: 0.5% isopropanol in hexanes; flow rate: 1.0
mL/min). Retention times: 19.3 min (major) and 17.8 min (minor).
Acylated product: 93.1 mg (49% yield; 53% ee; yellow oil); [Ca] 23D = -2.0 (c = 0.26,
CC14). The ee was determined by HPLC using a Daicel Chiralpak OD-H column (eluent: 1%
isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 12.4 min (major) and 11.3
min (minor).
Calculated conversion = 64%; s = 10.8.
Second run: conversion = 65%; s = 8.2 (indoline: 38.4 mg, 26% yield, 90% ee; N-acyl
indoline: 95.3 mg, 50% yield, 48% ee).
5-Methoxy-2-methylindoline (Table 2.6, entry 10). This compound was resolved
according to the General Procedure using 163 mg (1.00 mmol) of racemic indoline (-10 "C
for 2.5 days). After quenching, the reaction mixture was passed through a short pad of silica
gel (20% isopropanol in hexanes) to remove the catalyst and LiBr. Purification by flash
chromatography (15% --. 30% ethyl acetate in hexanes) furnished the indoline and the N-
acylated indoline.
Recovered indoline: 57.3 mg (35% yield; 92% ee); [a]23D= +16 (c = 0.17, CHC13).
The ee was determined by HPLC using a Daicel Chiralpak OD-H column (eluent: 7%
isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 15.6 min (major) and 8.3
min (minor).
Acylated product: 106 mg (52% yield; 60% ee; clear, colorless oil); [Ca] 23D = -28 (c =
0.70, CHC13). The ee was determined by HPLC using a Daicel Chiralpak OD-H column
(eluent: 7% isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 19.0 min
(major) and 17.0 min (minor).
Calculated conversion = 60%; s = 12.
Second run: conversion = 60%; s = 14 (indoline: 53.7 mg, 33% yield, 92% ee; N-acyl
indoline: 111 mg, 54% yield, 63% ee).
67 Scholl, B.; Hansen, H.-J. Helv. Chim. Acta 1980, 63, 1823-1832.
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5-Bromo-2-methylindoline (Table 2.6, entry 11). This compound was resolved
according to the General Procedure using 212 mg (1.00 mmol) of racemic indoline (r.t. for 23
days). After quenching, the reaction mixture was passed through a short pad of silica gel
(10% isopropanol in hexanes) to remove the catalyst and LiBr. Purification by flash
chromatography (5% -+ 20% ethyl acetate in hexanes) furnished the indoline and the N-
acylated indoline.
Recovered indoline: 63.0 mg (30% yield; 83% ee); [a]23D= -11 (c = 0.18, CHC13).
The ee was determined by HPLC using a Daicel Chiralpak OD-H column (eluent: 1%
isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 16.4 min (major) and 9.6
min (minor).
Acylated product: 121 mg (47% yield; 64% ee; clear, colorless oil); [a]23D= +45 (c =
0.12, CHC13). The ee was determined by HPLC using a Daicel Chiralpak OD-H column
(eluent: 1% isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 24.3 min
(major) and 21.7 min (minor).
Calculated conversion = 57%; s = 11.
Second run: conversion = 60%; s = 11 (indoline: 55.8 mg, 26% yield, 90% ee; N-acyl
indoline: 120 mg, 47% yield, 59% ee).
cis-Ethyl 2-(5-methoxy-2-methylindolin-3-yl)acetate (Table 2.6, entry 12). This
compound was resolved according to the General Procedure using 249 mg (1.00 mmol) of
racemic indoline (-10 'C for 4 days). After quenching, the reaction mixture was passed
through a short pad of silica gel (20% isopropanol in hexanes) to remove the catalyst and
LiBr. Purification by flash chromatography (15% -> 40% ethyl acetate in hexanes) furnished
the indoline and the N-acylated indoline.
Recovered indoline: 80.4 mg (32% yield; 85% ee); [a]23D = +9.6 (c = 0.27, CHCl3).
The ee was determined by HPLC using a Daicel Chiralpak OD-H column (eluent: 10%
isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 17.1 min (major) and 13.5
min (minor).
Acylated product: 159 mg (55% yield; 75% ee; white, crystalline solid); [a] 23D = -34
(c = 0.32, CHCl3). The ee was determined by HPLC using a Daicel Chiralpak OD-H column
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(eluent: 10% isopropanol in hexanes; flow rate: 1.0 mL/min). Retention times: 23.6 min
(major) and 17.5 min (minor).
Calculated conversion = 53%; s = 18.
Second run: conversion = 58%; s = 19 (indoline: 97.8 mg, 39% yield, 95% ee; N-acyl
indoline: 142 mg, 49% yield, 68% ee).
4,5-Difluoro-2-methylindoline (eq 2.13). This compound was resolved according to
the General Procedure using 169.2 mg (1.00 mmole) of racemic indoline, reacted at room
temperature for 23 days. After quenching, the reaction mixture was flashed across a short pad
of silica gel (10% isopropanol in hexanes) to remove the catalyst and lithium salt. The
solution was then concentrated and further purified by silica chromatography (15% -- 30%
ethyl acetate in hexanes) to separately afford the recovered indoline and acylated product.
Recovered indoline: 37.6 mg (22% yield; 79% ee); [a]23D = +10 (c = 0.26, CHC13).
The ee was determined by chiral GC, CP Chirasil Dex-CB; Heating program: 75 'C --
175 OC at 3 'C/min; flow: 1.0 mL/min. Retention times: 17.7 min (major) and 18.6 min
(minor). Acylated product was obtained as a white, crystalline solid (113.6 mg, 54% yield;
58% ee); [a]2 3 D = -23 (c = 0.67, CHC13). Product ee was determined by chiral GC, CP
Chirasil Dex-CB; Heating program: 75 'C -- 175 'C at 3 OC/min; flow: 1.0 mL/min.
Retention times: 28.0 min (major) and 27.0 min (minor).
Calculated conversion = 58%; s = 8.6.
Second run: conversion = 65%; s = 5.9 (indoline: 40.0 mg, 24% yield, 80% ee;
N-Acyl indoline: 125.2 mg, 59% yield, 44% ee).
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IV. Absolute Configuration of (+)-2.1
General. Low-temperature diffraction data were collected on a Siemens Platform three-
circle diffractometer coupled to a Bruker-AXS Apex CCD detector with graphite
monochromated Mo Ka radiation (A = 0.71073A), performing (- and co-scans. Raw data
frames were integrated using the Bruker program SAINT+ for NT version 6.01. All
structures were solved by direct methods using SHELXS and refined against F2 on all data
by full-matrix least squares with SHELXL-97 (Sheldrick, G. M. SHELXL 97, Universitit
G6ttingen, G6ttingen, Germany, 1997). SADABS absorption correction was performed. All
non-hydrogen atoms were refined anisotropically. All hydrogen atoms were included in the
model at geometrically calculated positions and refined using a riding model. The isotropic
displacement parameters of the hydrogen atoms were fixed to 1.2 times the U value of the
atoms they are linked to (1.5 times for methyl groups).
Experimental. A dark-purple needle (grown from a mixture of catalyst, acylating agent, 18-
crown-6, and LiBr) of dimensions 0.25 x 0.20 x 0.10 mm 3 was mounted under STP and
transferred to a Siemens Platform three-circle diffractometer equipped with a cold stream of
N2 gas. The data that were collected (185924 total reflections, 26781 unique, Rint = 0.058)
had the following Miller index ranges: (-20 to 20 in h, -27 to 27 in k, and -46 to 46 in 1).
The structure was solved in the monoclinic space group P2(1)2(1)2(1), a = 14.9080(4) A, b =
19.7937(6) A, c = 33.7362(10) A, a = 900; P3 = 90°; y = 900, and refined using standard
difference Fourier techniques. Final, full-matrix least squares refinement (26781 data for
1191 parameters) on F2 yielded residuals of R1 and wR2 of 0.0624 and 0.1734 for data I >
2c(I), and 0.0822 and 0.1872, respectively, for all data. Residual electron density amounted
to a maximum of 1.001 e/A3 and a minimum of-1.673 e/A 3. The absolute structure (Flack)
parameter for the correct enantiomer is 0.002(8), thus establishing the absolute
stereochemistry.
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Figure 2.9. A portion of the unit cell, focusing on (+)-2.1.
Figure 2.10. The entire unit cell: 2 x (+)-2.1, 2 x LiBr, toluene (identification code 06067).
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Table 1. Crystal data and structure refinement for 06067.
Identification code 06067
Empirical formula C121 H11124 Br2 Fe2 Li2 N4
Formula weight 1919.73
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group P2(1)2(1)2(1)
Unit cell dimensions a = 14.9080(4) A
b = 19.7937(6) A
c = 33.7362(10) A
Volume 9955.0(5) A3
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 29.130
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole 1.001 and -1.673 e.A -3
2.476 Mg/m3
2.290 mmnr
7536
0.25 x 0.20 x 0.10 mm3
1.19 to 29.130.
-20<=h<=20, -27<=k<=27, -46<=1<=46
185924
26781 [R(int) = 0.0578]
100.0 %
Semi-empirical from equivalents
0.8034 and 0.5983
Full-matrix least-squares on F2
26781 / 1362/1191
1.041
R1 = 0.0624, wR2 = 0.1734
R1 = 0.0822, wR2 = 0.1872
0.002(8)
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a= 90 .
3= 900.
Y= 900.
Chapter 3
Catalytic Enantioselective C-N Insertion Reactions
to Form 1,4-Benzoxazinones
130
3.1 Background
In 1966, Nozaki and Noyori reported the first examples of homogenous, transition
metal-based enantioselective catalysis, as applied to small-molecule synthesis. 68' 69 The report
contained accounts of copper-catalyzed cyclopropanation of styrene with ethyl diazoacetate
(eq 3.1) and a catalyzed methyl diazoacetate insertion into the C-O sigma bond of an oxetane,
proceeding with undetermined levels of selectivity (eq 3.2).
SCO0 2Et Ph 0.9% (S,S)-3.2(3.1)
N2  Ph CO02Et Ph C02Et
3.0 equiv 6% ee 6% ee
72% yield
-1:2.3 cis/trans
C0 2Me 0.9% (S,S)-3.2 
-C0 2Me (3.2)
N2  PhPh
ecar mic
5.0 equiv [a]D = -5.7
85% yield
-1:2 cis/trans
Me
(S,S)-3.2
The field of enantioselective organic synthesis through catalytic decomposition of
diazo compounds has expanded greatly since that first report and currently spans a wide
variety of processes.70 However, significant effort is still being focused on the development
of sigma-bond insertion processes, including literature on enantioselective C-X 71 and X-H 72
insertion reactions.
6 8 Nozaki, H.; Moruiti, S.; Takaya, H.; Noyori, R. Tetrahedron Lett. 1966, 22, 5239-5244.69 For a leading discussion on the history of enantioselective catalysis, see: Kagan, H. B. In Comprehensive
Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.: Springer-Verlag: Berlin, Heidelberg,
2004; Chapter 2.
70 For an overview, see: Doyle, M. P.; McKervey, M. A.; Ye, T. In Modern Catalytic Methods for Organic
Synthesis with Diazo Compounds: From Cyclopropanes to Ylides; John Wiley: New York, 1998.
71 Catalytic, enantioselective C-X insertions: Hodgson, D. M.; Pierard, F. Y. T. M.; Stupple, P. A. Chem. Soc.
Rev. 2001, 30, 50-61.72 For recent examples of catalytic, enantioselective O-H insertions, see: (a) Maier, T. C.; Fu, G. C. J. Am.
Chem. Soc. 2006, 128, 4594-4595. (b) Chen, C.; Zhu, S.-F., Liu, B.; Wang, L.-X.; Zhou, Q.-L. J. Am. Chem.
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On the basis of the first report by Nozaki and Noyori68 as well as subsequent
literature,73 we also pursued oxetane expansions in the Fu lab. In 2001, Michael Lo reported
an oxetane insertion using planar-chiral bisazaferrocene ligand, BIS-AF, which provides
either cis- or trans-tetrahydrofurans with good preservation of enantiopurity (eqs 3.3 and 3.4;
R = CMeCy2).74
1.0% CuOTf
1.1 % (S,S)-BIS-AF
1.0% CuOTf
1.1 % (R,R)-BIS-AF
Me\ Me
Me M' Me
Me Fe Me
Me::Z Me
Me
(R,R)-BIS-AF
O 0
OR
Ph
95% ee
74% yield
84:16 cis:trans
OR
Ph
98% ee
74% yield
19:1 trans:cis
Carbenoid insertion into the C-O sigma bond of an achiral substrates has also been
reported; Doyle used a dimeric rhodium species, Rh2(4S-MEOX)4, to catalyze the insertion
of ethyl diazoacetate into allylic ethers for the formation of [2,3]-sigmatropic rearrangement
products (eq 3.5).75
Soc. 2007, 129, 12616-12617. For recent N-H insertions, see: (c) Liu, B.; Zhu, S.-F.; Zhang, W.; Chen. C.;
Zhou, Q.-L. J. Am. Chem. Soc. 2007, 129, 5834-5835. (d) Lee, E. C.; Fu, G. C. J. Am. Chem. Soc. 2007, 129,
12066-12067.
73 Nozaki, H.; Takaya, H.; Moriuti, S.; Noyori, R. Tetrahedron 1968, 24, 3655-3669.
74 Lo, M. M.-C.; Fu, G. C. Tetrahedron 2001, 57, 2621-2634.
75 Doyle, M. P. Forbes, D. C.; Vasbinder, M. M.; Peterson, C. D. J. Am. Chem. Soc. 1998, 120, 7653-7654.
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0
N OR
N2Ph
99% ee
N2OR
N2
99% ee
(3.3)
(3.4)
1 3
Ph OMe OEtN2
1.0% Rh2(4S-MEOX)
Me0 2C"N§. 0 I
Rh-Rh 4
O
MeO,, OEt
Ph398%
98% ee
Rh2(4S-MEOX)4
We are aware of no catalytic, enantioselective C-N insertion processes in the
chemical literature. However, in several instances, non-enantioselective variants of these
reactions have been used to prepare chiral organic fragments. 76 In 1993, West reported a
system that prepares dialkylated amino ester products in a single step from commercially
available starting materials (eq 3.6). 77
Cu powder
refluxing toluene
Bn CO 2 Et
Me" NMe
racemic
Padwa demonstrated that the process could be applied to natural-product-type
scaffolds, such as those in eq 3.7.78 These systems incorporated amide-based nitrogen
substrates and low amounts of rhodium acetate catalyst. The authors argued that this
transformation may ultimately be applicable in future syntheses of lennoxamine or chilenine.
76 For reviews, see: (a) Vanecko, J. A.; Wan, H.; West, F. G. Tetrahedron 2006, 62, 1043-1062. (b) Kiirti, L.;
Czak6, B. Strategic Applications of Named Reactions in Organic Synthesis; Elsevier Inc: Amsterdam, 2005; pp
434-435.
77 West, F. G.; Glaeske, K. W.; Naidu, B. N. Synthesis, 1993, 977-980.78 Padwa, A.; Beall, L. S.; Eidell, C. K.; Worsencroft, K. J. J. Org. Chem. 2001, 66, 2414-2421.
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(3.5)
Bn
Me N'Me rCO2EtN2
(3.6)
NOD
\. N
S N 2
CO2Me
<1% Rh2(OAc) 4
refluxing toluene
O
N
Me0 2C
racemic
R1 = R2 = H: lennoxamine;
R1 = OH; R2 = carbonyl: chilenine
Additionally, West applied the Cu-powder systems to the preparation of 1,4-
benzoxazinones (eq 3.8). 79 This system was capable of mediating reactions with arylamine,
allylamine, or cyanomethylamine substrates.
Me
N,
I Bn
O 1 N2
Ac
Cu powder
refluxing toluene
Me
iBn
Or Ac
racemic
(3.8)
It is notable in the above context, and in Section 3.2, that the 1,4-benzoxazinone
framework is common to some biologically active targets. Plants such as corn, wheat, rye,
and maize produce allelochemicals80 with a chiral 1,4-benzoxazinone subunit, such as
glycosylated compounds 3.3 and 3.4. These compounds can undergo enzymatic conversion
to the corresponding aglycons, DIMBOA and DIBOA (eq 3.9), and other metabolites that
possess antimicrobial, antifungal, anti-inflammatory, and mutagenic properties. 81 Achiral,
79 West, F. G.; Naidu, B. N. J. Org. Chem. 1994, 59, 6051-6056.
80 An allelochemical is a compound produced by an organism that goes on to induce some biological response
in a separate species (e.g., a natural insecticide).
81 For reviews on naturally occurring benzoxazinoids, see: (a) Hashimoto, Y.; Shudo, K. Phytochemistry 1996,
43, 551-559. (b) Fomsgaard, I. S.; Mortensen, A. G.; Carlsen, S. C. K. Chemosphere 2004, 54, 1025-1038. (c)
Gierl, A.; Frey, M. Planta 2001, 213, 493-498.
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(3.7)
synthetic variants of 1,4-benzoxazinones have also been prepared, and their biological
activities surveyed.82
OH
HO r\ OH
HO%"'
I
OH
(3.3) R = OMe;(3.4) R = H
RNO
OH
R = OMe, DIMBOA;
R = H, DIBOA
The general utility of 1,4-benzoxazinones, in conjunction with their rigid 6,6-fused
ring architecture, seems to render them promising targets for asymmetric catalysis. A few
such methods have appeared in the literature. Lectka used a benzoylquinidine catalyst, BDq,
to produce a series of N-protected products in good yields and excellent enantioselectivities
(eq 3.10).83 This report also demonstrated subsequent derivatization of those products,
delivering the free amino acid derivatives.
CI
Me
CI NFmoc
Cl O
Bn
10% BDq
DIPEA, THF, -78 -C
Me O O
CMe N Bn
Fmoc
63% yield, >99% ee
OCOPh
BDq
MacMillan and Rueping have individually accessed chiral 1,4-benzoxazinones
through organocatalytic hydrogenation. MacMillan demonstrated that the chiral phosphoric
acid catalyst 3.5 could be used in conjunction with a Hantzsch ester to yield these products
82 For leading references, see: Wolfer, J.; Bekele, T.; Abraham, C. J., Dogo-Isonagie, C.; Leckta, T. Angew.
Chem., Int. Ed. 2006, 45, 7298-7400.
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(3.9)
(3.10)
with high enantioselectivity (eq 3.11).83 In the following year, Rueping used a related system
to prepare several families of compounds with the 6,6-fused ring structure, including
arylglycine derivatives (eq 3.12).84 Both systems produced the same absolute sense of
enantioselectivity with a given enantiomer of phosphoric acid catalyst.
N Me
N Ph
H .H
EtO2C CO2Et
Me N Me
H
H ,H
EtO2C CO2Et
Me N Me
H
1.25 equiv
10% 3.5
5A M.S., benzene, 50 oC
1% 3.6
CH2CI2, r.t.
- 9-phenanthryl
0. //
S OH
9-phenanthryl
3.6
0 O0
N Me
H
82% yield, 97% ee
N Ph
H
85% yield, 98% ee
Finally, in a non-catalytic realm, Takemoto has prepared the corresponding
quaternary stereocenters with chiral Lewis acid-mediated imine alkylations (eq 3.13).85
These substrates required 5-hydroxy or 5-methoxy substitution and, in varying yields and
enantioselectivities, underwent a concomitant aryl-alkylation process. The mechanistic
pathways leading to these products were unclear, but the authors speculate that they may
involve alkyl radical addition to a metal-coordinated imine.
83 Storer, I. J.; Carrera, D. E.; Ni, Y.; MacMillan, D. W. C. J. Am. Chem. Soc. 2006, 128, 84-86.
84 Rueping, M.; Antonchik, A. P.; Theissmann, T. Angew. Chem., Int. Ed. 2006, 45, 6751-6755. These ester
products could be further derivatized into a corresponding amino acid derivative with pyrridin-2-ol and
benzylamine.
85 Miyabe, H.; Yamaoka, Y.; Takemoto, Y. J. Org. Chem. 2006, 71, 2099-2106.
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(3.11)
(3.12)
OH
N Me
OH
1.0 equiv 3.7
1.0 equiv Zn(OTf)2
2.5 equiv BEt3
CHCl3, -70 0C
Me Me
I
SO0w Me
N Et
OH H
Et 0 0
w Me
OH H Et
OH
49% yield, 33% ee 35% yield, 78% ee
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(3.13)
3.2 Results and Discussion
We began our studies in this area with the goal of reporting the first enantioselective
C-N insertion reaction. Clearly, for the broadest interest to the synthetic community, we first
pursued systems with the potential to produce useful products downstream.
Significant effort was spent attempting to locate a chiral variant of the amino ester
synthesis by West (for example, eq 3.14). We also found a preliminary lead by screening the
amide-based insertion method by Pawda, across chiral rhodium catalysts (eq 3.15).
2.5% CuOAc
5.0% (+)-3.1
toluene, 60 "C
CN
K N HN
Ph Ph(+)-3.1
2.5% (+)-Rh 2(DOSP)4
1,4-dioxane/toluene (10:1)
BnyCO2t-Bu
Me N ' Me
ca. 19% yield, 14% ee
49% yield, 22% ee
Our best preliminary results pertained to enantioselective variants of the 1,4-
benzoxazinones system by West. For example, in eq 3.16, the use of systems with copper
triflate and semicorrin ligand 3.1 gave promising levels of enantioselectivity in tert-butanol
solvent. At increased temperature (80 'C), the system provided quantitative conversion to
product, but at the cost of enantioselectivity.
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Bn
Me N ' Me
(CO 2t-Bu
N2
(3.14)
(3.15)
Mei 5% CuOTf Ye Bn
10% (+)-3.1 N
S"Ac
t-BuOH, temp C X I
13% yield, 72% ee (40 *C);
41% yield, 65% ee (60 *C);
100% yield, 53% ee (80 *C)
(3.16)
We decided to further investigate this family of substrates. In Figure 3.1 are the
results of some early studies that investigate the effects of modified substrate scaffolding, as
well as solvent. Polar solvents tend to produce lower yields and rates of conversion in these
systems, with higher enantioselectivity (eq 3.17). Reaction rates were always improved by
incorporation of 7-methoxy- or thioether-substitution, whereas reaction rates were hampered
by bulkier N-substitution. Interestingly, bulkier substitution at the arylamine 5-position, ortho
to nitrogen, increased reaction rate.86 In the case of a 2-naphthylamine-derived substrate,
both reaction rates and enantioselectivities were improved (71% yield and 91% ee, after two
days).
ie .
10o% Cu'-source
15% (+43010
DMA, 40 *C
ye Bn
- O- Ac
0- `0
15% yield, 80% ee(1 d)
YNe Bn
MeO 0 O
99% yield, 46% ee
(CH2C12, 1 d)
Ye Bn
N(7 OAc
77% yield, <5% ee(CH2CI2, 1 d)
n-Nr Bn
'Ac
00
14% yield, 67% ee(t-amyl alcohol, 1 d)
Me Me
bAc
00
78% yield, 81% ee(2 d)
Figure 3.1. Variation of fused-ring scaffold and the N-alkyl substituent.
86 This may be due to an increase in sp3 character of the aryl nitrogen.
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(3.17)
Exploration of 2-naphthylamine-derived substrates revealed some boundaries in
reaction scope. The substitution on the a-position of the diazoester was critical to selectivity,
as phenyl, cyano, or proton substitution all gave low ee's (entries 1-3; Table 3.1). A substrate
with c-ethyl substitution did not convert to the desired product (entry 4), but produced the
corresponding unsaturated aryl ester, presumably via C-Halkyl insertion.
Table 3.1. Variation of the substrate's diazoester portion.
Me
NBn
0 N2
R
10% CuOTf
15% (+)-3.1
DMA, 40 0C
entry R yield (%) ee (%)
1 Ph 77 26
2 CN 21 25
3 H 10 37
4 Et <5 -
Other modifications on the substrate were unsuccessful (Figure 3.2). Inclusion of
N,N-dibenzyl substitution on the substrate did not produce product in useful yields or
selectivities. No product was observed for isopropyl or phenethyl migrating groups, nor from
1-naphthylamine-based substrates. Substrates with bisallylamine substitution formed
cyclopropanation product, to the exclusion of desired C-N insertion product.
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n"Ac
00
65% ee, 33% yield(CH2CI2, 1 d)
Me
I i-Pr
Nt u Ac
not detected
e Bn Me
Ac "Ac
not detected only traces detected(C-HaryI insertion product suspected Cyclopropanation product obtainedto be in the mixture) (88% ee, 12 to 76% yield)
Figure 3.2. Further unsuccessful variation of naphthylamine-derived substrates.
We went on to finalize the reaction conditions (eq 3.18) and develop a set of working
substrates (Tables 3.2 and 3.3). The C-N insertion proceeds with high levels of
enantioselectivities for a range of benzylamine-derived substrates (entries 1-5; Table 3.2),
including those with electronic perturbations (entries 2 and 3) and with increased steric
demand at the ortho-position of the benzylic migrating group (entries 4 and 5).87 Interestingly,
we observed good enantioselectivity in reactions of a substrate with an ac-aminoethylester
fragment (entry 6).7
87 Neither the 5-endo nor the 6-exo cyclization products were observed in the crude reaction mixture (formation
of either ring would be Baldwin-favored).
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Me me
N Ph
not detected
Table 3.2. Catalytic Enantioselective C-N Insertion Reactions.a
10% CuOTf
13% (+)-3.1
DMA, 40 °C
(3.18)
R1
Bn
4-(MeO)Bn
4-BrBn
2-MeBn
2-allylbenzyl
CH2CO2Et
data are the average c
yield (%) ee (%)
81 91
74 93
56 90
62 93
57 93
72 93
)f two experiments.
Allylamine-derived substrates, with branching at the 2-position, also converted to the
desired products in good enantioselectivities (71-97% ee, entries 1-5; Table 3.3). With the
straight-chain cinnamylamine-derived substrate in entry 6, several cyclization products were
formed. The reaction gave high selectivity for the branched [2,3]-rearrangement products
over the straight-chain [1,2] product (ca. 98:2, (R,S)-3.8 and (R,R)-3.8 vs. (R)-3.9).
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entry
1
2
3
4
5
6
a All
I
Table 3.3. Insertion Reactions with Allylamine Substrates.a
Me
.NRI 10% CuOTf13%(+)-3.1
DMA, 40 oC
le R
SR2
O
entry R1  R2  yield (%)b ee (%)
1 2-methylallyl Ac 84 97
2 2-methylallyl COPh 63 90
3 2-methylallyl CO 2Et 74 71
4 2-phenyallyl Ac 73 97
5 2-(ethoxycarbonyl)allyl Ac 57 95
6 1-cinnamyl Ac (R,S)-3.8: 51 (73)c  71
(R,R)-3.8: - (25)c -
(R)-3.9: - (2)c -
a All data are the average of two experiments. b Isolated yield.
cPercent isomer composition by 1H NMR analysis of unpurified
reaction mixture.
(R, S)-3.8 (R,R)-3.8 (R)-3.9
The remaining synthetic work for this project will likely focus on derivatization of the
tricyclic products to access the free quaternary amino acid. Additionally, we plan to submit
the final products for screening of their biological activities.
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3.3 Mechanistic Discussion
The mechanism involved in these processes is an area of some dispute, and three
limiting cases have been proposed.76a Each mechanism initiates first through metal carbenoid
formation, and then amine association with the electrophilic carbenoid center, generating the
C-N bond in the product (eq 3.19). The resulting metallocarbenoid complex can be
represented in either the dissociated or associated form.
BnCU Ln I OnEtO 2C 0 EtO2C NMe 2  EtO2> eNMe2 Et• 2C NMe2BnO  Ne2 Br
N2  N2  I, C UL .CuL~M  J (3.19)
N2 n  Cu'Ln
dissociated associated
The mechanistic pathways diverge after formation of the metallocarbenoid
intermediate (Figure 3.3). Pathway A, which is favored by West,76a,77 proceeds from the
metal-dissociated structure, and features a radical bond homolysis to cleave the C-N bond.
Then, radical recombination produces the C-C bond of product.
Pathway B, which has also been suggested for oxetane expansions (e.g., eqs 3.2-
3.4),71 proceeds from the associated complex, through an SNl-like dissociation of the benzyl
cation from the ammonium, to cleave the C-N bond. The C-C bond is formed though
heterolytic C-Cu cleavage and recombination with the benzyl cation.
Finally, Pathway C is a catalytic variant of a previous proposal by Woodward and
Hoffinann for the mechanistic pathway of base-induced Stevens rearrangements of
ammonium ylides.8 8 In this pathway, the associated form of the metallocarbenoid
intermediate undergoes a formal [a2a + ,2s] rearrangement to deliver the product in a single
step. Schematically, this could be viewed as simultaneous ac-cu -> o*c-N and aC-N - a*C-Cu
donation processes, wherein the C-Cu component is antarafacial, and the C-N component is
suprafacial (a symmetry-allowed process).89
88 Woodward, R. B.; Hoffmann, R. Angew. Chem., Int. Ed. 1969, 8, 781-932.
89 For a discussion on the generalized orbital symmetry rule, and for a discussion on suprafacial and antarafacial
nomenclature as it pertains to sigma-bonds, see: Anslyn, E. V.; Dougherty, D. A. In Modern Physical Organic
Chemistry; University Science Books: Sausalito, 2006; pp 890-892.
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Pathway A:
On C-N homolysisEto 2C,.NMe 2
Cu'Ln
dissociated
Bn qn radical pair EtO 2CY NMe 2
. collapse
EtO 2 C,,NMe 2 -*- EtO 2C,.NMe 2 I Bn
,• ,
Cu'Ln Cu'L n UU'L n
Pathway B:
EtO 2H2C NMe 2Bn O EtO2C NMe 2hY,-- Bn@
SCu'Ln ) Cu'Ln
associated
EtO 2C NMe 2
Bn
Cu'Ln
Pathway C:
EtO 2CyNMe 2 8Bn
o Cu'Ln
associated
CuLn
- 
Me
EtO2 C ", .... e,
[a2a + a2s]
* inversion at the carbenoid carbon
* inversion at nitrogen
Figure 3.3. Divergent Mechanistic Pathways for the C-N Bond-Breaking Process.
Unfortunately, attempts to identify intermediates empirically through reaction
monitoring by 1H NMR were inconclusive, as the spectra of these heterogeneous reactions
showed significant line-broadening 90 and baseline distortion91 in all cases. Additionally, we
were unable to obtain crystals of an intermediate suitable for X-ray crystallographic analysis
despite significant experimentation. 92
In light of the high enantioselectivities obtained in Tables 3.2 and 3.3, the dissociative
Pathway A seems unlikely. Additionally, on the basis of reactivity difference between the 7-
90 Line-broadening has been previously observed for other Cu(1)-based systems, presumably due to oligomeric,
aggregate formation. See, for example: Strieter, E. R.; Blackmond, D. G.; Buchwald, S. L. J. Am. Chem. Soc.
2005, 127, 4120-4121.
91 Cu(I) complexes, having a d1o electronic configuration, are not usually expected to be paramagnetic. However,paramagnetic species could be present if decomposition occurs, forming Cu(0) or Cu(II) species.92 In one case we obtained a crystal structure of a decomposition product, Cu(I)L2 (see Section 3.5, part V).
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9
Etn2CH C u LnF --N ,Me
Bn Me
a - CY * Ca*1i
f %
I N)c)
methoxy-derivative and the parent compound in Figure 3.1, it appears that the rate constant
for the amine-metallocarbenoid association (eq 3.19) probably factors heavily into the
observed rate constant.
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3.4 Conclusion
We have demonstrated the first examples of catalytic, enantioselective C-N insertion
reactions with high enantioselectivities for a variety of migrating groups. The reactions
produce 1,4-benzoxazinone fused-ring cores, which are subunits in a series of pharmaceutical
targets and chiral natural products.
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3.5 Experimental Section
I. General
Copper (I) triflate benzene complex93 (CuOTf V/2 benzene; Aldrich or Alfa Aesar)
was recrystallized out of benzene/n-hexane under a nitrogen atmosphere prior to use. N,N-
Dimethylacetamide (DMA; anhydrous in a Sure-Seal bottle; Fluka) and N,N-
Dimethylformamide (DMF; anhydrous in a Sure-Seal bottle; Fluka) were used as received.
Tetrahydrofuran (THF) was dried by passage through a neutral alumina column under argon
pressure. Aqueous formaldehyde solution (ca. 37%) was purchased from Alfa Aesar, and 1-
amino-2-naphthol hydrochloride was purchased from TCI. All other chemicals were reagent-
grade and used as received.
HPLC analyses were performed on an Agilent 1100 Series system with Daicel
Chiralpak columns in hexanes/isopropanol solvent mixtures. SFC analyses were performed
on a Berger SFC MiniGram system with Daicel Chiralpak columns in carbon
dioxide/methanol mixtures. Low-resolution mass spectrometric measurements were
performed on an Agilent LC/MSC SL Multimode (ES/APCI) system with a Zorbax Eclipse
(Agilent) XDB-C18 column in methanol solvent.
93 Salomon, R. G.; Kochi, J. K. J. Chem. Soc., Chem. Comm. 1972, 559-560.
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II. Preparation of Substrates
The yields in this section have not been optimized. All reactions were conducted
under a nitrogen atmosphere, unless otherwise noted.
General Procedure for Benzylation of Amines. In CH2C12, 1-amino-2-naphthol
hydrochloride (TCI) and triethylamine were stirred for 30 min. Then, the aldehyde was added
and the resulting mixture was stirred for 2 h. NaBH(OAc) 3 and glacial acetic acid were then
added and the mixture was stirred for an additional 2 h.
The mixture was then concentrated and partitioned between CH2C12 and 50%
saturated brine solution (100 mL each), and the organic layer was collected. The aqueous
layer was washed with additional CH 2C12 (100 mL), and the combined organic layers were
concentrated and further purified by silica chromatography.
I'Bn
)H
1-(Benzylamino)naphthalen-2-ol. This compound was prepared according to the
General Procedure for Benzylation of Amines using CH2C12 (250 mL), 1-amino-2-naphthol
hydrochloride (10.0 g, 51.1 mmol), triethylamine (5.43 g, 53.7 mmol), benzaldehyde (6.51 g,
61.3 mmol), NaBH(OAc) 3 (13.5 g, 63.9 mmol), and glacial acetic acid (3.84 g, 63.9 mmol).
After extraction and silica chromatography (5% -, 10% ethyl acetate in hexanes), the
product was isolated as a light-pink solid (6.39 g, 50%).
'H NMR (CDC13, 500 MHz): 8 7.84 (d, J= 8.0 Hz, 1H), 7.83 (d, J= 8.6 Hz, 1H),
7.66 (d, J= 8.8 Hz, 1 H), 7.52 (ddd, J= 1.3, 6.9, 8.2 Hz, 1H), 7.47-7.33 (m, 6H), 7.25 (dd, J
= 8.8, 1.7 Hz, 1 H), 7.19 (br s, 1H), 4.17 (s, 2H), 3.23 (br s, 1 H);
13C NMR (CDCl 3, 100 MHz): 6 150.4, 139.3, 130.9, 129.2, 129.0, 128.7, 128.2, 127.6,
127.1, 126.6, 125.1, 122.9, 120.3, 116.5, 54.1;
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IR (film): 3328, 3061, 3029, 2859, 1629, 1602, 1581, 1517, 1472, 1392, 1311, 1272,
1221, 1079, 955, 810 cm-;
LR-MS (ES/APCI): calculated for C17H 16NO [M + H+]: 250.1; found: 250.1;
mp 111-112 oC.
Me
H
1-(2-Methylallylamino)naphthalen-2-ol. This compound was prepared according to
the General Procedure for Benzylation of Amines using CH2C12 (200 mL), 1-amino-2-
naphthol hydrochloride (5.0 g, 25.6 mmol), triethylamine (2.72 g, 26.8 mmol), methacrolein
(2.15 g, 30.7 mmol), NaBH(OAc) 3 (6.77 g, 32.0 mmol), and glacial acetic acid (1.92 g, 32.0
mmol).
After extraction and silica chromatography (5% -- 10% ethyl acetate in hexanes), the
product was isolated as a light-yellow solid (3.21 g, 59%).
'H NMR (CDCl 3, 500 MHz): 6 7.81 (d, J= 8.2 Hz, 1H), 7.79 (d, J= 8.5 Hz, 1H),
7.64 (d, J= 8.8 Hz, 1H), 7.51 (ddd, J= 1.2, 6.9, 8.3 Hz, 1H), 7.33 (ddd, J= 1.1, 6.8, 8.1 Hz,
1H), 7.25 (d, J= 8.8 Hz, 1H), 7.19 (br s, 1H), 5.18 (s, 1H), 5.00 (s, 1H), 3.54 (s, 2H), 3.10 (br
s, 1H), 1.92 (s, 3H);
13C NMR (CDCl 3, 100 MHz): 6 150.0, 143.8, 130.8, 129.1, 128.9, 126.7, 126.5, 125.6,
122.9, 120.2, 116.5, 111.2, 55.8, 21.0;
IR (film): 3331, 3064, 2970, 2361, 1628, 1602, 1519, 1469, 1392, 1273, 1221, 1145,
1095, 901, 807 cm';
LR-MS (ES/APCI): calculated for C14H 16NO [M + H+]: 214.1; found: 214.1;
mp 79-83 OC.
General Procedure for Methylation of Amines. The mono-alkylated aminol was
stirred into ethanol, and then formaldehyde solution, NaBH 3CN, and glacial acetic acid were
added sequentially to the mixture, which was then stirred for 1 h.
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The mixture was then concentrated and partitioned between CH2C12 and 50%
saturated brine solution (100 mL each), and the organic layer was collected. The aqueous
layer was washed with additional CH2C12 (100 mL), and the combined organic layers were
concentrated and further purified by silica chromatography.
SMe
N.Bn
O "OH
1-(Benzyl(methyl)amino)naphthalen-2-ol. This compound was prepared according
to the General Procedure for Methylation of Amines using ethanol (150 mL), 1-
(benzylamino)naphthalen-2-ol (5.68 g, 22.6 mmol), aqueous formaldehyde solution (2.37 mL,
31.6 mmol), NaBH 3CN (1.99 g, 31.6 mmol), and glacial acetic acid (1.90 g, 31.6 mmol).
After extraction and silica chromatography (5% ethyl acetate in hexanes), the product
was obtained as a clear, yellow oil (5.82 g, 98%).
'H NMR (CDC13, 300 MHz): 6 7.90 (d, J= 8.4 Hz, 1H), 7.76 (d, J= 8.3 Hz, 1H),
7.59 (d, J= 8.8 Hz, 1H), 7.44 (ddd, J= 1.3, 6.9, 8.4 Hz, 1H), 7.28-7.23 (m, 6H), 7.20 (br s,
1H), 7.16 (d, J= 8.8 Hz, 1H), 4.41 (d, J= 13.1 Hz, 1H), 4.23 (d, J= 13.0 Hz, 1H), 2.91 (s,
3H);
13C NMR (CDC13, 100 MHz): S 151.6, 139.0, 131.9, 129.58, 129.59, 129.5, 128.9,
128.6, 128.3, 127.5, 126.1, 122.5, 122.0, 116.1, 61.2, 41.1;
IR (film): 3283, 3061, 3029, 2850, 1623, 1599, 1520, 1520, 1466, 1392, 1348, 1273,
1208, 1148, 1116, 1049, 961, 817, 749 cm-;
LR-MS (ES/APCI): calculated for C18H18NO [M + H+]: 264.1; found: 264.1.
le Me
H
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1-(Methyl(2-methylallyl)amino)naphthalen-2-ol. This compound was prepared
according to the General Procedure for Methylation of Amines using ethanol (100 mL), 1-(2-
methylallylamino)naphthalen-2-ol (1.44 g, 6.74 mmol), aqueous formaldehyde solution (2.37
mL, 9.44 mmol), NaBH 3CN (593 mg, 9.44 mmol), and glacial acetic acid (567 mg, 9.44
mmol).
After extraction and silica chromatography (4% ethyl acetate in hexanes), the product
was obtained as a clear, colorless oil (1.14 g, 75%).
'1H NMR (CDC13, 400 MHz): 6 8.07 (br s, 1H), 7.88 (d, J= 8.5 Hz, 1H), 7.82 (d, J
8.2 Hz, 1H), 7.66 (d, J= 8.8 Hz, 1H), 7.48 (ddd, J= 1.3, 6.9, 8.4 Hz, 1H), 7.32 (ddd, J= 1.1,
6.9, 8.0 Hz, 1H), 7.26 (d, J= 8.8 Hz, 1H), 5.07 (s, 1H), 4.97 (s, 1H), 4.05 (d, J= 13.8 Hz,
1H), 3.57 (d, J= 13.8 Hz, 1H), 2.95 (s, 3H), 1.89 (s, 3H);
13C NMR (CDC13, 100 MHz): 6 151.7, 142.6, 131.8, 130.1, 129.6, 129.5, 128.2, 126.0,
122.5, 122.1, 116.1, 113.4, 63.6, 40.7, 20.6;
IR (film): 3290, 3076, 2972, 2940, 1623, 1599, 1519, 1468, 1451, 1393, 1342, 1270,
1206, 1149, 1119, 1051, 964, 901, 816, 747 cm';
LR-MS (ES/APCI): calculated for C15H18NO [M + H+]: 228.1; found: 228.1.
General Procedure for Diazo-transfer.so The dialkylated aminol was dissolved into
dry THF and cooled to -15 oC in an isopropanol-ice bath. LHMDS (ca. 1.06 M THF solution;
Alfa Aesar) was added via syringe, whereupon the solution turned dark red in color, and then
diketene was added by syringe. After stirring for the indicated time, p-
acetamidobenzenesulfonyl azide (p-ABSA; Alfa Aesar) was added, and the cold solution was
allowed to warm to room temperature overnight.
The mixture was then concentrated and partitioned between CH2C12 and 50%
saturated brine solution (100 mL each), and the organic layer was collected. The aqueous
layer was washed with additional CH 2C12 (100 mL), and the combined organic layers were
concentrated and further purified by silica chromatography.
152
Me
N-Bn
IZO
Ac
1-(Benzyl(methyl)amino)naphthalen-2-yl 2-diazo-3-oxobutanoate. This compound
was prepared according to the General Procedure for Diazo-transfer. Dry THF (10 mL), 1-
(benzyl(methyl)amino)naphthalen-2-ol (3.00 g, 11.4 mmol), LHMDS solution (11.3 mL,
12.0 mmol), and diketene (1.05 g, 12.5 mmol) were stirred together for 30 min, followed by
the addition of p-ABSA (3.28 g, 13.7 mmol).
After extraction and silica chromatography (4% -, 12% ethyl acetate in hexanes), the
product was obtained as an amber-colored resin (2.16 g, 51%).
'H NMR (CDC13, 500 MHz): 3 8.47 (dd, J= 0.6, 8.5 Hz, 1H), 7.90 (dd, J= 0.6, 8.0
Hz, 1H), 7.73 (d, J= 8.9 Hz, 1H), 7.61 (ddd, J= 1.3, 6.8, 8.4 Hz, 1H), 7.55 (ddd, J= 1.3, 6.9,
8.1 Hz, 1H), 7.41-7.29 (m, 5H), 7.24 (d, J= 8.9 Hz, 1H), 4.31 (s, 2H), 2.86 (s, 3H), 2.58 (s,
3H);
13C NMR (CDCl3, 125 MHz): 3 189.8, 160.2, 144.1, 139.4, 138.9, 132.9, 132.6, 128.6,
128.3, 128.2, 127.2, 126.5, 126.1, 126.0, 124.4, 122.2, 60.7, 40.8, 28.3; the resonance of the
diazo-bearing carbon was not detected;
IR (film): 3061, 3029, 2846, 2800, 2268, 2140 (C=N), 1732, 1662, 1594, 1454, 1396,
1365, 1313, 1060, 1039, 965, 731 cm ;
LR-MS (ES/APCI): calculated for C22H20N30 3 [M + H+]: 374.2; found: 374.1.
153
1-((4-Methoxybenzyl)(methyl)amino)naphthalen-2-yl 2-diazo-3-oxobutanoate.
This compound was prepared beginning with the General Procedure for Benzylation of
Amines using CH 2C12 (150 mL), 1-amino-2-naphthol hydrochloride (2.50 g, 12.8 mmol),
triethylamine (1.42 g, 14.1 mmol), p-anisaldehyde (1.92 g, 14.1 mmol), NaBH(OAc)3 (2.98 g,
14.1 mmol), and glacial acetic acid (0.846 g, 14.1 mmol). After extraction and silica
chromatography (10% -- 12.5% ethyl acetate in hexanes), and the benzylated intermediate
was isolated as a waxy, red solid (1.51 g).
The benzylated intermediate was then methylated according to General Procedure for
Methylation of Amines using ethanol (100 mL), aqueous formaldehyde solution (0.610 mL,
8.12 mmol), NaBH3CN (510 mg, 8.12 mmol), and glacial acetic acid (0.488 mg, 8.12 mmol).
After extraction and silica chromatography (7.5% -, 10% ethyl acetate in hexanes), the
methylated intermediate was obtained as a clear, yellow oil (1.52 g).
Finally, the methylated intermediate was diazatized according to the General
Procedure for Diazo-transfer using dry THF (10 mL), LHMDS solution (1.04 mL, 4.82
mmol), and diketene (473 mg, 5.62 mmol) stirred together for 1 h, followed by the addition
ofp-ABSA (1.47 g, 6.12 mmol). After extraction and silica chromatography (7.5% -- 15%
ethyl acetate in hexanes), the product was obtained as a clear, yellow resin (0.895 g, 17%;
three steps).
'H NMR (CDCl 3, 400 MHz): a 8.42 (d, J= 8.3 Hz, 1H), 7.87 (d, J= 8.0 Hz, 1H),
7.70 (d, J= 8.8 Hz, 1H), 7.60-7.51 (m, 2H), 7.25 (d, J= 8.3 Hz, 2H), 7.20 (d, J= 8.9 Hz, 1H),
6.87 (d, J= 8.3 Hz, 2H), 4.22 (s, 2H), 3.81 (s, 3H), 2.82 (s, 3H), 2.55 (s, 3H);
13C NMR (CDC13, 125 MHz): a 189.8, 160.1, 158.7, 144.1, 139.3, 132.9, 132.6, 130.9,
129.8, 128.1, 126.4, 126.0, 124.4, 122.2, 113.6, 60.0, 55.1, 40.6, 28.3; the resonance of the
diazo-bearing carbon was not detected;
IR (film): 3057, 3000, 2935, 2836, 2256, 2139 (C=N), 1732, 1662, 1610, 1512, 1465,
1365, 1247, 1143, 1059, 803, 730 cm-';
LR-MS (ES/APCI): calculated for C23H22N30 4 [M + H+]: 404.2; found: 404.1
154
xO x NBr
Ac
1-((4-Bromobenzyl)(methyl)amino)naphthalen-2-yl 2-diazo-3-oxobutanoate. This
compound was prepared beginning with the General Procedure for Benzylation of Amines
using CH 2C12 (100 mL), 1-amino-2-naphthol hydrochloride (2.50 g, 12.8 mmol),
triethylamine (1.30 g, 12.8 mmol), 4-bromobenzaldehyde (2.94 g, 15.9 mmol), NaBH(OAc)3
(2.98 g, 14.1 mmol), and glacial acetic acid (846 mg, 14.1 mmol). After extraction and silica
chromatography (7.5% ethyl acetate in hexanes), and the product was isolated as a light-
yellow solid (1.14 g, 27%).
That intermediate was then methylated according to General Procedure for
Methylation of Amines using ethanol (10 mL), aqueous formaldehyde solution (311 mL,
4.15 mmol), NaBH 3CN (261 mg, 4.15 mmol), and glacial acetic acid (250 mg, 4.16 mmol).
After extraction and silica chromatography (7.5% ethyl acetate in hexanes), the product A
was obtained as a clear, colorless oil (769 mg, 65%).
Finally, the second intermediate (A; 750 mg, 2.19 mmol) was diazatized according to
the General Procedure for Diazo-transfer using dry THF (10 mL), LHMDS solution (2.17
mL, 2.30 mmol), and diketene (184 mg, 2.30 mmol) stirred together for 20 min, followed by
the addition ofp-ABSA (685 mg, 2.85 mmol). After extraction and silica chromatography
(5% -- 10% ethyl acetate in hexanes), the product was obtained as a clear, amber-colored
resin (150 mg, 15%).
1H NMR (CDCl3, 500 MHz): 6 8.38 (d, J= 8.4 Hz, 1H), 7.88 (d, J= 8.0 Hz, 1H),
7.72 (d, J= 8.9 Hz, 1H), 7.59 (ddd, J= 1.3, 6.9, 8.4 Hz, 1H), 7.55-7.52 (m, 1H), 7.46 (d, J=
8.4 Hz, 1H), 7.23 (d, J= 8.4 Hz, 1H), 7.21 (d, J= 8.9 Hz, 1H), 4.23 (s, 2H), 2.82 (s, 3H),
2.56 (s, 3H);
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13C NMR (CDCl3, 125 MHz): 8 189.8, 160.2, 144.1, 139.0, 137.9, 133.0, 132.5, 131.4,
130.3, 128.3, 126.6, 126.4, 126.1, 124.2, 122.2, 121.1, 60.1, 41.0, 28.4; the resonance of the
diazo-bearing carbon was not detected;
IR (film): 3056, 2849, 2364, 2139 (C=N), 1732, 1662, 1593, 1507, 1487, 1312, 1247,
1211, 1060, 1038, 964, 801 cm';
LR-MS (ES/APCI): calculated for the deacylated product A, C1 8H17BrNO [M + H+]:
342.1; found: 342.0.
OQK N2
Ac
1-(Methyl(2-methylbenzyl)amino)naphthalen-2-yl 2-diazo-3-oxobutanoate. This
compound was prepared starting with the General Procedure for Benzylation of Amines
using CH 2C12 (150 mL), 1-amino-2-naphthol hydrochloride (3.00 g, 15.3 mmol),
triethylamine (1.55 g, 15.3 mmol), 2-methylbenzaldehyde (2.03 g, 16.9 mmol), NaBH(OAc) 3
(3.57 g, 16.8 mmol), and glacial acetic acid (1.01 g, 16.8 mmol). After extraction and silica
chromatography (5% - 10% ethyl acetate in hexanes), the product was isolated as a pink
solid and directly carried forward to the next step.
That intermediate was then methylated according to General Procedure for
Methylation of Amines using ethanol (100 mL), aqueous formaldehyde solution (1.61 mL,
21.4 mmol), NaBH 3CN (1.34 g, 21.4 mmol), and glacial acetic acid (1.29 g, 21.4 mmol).
After extraction and silica chromatography (5% ethyl acetate in hexanes), the product was
obtained as a clear, colorless oil (1.81 g, 43%; two steps).
Finally, the second intermediate was diazatized according to the General Procedure
for Diazo-transfer using dry THF (20 mL), LHMDS solution (6.16 mL, 6.53 mmol), and
diketene (604 mg, 7.18 mmol) stirred together for 20 min, followed by the addition ofp-
ABSA (2.04 g, 7.18 mmol). After extraction and silica chromatography (6% -- 8% ethyl
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acetate in hexanes), the diazoester product was obtained as a clear, amber-colored resin (0.66
g, 26%).
'H NMR (CDCl3, 500 MHz): 6 8.39 (d, J= 8.3 Hz, 1H), 7.89 (d, J= 7.9 Hz, 1H),
7.74 (d, J= 8.9 Hz, 1H), 7.58-7.51 (m, 2H), 7.46-7.44 (m, 1H), 7.25-7.20 (m, 4H), 4.32 (s,
2H), 2.88 (s, 3H), 2.59 (s, 3H), 2.26 (s, 3H);
13C NMR (CDCl3, 125 MHz): 6 189.7, 160.3, 144.00, 143.98, 139.9, 136.8, 132.9,
132.5, 130.4, 129.2, 128.2, 127.2, 126.4, 126.1, 126.0, 125.6, 124.4, 122.3, 58.1, 41.3, 28.3,
19.1; the resonance of the diazo-bearing carbon was not detected;
IR (film): 3057, 2945, 2849, 2257, 2140 (C=N), 1733, 1663, 1594, 1463, 1463, 1365,
1313, 1143, 1039, 802, 744 cm-';
LR-MS (ES/APCI): calculated for C23H22N30 3 [M + H+]: 388.2; found: 388.2;
mp 83-86 'C.
1-((2-Allylbenzyl)(methyl)amino)naphthalen-2-yl 2-diazo-3-oxobutanoate. This
compound was prepared starting with the General Procedure for Benzylation of Amines
using CH2C12 (150 mL), 1-amino-2-naphthol hydrochloride (4.66 g, 23.8 mmol),
triethylamine (2.53 g, 25.0 mmol), 2-allylbenzaldehyde 94(4.00 g, 27.4 mmol), NaBH(OAc) 3
(6.31 g, 29.8 mmol), and glacial acetic acid (1.79 g, 29.8 mmol). After extraction and silica
chromatography (5% -- 15% ethyl acetate in hexanes), the product was isolated as a pink
solid (2.62 g, 38%).
That intermediate was then methylated according to General Procedure for
Methylation of Amines using ethanol (100 mL), aqueous formaldehyde solution (951 mL,
94 Knight, J.; Parsons, P. J. J. Chem. Soc., Perkin Trans. 11989, 979-984.
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12.7 mmol), NaBH 3CN (797 mg, 12.7 mmol), and glacial acetic acid (761 mg, 12.7 mmol).
After extraction and silica chromatography (3% ethyl acetate in hexanes), the product B was
obtained as a clear, colorless oil (2.57 g, 93%).
Finally, the second intermediate (B; 2.57g, 8.47 mmol) was diazatized according to
the General Procedure for Diazo-transfer using dry THF (20 mL), LHMDS solution (8.00
mL, 8.47 mmol), and diketene (784 mg, 9.32 mmol) stirred together forl5 min, followed by
the addition ofp-ABSA (2.85 g, 11.9 mmol). After extraction and silica chromatography (5%
-- 10% ethyl acetate in hexanes), the diazoester product was obtained as a clear, amber-
colored resin (1.64 g, 47%).
IH NMR (CDCl3, 500 MHz): 6 8.39 (d, J= 8.3 Hz, 1H), 7.88 (d, J= 7.8 Hz, 1H),
7.73 (d, J= 8.9 Hz, 1H), 7.58-7.51 (m, 3H), 7.30-7.20 (m, 4H), 5.90 (ddt, J= 6.1, 10.1, 16.3
Hz, 1H), 5.00 (ddt, J= 1.6, 3.2, 10.1 Hz, 1H), 4.81 (ddt, J= 1.8, 1.8, 17.1 Hz, 1H), 4.32 (s,
2H), 3.39 (ddd, J= 1.5, 1.5, 6.1 Hz, 2H), 2.86 (s, 3H), 2.58 (s, 3H);
13C NMR (CDCl3, 125 MHz): 6 189.7, 160.3, 144.0, 139.9, 138.2, 136.8, 136.7, 133.0,
132.6, 129.9, 129.4, 128.2, 127.4, 126.4, 126.3, 126.2, 126.0, 124.4, 122.3, 115.8, 57.3, 41.3,
36.7, 28.4; the resonance of the diazo-bearing carbon was not detected;
IR (film): 3060, 2977, 2848, 2379, 2268, 2140 (C=N), 1733, 1663, 1594, 1394, 1365,
1313, 1142, 1039, 755, 635 cm ';
LR-MS (ES/APCI): calculated for the deacylated product B, C21H22NO [M + H+]:
304.2; found: 304.2;
S Me
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1-((2-Ethoxy-2-oxoethyl)(methyl)amino)naphthalen-2-yl 2-diazo-3-oxobutanoate.
A 1 L round-bottomed flask was charged with 1-amino-2-naphthol hydrochloride (2.50 g,
14.4 mmol), triethylamine (1.46g, 14.4 mmol), and ethanol (600 mL). NaBH3CN (2.72, 43.3
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mmol) and acetic acid (2.60 g, 43.3 mmol) were then stirred into solution, and ethyl
glyoxalate solution (ca. 50% solution in toluene, 6.0 mL; 30.7 mmol; Fluka) was added to the
mixture portionwise (6 x 1.0 mL each) by syringe, over the course of 1.5 hours. The mixture
was then stirred an additional 2 hours at room temperature. The mixture was then
concentrated and partitioned between CH2C12 and water (100 mL each), and the organic layer
was collected. The aqueous layer was washed with additional CH 2C12 (100 mL), and the
combined organic layers were concentrated and purified by silica chromatography (15%
ethyl acetate in hexanes), and the product was obtained as a clear, red oil (523 mg, 15%).
That intermediate (823 mg, 3.40 mmol; combined from multiple runs) was then
methylated according to General Procedure for Methylation of Amines using ethanol (50
mL), aqueous formaldehyde solution (0.360 mL, 4.80 mmol), NaBH 3CN (300 mg, 4.77
mmol), and glacial acetic acid (285 mg, 4.75 mmol). After extraction and silica
chromatography (10% ethyl acetate in hexanes), the methylated intermediate was obtained as
a clear, red oil (683 mg, 77%).
Finally, the dialkylated aminol was diazotized according to the General Procedure for
Diazo-transfer using dry THF (10 mL), LHMDS solution (2.48 mL, 2.63 mmol), and
diketene (310 mg, 3.68 mmol) stirred together for 20 min, followed by the addition ofp-
ABSA (885 mg, 3.68 mmol). After extraction and silica chromatography (15% ethyl acetate
in hexanes), the product was obtained as a clear, amber-colored resin (403 mg, 41%).
'H NMR (CDC13, 500 MHz): 6 8.35 (d, J= 8.5 Hz, 1H), 7.86 (d, J= 8.1 Hz, 1H),
7.71 (d, J= 8.8 Hz, 1H), 7.57 (ddd, J= 1.3, 6.8, 8.4 Hz, 1H), 7.51 (ddd, J= 1.3, 6.8, 8.1 Hz,
1H), 7.22 (d, J= 8.9 Hz, 1H), 4.18 (q, J= 7.2 Hz, 2H), 3.91 (s, 2H), 3.03 (s, 3H), 2.57 (s,
3H), 1.26 (t, J= 7.1 Hz, 3H);
13C NMR (CDCl3, 125 MHz): 6 189.9, 171.0, 160.4, 144.1, 138.6, 133.0, 132.6, 128.2,
126.6, 126.5, 126.0, 124.4, 122.0, 60.6, 57.4, 41.9, 28.3, 14.2; the resonance of the diazo-
bearing carbon was not detected;
IR (film): 3449, 3305, 3058, 2982, 2904, 2379, 2268, 2142 (C=N), 1733, 1662, 1594,
1508, 1473, 1401, 1366, 1316, 1248, 1215, 1141, 965 cm-';
LR-MS (ES/APCI): calculated for C19H20N30 5 [M + I+]: 370.1; found: 370.1.
159
S Me Me
1 N
Ac
1-(Methyl(2-methylallyl)amino)naphthalen-2-yl 2-diazo-3-oxobutanoate. This
compound was prepared according to diazo-transfer procedure using dry THF (20 mL), 1-
(methyl(2-methylallyl)amino)naphthalen-2-ol (474 mg, 2.09 mmol), LHMDS solution (2.10
mL, 2.23 mmol), diketene (193 mg, 2.29 mmol), and p-ABSA (703 mg, 2.93 mmol). After
silica chromatography (5% -- 10% ethyl acetate in hexanes), the product was obtained as a
white, crystalline solid (240 mg, 34%).
'H NMR (CDCl 3, 500 MHz): 6 8.40 (d, J= 8.4 Hz, 1H), 7.86 (d, J= 8.0 Hz, 1H),
7.70 (d, J= 8.0 Hz, 1H), 7.56 (ddd, J= 1.4, 6.8, 8.4 Hz, 1H), 7.51 (ddd, J= 1.4, 6.8, 8.1 Hz,
1H), 7.21 (d, J= 8.9 Hz, 1H), 5.05 (s, 1H), 4.95 (s, 1H), 3.64 (s, 2H), 2.80 (s, 3H), 2.58 (s,
3H), 1.85 (s, 3H);
13C NMR (CDCl3, 125 MHz): 6 189.9, 160.3, 144.0, 143.1, 139.9, 132.95, 132.89,
128.1, 126.1, 126.0, 124.3, 122.2, 115.4, 113.0, 63.2, 40.8, 28.4, 20.6; the resonance of the
diazo-bearing carbon was not detected;
IR (film): 3073, 2973, 2941, 2845, 2381, 2139 (C=N), 1733, 1664, 1593, 1508, 1365,
1312, 1247, 1207, 1142, 1039, 801, 731 cm-1;
LR-MS (ES/APCI): calculated for C19H20N30 3 [M + H+]: 338.2; found: 338.1;
mp 99-102 OC.
eMe
O N2COPh
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1-(Methyl(2-methylallyl)amino)naphthalen-2-yl 2-diazo-3-oxo-3-phenyl-propanoate.
A 40-mL vial was charged with 1-(methyl(2-methylallyl)amino)naphthalen-2-ol (1.20 g, 5.28
mmol), 3-oxo-3-phenylpropanoic acid95 (867 mg, 5.28 mmol), and dry CH 2C12 (20 mL).
Then N,N-dicyclohexylcarbodiimide (667 mg, 5.28) was added via syringe, and the reaction
mixture was stirred for 1 h at room temperature, partitioned between DCM and 0.50 M
aqueous HCI (100 mL each), and the organic layer was collected. The aqueous layer was
washed with additional CH 2C12 (100 mL), and the combined organic layers were
concentrated and further purified by silica chromatography (4% ethyl acetate in hexanes).
The f-ketoester intermediate was obtained as a clear, colorless oil (602.2 mg, 32 %), along
with recovered starting material (660 mg, 55%).
The 3-ketoester intermediate (259 mg, 0.723 mmol) was dissolved into dry acetonitrile
(20 mL) and then tosyl azide (155 mg, 0.788 mmol) and triethylamine (87.8 mg, 0.868
mmol) were added to the mixture. After 30 minutes, second additions of tosyl azide (155 mg,
0.788 mmol) and triethylamine (87.8 mg, 0.868 mmol) were made, and the reaction was
stirred at room temperature overnight. The crude reaction mixture was then concentrated, and
purified by silica chromatography (4% -- 8% ethyl acetate in hexanes) to afford the
diazoester product as a clear yellow resin (150 mg, 52%).
'H NMR (CDC13, 400 MHz): 6 8.38 (d, J= 8.4 Hz, 1H), 7.87 (d, J= 8.0 Hz, 1H), 7.73 (d,
J= 9.0 Hz, 1H), 7.66 (d, J= 8.9 Hz, 1H), 7.55-7.41 (m, 5H), 7.19 (d, J= 8.9 Hz, 1H), 5.06 (s,
1H), 4.94 (s, 1H), 3.60 (s, 3H), 2.75 (s, 3H), 1.84 (s, 3H);
'
3C NMR (CDC13, 100 MHz): 6 186.4, 159.9, 144.2, 143.2, 139.90, 139.86, 132.9, 132.6,
132.3, 128.5, 128.1, 128.0, 126.3, 126.0, 125.9, 124.3, 122.2, 112.9, 63.1, 40.7, 20.6; the
resonance of the diazo-bearing carbon was not detected;
IR (film): 3445, 2917, 2849, 2142 (C=N), 1814, 1737, 1633, 1448, 1390, 1306, 1294,
1063, 801 cm-';
LR-MS (ES/APCI): calculated for the deacylated fragment, 1-(methyl(2-
methylallyl)amino)naphthalen-2-ol, C15H18NO [M + I+]: 228.1; found: 228.1.
95 Barnick, J. W. F. K.; Van Der Baan, J. L.; Bickelhaupt, F. Synthesis 1979, 787-788.
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1-Ethyl 3-(1-(methyl(2-methylallyl)amino)naphthalen-2-yl) 2-diazomalonate. A
40-mL vial was charged with 1-(methyl(2-methylallyl)amino)naphthalen-2-ol (577 mg, 2.54
mmol), ethyl 3-chloro-2-diazo-3-oxopropanoate 96 (718 mg, 4.06 mmol), and dry CH2C12 (20
mL). The reaction mixture was stirred overnight at room temperature, and then partitioned
between DCM and 50% brine solution (100 mL each), and the organic layer was collected.
The aqueous layer was washed with additional CH2C12 (100 mL), and the combined organic
layers were concentrated and further purified by silica chromatography (4% -. 6% ethyl
acetate in hexanes) which afforded the diazoester product as a yellow resin (491 mg, 53 %).
1H NMR (CDCl 3, 500 MHz): 6 8.42 (d, J= 8.4 Hz, 1H), 7.84 (d, J= 8.0 Hz, 1H),
7.67 (d, J= 9.0 Hz, 1H), 7.54 (ddd, J= 1.4, 6.8, 8.4 Hz, 1H), 7.49 (ddd, J= 1.3, 6.8, 8.0 Hz,
1H), 7.22 (d, J= 8.9 Hz, 1H), 5.07 (s, 1H), 4.94 (s, 1H), 4.41 (q, J= 7.1 Hz, 2H), 3.65 (s,
2H), 2.80 (s, 3H), 1.86 (s, 3H), 1.39 (t, J= 7.1 Hz, 3H);
13C NMR (CDC13, 125 MHz): 3 160.6, 159.9, 144.4, 143.4, 139.8, 132.9, 132.8, 128.0,
126.2, 125.9, 125.8, 124.3, 122.5, 112.8, 63.0, 62.1, 40.7, 20.6, 14.4; the resonance of the
diazo-bearing carbon was not detected;
IR (film): 2980, 2846, 2144 (C=N), 1770, 1737, 1704, 1594, 1446, 1394, 1371, 1319,
1210, 1088, 1052, 898, 756 cm-';
LR-MS (ES/APCI): calculated for C20H 22N 304 [M + H+]: 368.2; found: 368.2.
96Marino, J. P.; Osterhout, M. H.; Price, A. T.; Sheehan, S. M.; Padwa, A. Tetrahedron Lett. 1994, 35, 849-852.
162
S Me Ph
/N
O
O-1 N2
Ac
1-(Methyl(2-phenylallyl)amino)naphthalen-2-yI 2-diazo-3-oxobutanoate. This
compound was prepared starting with the General Procedure for Benzylation of Amines
using CH 2C12 (250 mL), 1-amino-2-naphthol hydrochloride (4.69 g, 27.1 mmol),
triethylamine (2.74 g, 27.1 mmol), 2-phenylacrylaldehyde 97 (3.58 g, 27.1 mmol),
NaBH(OAc) 3 (6.32 g, 29.8 mmol), and glacial acetic acid (1.79 g, 29.9 mmol). After
extraction the reaction mixture was passed across a pad of silica (10% ethyl acetate in
hexanes), and the crude product mixture was directly carried forward to the next step.
The crude intermediate underwent methylation according to General Procedure for
Methylation of Amines using ethanol (100 mL), aqueous formaldehyde solution (1.22 mL,
16.3 mmol), NaBH3CN (1.02 g, 16.2 mmol), and glacial acetic acid (979 mg, 16.3 mmol).
After extraction and silica chromatography (2.5% ethyl acetate in hexanes) the intermediate,
1-(methyl(2-phenylallyl)amino)naphthalen-2-ol, was obtained as a clear, colorless oil (525
mg, 11%; two steps).
Finally, the 1-(methyl(2-phenylallyl)amino)naphthalen-2-ol was diazotized according
to the General Procedure for Diazo-transfer using dry THF (20 mL), LHMDS solution (1.71
mL, 1.81 mmol), and diketene (168 mg, 2.00 mmol) stirred together for 30 min, followed by
the addition ofp-ABSA (545 mg, 2.27 mmol). After extraction and silica chromatography
(4% -- 8% ethyl acetate in hexanes), the diazoester product was obtained as an amber-
colored resin (479 mg, 66%).
1H NMR (CDCl 3, 500 MHz): 6 7.90 (d, J= 8.0 Hz, 1H), 7.83 (d, J= 8.2 Hz, 1H),
7.70 (d, J= 8.9 Hz, 1H), 7.47-7.27 (m, 7H), 7.22 (d, J= 8.8 Hz, 1H), 5.50 (s, 1H), 5.39 (s,
1H), 4.17 (s, 2H), 2.82 (s, 3H), 2.57 (s, 3H);
97 Nsanzumuhire, C.; Clement, J.-L.; Ouari, O.; Karoui, H.; Finet., J.-H.; Tordo, P. Tetrahedron Lett. 2004, 45,
6385-6389.
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"C NMR (CDC13, 125 MHz): 6 189.8, 160.3, 145.5, 144.2, 139.7, 139.6, 132.9, 132.8,
128.2, 127.9, 127.5, 126.5, 126.2, 126.1, 126.0, 124.7, 122.1, 114.8, 60.7, 41.0, 28.4; the
resonance of the diazo-bearing carbon was not detected;
IR (film): 2980, 2847, 2425, 2143 (C=N), 1770, 1737, 1508, 1394, 1372, 1320, 1211,
1089, 1052, 756 cm ;
LR-MS (ES/APCI): calculated for C24H 22N 303 [M + H+]: 400.2; found: 400.1.
1-((2-(Ethoxycarbonyl)allyl)(methyl)amino)naphthalen-2-yl 2-diazo-3-
oxobutanoate. A dry 100-mL round-bottomed flask was charged with NaH (287 mg, 12.0
mmol) and dry DMF (10 mL), and cooled to 0 oC. Then a solution of 1-amino-2-naphthol
hydrochloride (4.69 g, 27.1 mmol) in dry DMF (20 mL) was added carefully over the course
of 5 minutes, followed by the addition of ethyl 2-(bromomethyl)acrylate (1.1 g, 5.7 mmol;
TCI) by syringe. The reaction mixture was allowed to warm to room temperature overnight,
and then it was partitioned between diethyl ether and saturated aqueous ammonium chloride
(150 mL each), and the organic layer was collected. The aqueous layer was then washed with
additional diethyl ether (150 mL), and the combined organic layers were concentrated and
further purified by silica chromatography (15% ethyl acetate in hexanes, loaded with the aid
of toluene). The allylamine intermediate was obtained as a clear, red oil (520 mg, 34 %).
That allylamine intermediate was then methylated according to General Procedure for
Methylation of Amines using ethanol (100 mL), aqueous formaldehyde solution (201 mL,
2.68 mmol), NaBH 3CN (170 mg, 2.68 mmol), and glacial acetic acid (162 mg, 2.68 mmol).
After extraction and silica chromatography (10% ethyl acetate in hexanes), the product C
was obtained as a clear, colorless oil (394 mg, 72%).
Finally, the second intermediate (C) was diazotized according to the General
Procedure for Diazo-transfer using dry THF (20 mL), LHMDS solution (1.30 mL, 1.38
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mmol), and diketene (128 mg, 1.52 mmol) stirred together for 10 min, followed by the
addition ofp-ABSA (464 mg, 1.93 mmol). After extraction and silica chromatography (7%
-- 15% ethyl acetate in hexanes), the diazoester product was obtained as an amber-colored
resin (403 mg, 74%).
'H NMR (CDC13, 500 MHz): 6 8.27 (d, J= 8.2 Hz, 1H), 7.85 (d, J= 7.7 Hz, 1H),
7.70 (d, J= 8.9 Hz, 1H), 7.55-7.48 (m, 2H), 7.21 (d, 8.9 Hz, 1H), 6.28 (s, 1H), 5.81 (s, 1H),
4.09 (q, J= 7.1 Hz, 2H), 4.00 (s, 2H), 2.86 (s, 3H), 2.58 (s, 3H), 1.09 (t, J= 7.1 Hz, 3H);
13C NMR (CDCl3, 125 MHz): 6 189.8, 166.8, 160.3, 144.2, 139.2, 137.7, 132.9, 132.8,
128.1, 126.41, 126.36, 126.05, 126.03, 124.3, 122.1, 60.7, 57.0, 41.4, 28.4, 13.9; the
resonance of the diazo-bearing carbon was not detected;
IR (film): 2982, 2850, 2380, 2268, 2141 (C=N), 1732, 1663, 1594, 1472, 1395, 1366,
1314, 1248, 1207, 1144, 1039, 964, 803, 732 cm 1 ;
LR-MS (ES/APCI): calculated for the deacylated fragment C, C17H20NO3 [M + H+]:
286.1; found: 286.1.
S Me
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(E)-l-(Cinnamyl(methyl)amino)naphthalen-2-yl 2-diazo-3-oxobutanoate. This
compound was prepared beginning with the General Procedure for Benzylation of Amines
using CH2C12 (150 mL), 1-amino-2-naphthol hydrochloride (5.00 g, 25.6 mmol),
triethylamine (2.59 g, 25.6 mmol), trans-cinnamaldehyde (3.73 g, 28.2 mmol), NaBH(OAc)3
(5.97 g, 28.2 mmol), and glacial acetic acid (1.69 g, 28.2 mmol). After extraction and silica
chromatography (10% -- 15% ethyl acetate in hexanes), the product was isolated as a brown
solid (800 mg, 11%).
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That intermediate was then methylated according to General Procedure for
Methylation of Amines using ethanol (150 mL), aqueous formaldehyde solution (0.33 mL,
4.4 mmol), NaBH 3CN (275 mg, 4.37 mmol), and glacial acetic acid (262 mg, 4.37 mmol).
After extraction and silica chromatography (15% ethyl acetate in hexanes), the product was
obtained as a clear yellow oil (545 mg, 65%).
Finally, the dialkylated aminol was diazotized according to the General Procedure for
Diazo-transfer using dry THF (10 mL), LHMDS solution (1.77 mL, 1.88 mmol), and
diketene (174 mg, 2.07 mmol) stirred together for 30 min, followed by the addition ofp-
ABSA (587 mg, 2.44 mmol). After extraction and silica chromatography (10% ethyl acetate
in hexanes), the product was obtained as a clear, amber-colored resin (327 mg, 44%).
'H NMR (CDCl 3, 400 MHz): 6 8.38 (d, J= 8.4 Hz, 1H), 7.87 (d, J= 7.8 Hz, 1H),
7.07 (d, J= 8.5 Hz, 1H), 7.58 (ddd, J= 1.4, 6.9, 8.4 Hz, 1H), 7.52 (ddd, J= 1.3, 6.8, 8.0 Hz,
1H), 7.39-7.25 (m, 5H), 7.21 (d, J= 9.0 Hz, 1H), 6.59 (d, J= 15.8 Hz, 1H), 6.30 (dt, J= 6.6,
15.8 Hz, 1H), 3.89 (d, J= 6.5 Hz, 2H), 2.94 (s, 3H), 2.52 (s, 3H);
13C NMR (CDCl3, 100 MHz): 5 189.8, 160.3, 144.0, 139.1, 136.8, 133.0, 132.8, 132.4,
128.6, 128.2, 127.5, 127.0, 126.4, 126.3, 126.1, 126.0, 124.4, 122.2, 58.8, 40.8, 28.3; the
resonance of the diazo-bearing carbon was not detected;
IR (film): 3058, 3026, 2931, 2378, 2269, 2139 (C=N), 1949, 1732, 1663, 1594, 1579,
1472, 1449, 1397, 1365, 1313, 1209, 965, 802, 747, 694 cm' ;
LR-MS (ES/APCI): calculated for C24H22N30 3 [M + H÷]: 400.2; found: 400.1;
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III. C-N Insertion Reactions
General Procedure for Table Entries. In a nitrogen-filled glovebox, a 40-mL vial
was charged with the diazoester (0.50 mmol), CuOTf * /2 benzene (13 mg, 0.050 mmol),
ligand (+)-1 (22 mg, 0.065 mmol), and DMA (7.0 mL) resulting in a white, colloidal reaction
mixture. The vial was then sealed with a Teflon cap, removed from the glovebox, and placed
into a heated oil bath where it was stirred for the indicated time. After that time had elapsed,
the reaction mixture was directly purified by flash chromatography.
The second runs were performed with ligand (-)-1. The absolute stereochemistries of
products in table entries 3 and 9 were determined by X-ray crystallography (see Section IV).
All other assignments were made by analogy.
Reaction notes: Use of higher temperatures results in higher rates of conversion, at
the cost of lower enantioselectivity. Very low conversion was observed in reactions
contaminated with air. Use of CuTC98 as catalyst reduces the reaction sensitivity to air, but
gives lower product yields (55% yield, 90% ee; under analogous conditions to those of Table
3.2, entry 1).
B Me
lkNA c
Table 3.2, entry 1. This product was prepared according to the General Procedure for
Table Entries using 187 mg (0.500 mmol) of diazoester substrate, stirred for 2.0 days. The
reaction mixture was then passed through a short pad of silica gel (1:1 diethyl ether in
hexanes) to remove the copper, ligand, and most of the DMA. Further purification by silica
chromatography (5% ethyl acetate, 0.3% triethylamine in hexanes -- 8% ethyl acetate, 0.3%
triethylamine in hexanes; loaded with the aid of toluene) afforded the product as a white,
waxy solid.
1st run: 143 mg (83%; 91% ee);
98 CuTC (copper (I) thiophene-2-carboxylate) is available from Aldrich. For a method of preparation, see:
Allred, G. D.; Liebeskind, L. S. J. Am. Chem. Soc. 1996, 118, 2748-2749.
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The ee's were determined via HPLC on an AS-H column (eluent: 3% isopropanol in
hexanes; flow rate: 1.0 mL/min). Retention times: 30.0 min (major) and 21.3 min (minor).
[oa]23D = -230 (c = 0.0016, CHC13);
IH NMR (CDC13, 300 MHz): 8 8.22 (d, J= 8.4 Hz, 1H), 7.86 (d, J= 8.2 Hz, 1H), 7.69 (d,
J= 9.1 Hz, 1H), 7.68-7.64 (m, 1H), 7.53-7.30 (m, 6H), 7.19 (d, J= 9.0 Hz, 1H), 3.82 (d, J=
14.6 Hz, 1H), 3.47 (d, J= 14.6 Hz, 1H), 3.03 (s, 3H), 1.36 (s, 3H);
13C NMR (CDC13, 125 MHz): 6 205.3, 165.6, 144.4, 134.0, 131.3, 129.4, 129.1, 128.7,
128.4, 128.0, 127.7, 127.5, 126.9, 125.8, 121.9, 117.2, 78.1, 38.1, 37.0, 26.1;
IR (film): 3584, 3063, 2969, 1774, 1718, 1629, 1598, 1466, 1391, 1353, 1249, 1226,
1181, 1115, 1029, 992, 812, 733, 701 cm ';
LR-MS (ES/APCI): calculated for C22H20NO3 [M + H+]: 346.1; found: 346.1;
mp 122-125 OC;
2 nd run: 136 mg (79%; 91% ee).
Table 3.2, entry 2. This product was prepared according to the General Procedure for
Table Entries using 202 mg (0.500 mmol) of diazoester substrate, stirred for 3.0 days. The
reaction mixture was then passed through a short pad of silica gel (1:1 diethyl ether in
hexanes) to remove the copper, ligand, and most of the DMA. Further purification by silica
chromatography (8% ethyl acetate, 0.3% triethylamine in hexanes -> 13% ethyl acetate,
0.3% triethylamine in hexanes; loaded with the aid of toluene) afforded the product as a
yellow oil.
1st run: 146 mg (78%; 91% ee).
The ee's were determined via HPLC on an IA-H column (eluent: 5% isopropanol in
hexanes; flow rate: 1.0 mL/min). Retention times: 18.5 min (major) and 20.5 min (minor).
[a]23D = -120 (c = 0.0045, CHC13);
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'H NMR (CDC13, 400 MHz): 8 8.22 (d, J= 8.4Hz, 1H), 7.86 (d, J= 8.3 Hz, 1H), 7.69 (d,
J= 9.1 Hz, 1H), 7.65 (ddd, J= 1.1, 7.9, 8.2 Hz, 1H), 7.53-7.49 (m, 1H), 7.39 (d, J= 8.7 Hz,
2H), 7.19 (d, J= 9.0 Hz, 1H), 6.89 (d, J= 8.8 Hz, 2H), 3.81 (s, 3H), 3.77 (d, J= 14.6 Hz,
1H), 3.40 (d, J = 14.6 Hz, 1H), 3.01 (s, 3H), 1.40 (s, 3H);
13C NMR (CDCl3, 125 MHz): 8 205.1, 165.1, 159.7, 144.4, 131.48, 131.46, 131.3, 128.7,
127.9, 127.7, 125.8, 121.9, 117.2, 116.6, 114.2, 114.0, 78.0, 55.2, 38.0, 36.3, 25.9;
IR (film): 3418, 2922, 2851, 1770, 1631, 1513, 1463, 1248, 1225, 1179, 1115, 1029, 992,
810 cm'-;
LR-MS (ES/APCI): calculated for C23H22NO4 [M + H+]: 376.2; found: 376.2;
2nd run: 133 mg (71%; 95% ee).
.Br
Table 3.2, entry 3. This product was prepared according to the General Procedure for
Table Entries using 226 mg (0.500 mmol) of diazoester substrate, stirred for 4.0 days. The
reaction mixture was then passed through a short pad of silica gel (1:1 diethyl ether in
hexanes) to remove the copper, ligand, and most of the DMA. Further purification by silica
chromatography (6% ethyl acetate, 0.3% triethylamine in hexanes -- 12% ethyl acetate,
0.3% triethylamine in hexanes; loaded with the aid of toluene) afforded the product as a
white, crystalline solid.
1st run: 127 mg (60%; 90% ee).
The ee's were determined via HPLC on an AD-H column (eluent: 1% isopropanol in
hexanes; flow rate: 1.0 mL/min). Retention times: 20.7 min (major) and 24.6 min (minor).
Crystals suitable for X-Ray crystallographic analysis were grown by slow CH2C12 -- hexanes
diffusion, see Section V.
[a]23D = -240 (c = 0.0080, CHCl3);
'H NMR (CDC13, 400 MHz): 8 8.20 (d, J= 8.4 Hz, 1H), 7.86 (d, J= 8.2 Hz, 1H),
7.70 (d, J= 8.9 Hz, 1H), 7.66 (ddd, J= 1.2, 7.0, 8.3 Hz, 1H), 7.52 (ddd, J= 1.2, 7.0, 8.3 Hz,
169
1H), 7.48 (d, J= 8.5 Hz, 2H), 7.36 (d, J= 8.5 Hz, 2H), 7.20 (d, J= 9.0 Hz, 1H), 3.79 (d, J=
14.5 Hz, 1H), 3.37 (d, J= 14.5 Hz, 1H), 2.99 (s, 3H), 1.46 (s, 3H);
13C NMR (CDC13, 100 MHz): 8 204.7, 165.5, 144.4, 133.1, 132.1, 131.8, 131.4, 128.9,
128.8, 128.3, 128.1, 127.8, 125.9, 121.8, 121.7, 117.1, 77.8, 38.0, 36.7, 26.0;
IR (film): 2969, 1775, 1717, 1598, 1490, 1466, 1490, 1466, 1391, 1354, 1275, 1248,
1226, 1194, 1116, 1074, 1012, 992, 813, 751 cm-';
LR-MS (ES/APCI): calculated for C22H19NBrO3 [M+H÷]: 424.1; found: 424.0;
mp 197-199 oC;
2 nd run: 111 mg (56%; 89% ee).
Table 3.2, entry 4. This product was prepared according to the General Procedure for
Table Entries using 194 mg (0.500 mmol) of diazoester substrate, stirred for 5.0 days. The
reaction mixture was then passed through a short pad of silica gel (1:1 diethyl ether in
hexanes) to remove the copper, ligand, and most of the DMA. Further purification by silica
chromatography (5% ethyl acetate, 0.3% triethylamine in hexanes --- 8% ethyl acetate, 0.3%
triethylamine in hexanes; loaded with the aid of toluene) afforded the product as a white,
crystalline solid.
1st run: 114 mg (64%; 92% ee).
The ee's were determined via HPLC on an AS-H column (eluent: 3% isopropanol in
hexanes; flow rate: 1.0 mL/min). Retention times: 20.8 min (major) and 17.7 min (minor).
[C]23D = -227 (c = 0.0122, CHC13);
1H NMR (CDC13, 500 MHz): 6 8.25 (d, J= 8.4 Hz, 1H), 7.86 (d, J= 8.2 Hz, 1H),
7.72-7.66 (m, 3H), 7.52 (ddd, J= 1.0, 7.1, 8.1 Hz, 1H), 7.33-7.17 (m, 3H), 7.20 (d, J= 9.0
Hz, 1H), 4.00 (d, J= 15.6 Hz, 1H), 3.41 (d, J= 15.6 Hz, 1H), 3.06 (s, 3H), 2.36 (s, 3H), 1.17
(s, 3H);
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13C NMR (CDCl3, 125 MHz): 6 205.6, 165.6, 144.4, 137.2, 132.6, 131.4, 130.9, 130.3,
129.4, 128.7, 128.6, 128.0, 127.8, 127.5, 126.3, 125.8, 121.9, 117.2, 78.0, 38.3, 31.1, 25.7,
20.2;
IR (film): 3457, 1776, 1706, 1465, 1390, 1352, 1249, 1227, 1187, 1118, 992, 812,
740 cm-1';
LR-MS (ES/APCI): calculated for C23H22NO3 [M + H+]: 360.2; found: 360.2;
mp 142-144 OC;
2nd run: 108 mg (62%; 93% ee).
Table 3.2, entry 5. This product was prepared according to the General Procedure for
Table Entries using 207 mg (0.500 mmol) of diazoester substrate, stirred for 5 days. The
reaction mixture was then passed through a short pad of silica gel (1:1 diethyl ether in
hexanes) to remove the copper, ligand, and most of the DMA. Further purification by silica
chromatography (5% ethyl acetate, 0.3% triethylamine in hexanes -- 10% ethyl acetate,
0.3% triethylamine in hexanes; loaded with the aid of toluene) followed with a second
purification by silica chromatography (pure CH 2C12) afforded the product as a clear, colorless
oil.
1st run: 102 mg (53%; 92% ee).
The ee's were determined via HPLC on an AD-H column (eluent: 3% isopropanol in
hexanes; flow rate: 1.0 mL/min). Retention times: 11.9 min (major) and 11.4 min (minor).
[a]23 D = -140 (c = 0.0043, CHCl3);
'H NMR (CDCl3, 400 MHz): 6 8.24 (d, J= 8.3 Hz, 1H), 7.86 (d, J= 8.1 Hz, 1H),
7.75 (d, J= 7.5 Hz, 1H), 7.71-7.65 (m, 2H), 7.54-7.50 (m, 1H), 7.36-7.32 (m, 1H), 7.25-
7.19 (m, 3H), 5.98 (dddd, J= 6.1, 6.1, 10.1, 16.5 Hz, 1H), 5.13 (dd, J= 1.5, 10.2 Hz, 1H),
5.02 (dd, J= 1.7, 17.1 Hz, 1H), 3.99 (d, J= 15.8 Hz, 1H), 3.51-3.35 (m, 2H), 3.40 (d, J=
15.7 Hz, 1H), 3.03 (s, 3H), 1.20 (s, 3H);
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13C NMR (CDCl3, 100 MHz): 6 205.5, 165.6, 144.4, 138.8, 136.6, 132.6, 131.4, 130.6,
130.5, 129.3, 128.7, 128.5, 128.0, 127.8, 127.7, 126.8, 125.9, 121.9, 117.2, 116.2, 78.1, 38.3,
37.6, 30.6, 25.8;
IR (film): 3064, 1775, 1708, 1598, 1466, 1392, 1249, 1226, 1185, 1114, 993, 812,
746 cm-1;
LR-MS (ES/APCI): calculated for C25H24NO3 [M + H+]: 386.2; found: 386.2;
2"d run: 116 mg (57%; 93% ee).
Me CO2Et
".Ac
Table 3.2, entry 6. This product was prepared according to the General Procedure for
Table Entries using 185 mg (0.500 mmol) of diazoester substrate, stirred for 4.0 days. The
reaction mixture was then passed through a short pad of silica gel (1:1 diethyl ether in
hexanes) to remove the copper, ligand, and most of the DMA. Purification by silica
chromatography (15% ethyl acetate, 0.3% triethylamine in hexanes -- 20% ethyl acetate,
0.3% triethylamine in hexanes; loaded with the aid of toluene) followed with a second
purification by silica chromatography (pure CH2C12) afforded the product as a clear, colorless
oil, which crystallized over a period of time.
1st run: 124 mg (73%; 93% ee).
The ee's were determined via HPLC on an IA-H column (eluent: 1% isopropanol in
hexanes; flow rate: 0.800 mL/min). Retention times: 49.9 min (major) and 55.1 min (minor).
[a]23 D = -170 (c = 0.0031, CHCl3);
1H NMR (CDCl 3, 400 MHz): 6 8.17 (d, J= 8.0 Hz, 1H), 7.86 (d, J= 8.2 Hz, 1H),
7.70 (d, J= 9.0 Hz, 1H), 7.67-7.62 (m, 1H), 7.53-7.49 (m, 1H), 7.21 (d, J= 9.0 Hz, 1H),
4.32-4.21 (m, 2H), 3.38 (d, J= 15.4 Hz, 1H), 3.19 (d, J= 15.4 Hz, 1H), 2.90 (s, 3H), 1.97 (s,
3H), 1.34 (t, J= 7.0 Hz, 3H);
13C NMR (CDCl3, 100 MHz): 8 203.5, 168.5, 165.3, 144.3, 131.5, 128.7, 128.3, 128.0,
127.71, 127.68, 125.8, 121.8, 117.0, 74.4, 61.6, 38.5, 37.6, 25.0, 14.0;
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IR (film): 3428, 2095, 1773, 1738, 1630, 1512, 1467, 1390, 1374, 1349, 1279, 1228,
1161, 1119, 1040, 992, 950 cm ;
LR-MS (ES/APCI): calculated for C19H20N0 5 [M + H÷]: 342.1; found: 342.1;
mp 138-141 OC;
2"nd run: 122 mg (72%; 93% ee).
Table 3.3, entry 1. This product was prepared according to the General Procedure for
Table Entries using 169 mg (0.500 mmol) of diazoester substrate, stirred for 1.5 days. The
reaction mixture was then passed through a short pad of silica gel (1:1 diethyl ether in
hexanes) to remove the copper, ligand, and most of the DMA. Purification by silica
chromatography (4% ethyl acetate, 0.3% triethylamine in hexanes -- 6% ethyl acetate, 0.3%
triethylamine in hexanes; loaded with the aid of toluene) followed with a second purification
by silica chromatography (pure CH2C12) afforded the product as a clear, colorless oil.
1st run: 128 mg (82%; 97% ee).
The ee's were determined via HPLC on an AS-H column (eluent: 3% isopropanol in
hexanes; flow rate: 1.0 mL/min). Retention times: 11.4 min (major) and 9.8 min (minor).
[a]23D = -240 (c = 0.0094, CHCl3);
1H NMR (CDC13, 400 MHz): a 8.20 (d, J= 8.4 Hz, 1H), 7.87 (d, J= 8.2 Hz, 1H),
7.69 (d, J= 8.9 Hz, 1H), 7.66 (ddd, J= 8.9 Hz, 1H), 7.52 (ddd, J= 2.2, 5.7, 9.6 Hz, 1H), 7.19
(d, J= 9.0 Hz, 1H), 4.99 (s, 1H), 4.98 (s, 1H), 3.21 (d, J= 14.1 Hz, 1H), 2.88 (d, J= 15.0 Hz,
1H), 2.85 (s, 3H), 2.03 (s, 3H), 1.81 (s, 3H);
13C NMR (CDCl3, 100 MHz): 6 204.9, 165.3, 144.4, 140.0, 131.4, 129.0, 128.7, 128.4,
127.9, 127.7, 125.8, 121.9, 117.5, 117.2, 77.6, 39.3, 37.7, 26.0, 23.4;
IR (film): 3411, 3072, 2972, 1777, 1716, 1599, 1467, 1391, 1353, 1249, 1226, 1115,
993, 906, 813, 752 cm-';
LR-MS (ES/APCI): calculated for C19H20NO3 [M + H+]: 310.1; found: 310.1;
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2n d run: 131 mg (85%; 97% ee).
Table 3.3, entry 2. This product was prepared according to the General Procedure for
Table Entries using 200 mg (0.500 mmol) of diazoester substrate, stirred for 4.0 days. The
reaction mixture was then passed through a short pad of silica gel (1:1 diethyl ether in
hexanes) to remove the copper, ligand, and most of the DMA. Purification by silica
chromatography (5% ethyl acetate in hexanes -- 10% ethyl acetate in hexanes; loaded with
the aid of toluene) followed with a second purification by silica chromatography (pure
CH 2C12) afforded the product as a white, crystalline solid.
1st run: 110 mg (63%; 87% ee).
The ee's were determined via HPLC on an AD-H column (eluent: 3% isopropanol in
hexanes; flow rate: 1.0 mL/min). Retention times: 12.7 min (major) and 14.0 min (minor).
[a]23 D = -220 (c = 0.0024, CHC13);
'H NMR (CDC13, 400 MHz): 6 8.00 (d, J= 7.4 Hz, 2H), 7.95 (d, J= 8.4 Hz, 1H),
7.66 (d, J= 8.1 Hz, 1H), 7.56 (d, J= 8.9 Hz, 1H), 7.40 (ddd, J= 1.0, 7.0, 8.2 Hz, 1H), 7.34-
7.30 (m, 1H), 7.26-7.13 (m, 4H), 4.78 (s, 1H), 4.70 (s, 1H), 3.46 (d, J= 13.6 Hz, 1H), 3.20
(d, J= 13.6 Hz, 1H), 2.90 (s, 3H), 1.87 (s, 3H);
13C NMR (CDCl3, 125 MHz): 6 195.2, 164.6, 145.0, 139.6, 134.4, 132.8, 130.9, 129.2,
129.0, 128.2, 128.1, 127.7, 127.6, 126.6, 125.2, 122.2, 118.1, 116.7, 77.4, 41.0, 37.6, 23.6;
IR (film): 3441, 2972, 1774, 1672, 1597, 1580, 1468, 1448, 1379, 1333, 1277, 1249,
1225, 1185, 992, 929, 810 cm';
LR-MS (ES/APCI): calculated for C24H 22NO 3 [M + Hf]: 372.2; found: 372.1;
mp 162-164 OC
2"d run: 123 mg (66%; 92%ee).
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Table 3.3, entry 3. This product was prepared according to the General Procedure for
Table Entries using 184 mg (0.500 mmol) of diazoester substrate, stirred for 3 days. The
reaction mixture was then passed through a short pad of silica gel (1:1 diethyl ether in
hexanes) to remove the copper, ligand, and most of the DMA. Further purification by silica
chromatography (5% ethyl acetate, 0.3% triethylamine in hexanes -- 8% ethyl acetate, 0.3%
triethylamine in hexanes; loaded with the aid of toluene) afforded the product as a clear,
colorless oil.
1st run: 122 mg (72%; 71% ee).
The ee's were determined via SFC on an OD-H column (eluent: 5% methanol in
supercritical carbon dioxide; flow rate: 1.0 mL/min). Retention times: 6.0 min (major) and
6.3 min (minor).
[a]23D = -229 (c = 0.0198, CHC13);
'H NMR (CDCl3, 500 MHz): 6 8.23 (d, J= 8.4 Hz, 1H), 7.83 (d, J= 8.1 Hz, 1H),
7.66 (d, J= 8.9 Hz, 1H), 7.62 (ddd, J= 1.1, 6.9, 8.3 Hz, 1H), 7.49 (ddd, J= 1.2, 6.9, 8.1 Hz,
1H), 7.20 (d, J= 8.9 Hz, 1H), 5.11 (s, 1H), 4.96 (s, 1H), 3.89-3.77 (m, 2H), 3.25 (d, J= 15.2
Hz, 1H), 2.95 (d, J= 15.1 Hz, 1H), 2.83 (s, 3H), 2.05 (s, 3H), 0.77 (t, J= 15.1 Hz, 3H);
13C NMR (CDCl3, 125 MHz): 6 167.1, 164.1, 143.9, 139.9, 131.3, 130.4, 129.0, 128.2,
127.2, 127.0, 125.7, 122.9, 116.5, 115.9, 72.2, 61.7, 38.6, 37.3, 23.4, 13.5;
IR (film): 2976, 1777, 1754, 1599, 1466, 1390, 1230, 1179, 1118, 1069, 991, 900,
811, 749 cm 1;
LR-MS (ES/APCI): calculated for C20H22NO4 [M + H+]: 340.2; found: 340.2;
2nd run: 130 mg (77%; 72% ee).
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Table 3.3, entry 4. This product was prepared according to the General Procedure for
Table Entries using 200 mg (0.500 mmol) of diazoester substrate, stirred for 3.5 days. The
reaction mixture was then passed through a short pad of silica gel (1:1 diethyl ether in
hexanes) to remove the copper, ligand, and most of the DMA. Further purification by silica
chromatography (5% ethyl acetate, 0.3% triethylamine in hexanes; loaded with the aid of
toluene) afforded the product as a feathery, white solid.
1st run: 133 mg (72%; 97% ee).
The ee's were determined via HPLC on an AD-H column (eluent: 2% isopropanol in
hexanes; flow rate: 1.0 mL/min). Retention times: 17.3 min (major) and 18.5 min (minor).
Crystals suitable for X-Ray crystallographic analysis were grown by slow CH2C12 -- hexanes
diffusion, see Section IV.
[a]23 D = -210 (c = 0.0032, CHCl3);
1H NMR (CDC13, 400 MHz): 6 8.05 (d, J= 8.4 Hz, 1H), 7.84 (d, J= 8.2 Hz, 1H),
7.66 (d, J= 9.0 Hz, 1H), 7.61 (ddd, J= 1.1, 7.0, 8.2 Hz, 1H), 7.49 (ddd, J= 1.1, 7.0, 8.1 Hz,
1H), 7.44-7.30 (m, 5H), 7.16 (d, J= 9.0 Hz, 1H), 5.63 (s, 1H), 5.48 (s, 1H), 3.70 (d, J= 15.2
Hz, 1H), 3.34 (d, J= 15.2 Hz, 1H), 2.77 (s, 3H), 1.50 (s, 3H);
13C NMR (CDCl3, 125 MHz): 8 205.4, 165.2, 144.1, 142.4, 142.1, 131.1, 129.3, 128.6,
128.5, 128.4, 127.80, 127.76, 127.6, 127.0, 125.7, 121.9, 120.1, 117.1, 77.6, 37.8, 36.9, 26.3;
IR (film): 3405, 1777, 1710, 1627, 1599, 1513, 1494, 1464, 1390, 1353, 1250, 1226,
1180, 992, 917, 820 cml';
LR-MS (ES/APCI): calculated for C24H22NO3 [M + H÷]: 372.2; found: 372.2;
mp 181-182 'C;
2nd run: 138 mg (74%; 97% ee).
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Table 3.3, entry 5. This product was prepared according to the General Procedure for
Table Entries using 198 mg (0.500 mmol) of diazoester substrate, stirred for 3.0 days. The
reaction mixture was then passed through a short pad of silica gel (1:1 diethyl ether in
hexanes) to remove the copper, ligand, and most of the DMA. Further purification by silica
chromatography (15% ethyl acetate, 0.3% triethylamine in hexanes --> 20% ethyl acetate,
0.3% triethylamine in hexanes; loaded with the aid of toluene) followed with a second
purification by silica chromatography (pure CH2C 2) afforded the product as a clear, colorless
oil.
1st run: 103 mg (56%; 95% ee).
The ee's were determined via HPLC on an AD-H column (eluent: 3% isopropanol in
hexanes; flow rate: 1.0 mL/min). Retention times: 13.8 min (major) and 13.1 min (minor).
[a]23D = -290 (c = 0.0018, CHC13);
1H NMR (CDC13, 400 MHz): 5 8.20 (d, J= 8.3 Hz, 1H), 7.86 (d, J= 8.2 Hz, 1H),
7.69 (d, J= 9.0 Hz, 1H), 7.65 (ddd, J= 1.6, 5.1, 8.3 Hz, 1H), 7.51 (ddd, J= 1.2, 7.0, 8.1 Hz,
1H), 7.18 (d, J= 9.0 Hz, 1H), 6.49 (s, 1H), 6.17 (s, 1H), 4.31-4.20 (m, 2H), 3.40 (d, J= 14.6
Hz, 1H), 3.33 (d, J= 14.6 Hz, 1H), 2.90 (s, 3H), 1.81 (s, 3H), 1.34 (t, J= 7.1 Hz, 3H);
13C NMR (CDC13, 100 MHz): 6 204.7, 167.2, 165.2, 144.2, 133.8, 131.5, 131.4, 128.9,
128.7, 128.3, 127.8, 127.7, 125.8, 121.9, 117.1, 77.1, 61.3, 37.7, 31.9, 25.8, 14.2;
IR (film): 2981, 1778, 1716, 1628, 1599, 1513, 1467, 1355, 1267, 1227, 1186, 1144,
1091, 992, 813 cm- ;
LR-MS (ES/APCI): calculated for C21H 22N0 5 [M + Hf]: 368.2; found: 368.2;
2 nd run: 107 mg (58%; 95% ee).
(R, S)-3.8
Table 3.3, entry 6. This product was prepared according to the General Procedure for
Table Entries using 68 mg (0.17 mmol) of diazoester substrate, stirred for 4.0 days. The
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reaction mixture was then passed through a short pad of silica gel (1:1 diethyl ether in
hexanes) to remove the copper, ligand, and most of the DMA. Further purification by silica
chromatography (3% ethyl acetate, 0.3% triethylamine in hexanes -- 5% ethyl acetate, 0.3%
triethylamine in hexanes; loaded with the aid of toluene) afforded both diastereomers of
product.
(R,S)-3.8 as a clear, colorless oil; 1st run: 33 mg (52%; 72% ee).
The ee's were determined via HPLC on an AD-H column (eluent: 3% isopropanol in
hexanes; flow rate: 0.750 mL/min). Retention times: 13.1 min (major) and 13.6 min (minor).
[Oc]23 D = +73 (c = 0.0050, CHC13);
1H NMR (CDCl3, 400 MHz): 5 8.16 (d, J= 8.2 Hz, 1H), 7.85 (d, J= 8.2 Hz, 1H),
7.67 (d, J= 9.0 Hz, 1H), 7.63 (ddd, J= 1.1, 7.0, 8.2 Hz, 1H), 7.53-7.47 (m, 3H), 7.34-7.24
(m, 3H), 7.18 (d, J= 8.9 Hz, 1H), 6.79 (ddd, J= 8.0, 10.2, 17.2 Hz, 1H), 5.24 (d, J= 10.2 Hz,
1H), 5.17 (d, J= 17.1 Hz, 1H), 4.37 (d, J= 8.0 Hz, 1H), 2.98 (s, 3H), 1.68 (s, 3H);
13C NMR (CDC13, 100 MHz): 3 203.1, 165.2, 144.4, 139.0, 138.5, 131.4, 129.9, 129.1,
128.72, 128.67, 128.0, 127.9, 127.6, 127.5, 125.7, 121.9, 117.9, 116.9, 79.9, 53.9, 39.9, 26.3;
IR (film): 3412, 3064, 1773, 1716, 1629, 1600, 1467, 1352, 1250, 1228, 1185, 1116,
994, 911, 813, 731, 703 cm -1;
LR-MS (ES/APCI): calculated for C24H22NO3 [M + H+]: 372.2; found: 372.2;
2"d run: 32 mg (50%; 70% ee).
The relative stereochemistry of (+)-(R,S)-3.8 was tentatively set by a 2D 'H-1H
NOESY experiment, with a mixing time of 200 ms (CDC13, 500 MHz). The relative cross-
peak volumes are listed in Table 3.4.
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Table 3.4. Relative NOESY cross-peak volumes
Newman projection for (R,S)-3.8.
and corresponding
entry left peak (ppm); right peak (ppm); relative cross-peak volume
tentative assignment tentative assignment
1 1.68; acyl methyl 6.81; vinyl A 0.050
2 5.23; vinyl B 0.004
3 5.17; vinyl C 0.051
4 4.37; methine 0.381
5 7.53; ortho-Ph 0.373
6 2.98; N-Me 6.81; vinyl A 0.373
7 5.23; vinyl B 0.099
8 5.17; vinyl C 0.321
9 4.37; methine 1.000
10 7.53; ortho-Ph 0.163
entry 4
entry5
A•c.
entnr
(R,S)-3.8
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Current Data Parameters
NAME Ac,Bn-PDT
EXPNO 1
PROCNO 1
F2 - Acquisition Parameters
Date- 20080615
Time 17.55
INSTRUM spect
PROBHD 5 mm BBO BB-1H
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 11
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 256
DW 60.400 usec
DE 6.00 usec
TE 293.2 K
D1 1.00000000 sec
TDO 1
======== CHANNEL fl ========
NUC1 1H
P1 15.07 usec
PL1 0.00 dB
SFO1 400.1324710 MHz
F2 - Processing parameters
SI 65536
SF 400.1300050 MHz
WDW EM
SSB 0
0.30 Hz
0
1.00
I I
1 ppm
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Current Data
NAME
EXPNO
PROCNO
Parameters
p-MeO-PDT
7
1
F2 - Acquisition Parameters
Date-_ 20080710
Time 18.24
INSTRUM spect
PROBHD 5 mm BBO BB-1H
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 16
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 406.4
DW 60.400 usec
DE 6.00 usec
TE 293.2 K
D1 1.00000000 sec
TDO 1
NUCI
P1
PL1
SFO1
F2 -
SI
SF
WDW
SSB
LB
GB
PC
CHANNEL fl
1H
15.07 usec
0.00 dB
400.1324710 MHz
Processing parameters
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400.1300054 MHz
EM
0
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0
1.00
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Current Data Parameters
NAME 5197
EXPNO 1
PROCNO 1
F2 - Acquisition Parameters
Date_ 20070331
Time 18.40
INSTRUM spect
PROBHD 5 mm BBO BB-1H
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 10
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 362
DW 60.400 usec
DE 6.00 usec
TE 293.2 K
D1 1.00000000 sec
TDO 1
CHANNEL fl
NUCl 1H
P1 15.07 usec
PL1 0.00 dB
SFO1 400.1324710 MHz
F2
SI
SF
WDI
SSJ
LB
GB
PC
- Processing parameters
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400.1300054 MHz
EM
B 0
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0
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STANDARD PROTON PARAMETERS
Solvent: CDC13
Ambient temperature
INOVA-S00 "rocky"
PULSE SEQUENCE
Pulse 79.0 degrees
Acq. time 3.200 sec
VWidth 10000.0 Hz
8 repetitions
OBSERVE H1, 500.2272153 MHz
DATA PROCESSING
FT size 131072
Total time 1 minute
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Data Parameters
2-AllylBn-PDT
1
F2 - Acquisition Parameters
Date- 20080605
Time 19.04
INSTRUM spect
PROBHD 5 mm QNP 1H/13
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 9
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 362
DW 60.400 usec
DE 6.00 usec
TE 293.2 K
D1 1.00000000 sec
TDO 1
======== CHANNEL fl ========
NUC1 1H
P1 14.00 usec
PL1 0.00 dB
SFO1 400.1324710 MHz
F2 -
SI
SF
WDW
SSB
LB
GB
PC
Processing parameters
65536
400.1300052 MHz
EM
0
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Data Parameters
HM-CO2Et-PDT
1
F2 - Acquisition Parameters
Date_ 20080605
Time 19.48
INSTRUM spect
PROBHD 5 mm QNP 1H/13
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 11
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 362
DW 60.400 usec
DE 6.00 usec
TE 293.2 K
D1 1.00000000 sec
TDO 1
NUC1
P1
PL1
SFO1
CHANNEL fl ========
1H
14.00 usec
0.00 dB
400.1324710 MHz
F2 - Processing parameters
SI 65536
SF 400.1300049 MHz
WDW EM
SSB 0
LB 0.30 Hz
GB 0
PC 1.40
I I I I'''
8
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Current Data Parameters
NAME Methallyl-Ac-PDT
EXPNO 1
PROCNO 1
F2 - Acquisition Parameters
Date 20080605
Time 16.58
INSTRUM spect
PROBHD 5 mm BBO BB-1H
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 9
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 228.1
DW 60.400 usec
DE 6.00 usec
TE 293.2 K
D1 1.00000000 sec
TDO 1
NUC1
P1
PL1
SFO1
CHANNEL fl
1H
15.07 usec
0.00 dB
400.1324710 MHz
F2 - Processing parameters
SI 65536
SF 400.1300048 MHz
WDW EM
SSB 0
LB 0.30 Hz
GB 0
PC 1.40
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Current Data Parameters
NAME R2-COPh-PDT
EXPNO 1
PROCNO 1
F2 - Acquisition Parameters
Date_ 20080606
Time 13.41
INSTRUM spect
PROBHD 5 mm QNP 1H/13
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 11
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 362
DW 60.400 usec
DE 6.00 usec
TE 293.2 K
D1 1.00000000 sec
TDO 1
======== CHANNEL fl ========
NUC1 1H
P1 14.00 usec
PL1 0.00 dB
SFO1 400.1324710 MHz
F2 - Processing parameters
SI 65536
SF 400.1300053 MHz
WDW EM
SSB 0
LB 0.30 Hz
GB 0
PC 1.00
I I I I I i I
1 ppm
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STANDARD PROTON PARAMETERS
Solvent: CDC13
Ambient temperature
INOVA-500 "rocky"
PULSE SEQUENCE
Relax. delay 1.000 sec
Pulse 79.0 degrees
Acq. time 3.200 sec
Width 10000.0 Hz
8 repetitions
OBSERVE H1, 500.2272154 MHz
DATA PROCESSING
FT size 131072
Total time 1 minute
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1.12
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ppm
0.97 1.93 0.900.91 1.02
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Data Parameters
Styrenyl-PDT
1
1
F2 - Acquisition Parameters
Date_ 20080606
Time 13.38
INSTRUM spect
PROBHD 5 mm QNP 1I/13
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 9
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 362
DW 60.400 usec
DE 6.00 usec
TE 293.2 K
D1 1.00000000 sec
TDO 1
======== CHANNEL fl ========
NUC1 1H
P1 14.00 usec
PLI 0.00 dB
SFO1 400.1324710 MHz
F2 -
SI
SF
WDW
SSB
LB
GB
PC
Processing parameters
65536
400.1300053 MHz
EM
0
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0
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Current Data Parameters
NAME UnsatEthylester-Ac-PDT
EXPNO 1
PROCNO 1
F2 - Acquisition Parameters
Date 20080605
Time 17.22
INSTRUM spect
PROBHD 5 mm BBO BB-1H
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 9
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 287.4
DW 60.400 usec
DE 6.00 usec
TE 293.2 K
D1 1.00000000 sec
TDO 1
======== CHANNEL fl ========
NUC1 1H
P1 15.07 usec
PL1 0.00 dB
SFO1 400.1324710 MHz
F2 - Processing parameters
SI 65536
SF 400.1300046 MHz
WDW EM
SSB 0
LB 0.30 Hz
GB 0
PC 1.40
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Current Data Parameters
NAME 6142d3d5
EXPNO 1
PROCNO 1
F2 - Acquisition Parameters
Date_ 20080407
Time 18.09
INSTRUM spect
PROBHD 5 zme BBO BB-1H
PULPROG zg30
TD 65536
SOLVENT CDC13
NS 16
DS 2
SWH 8278.146 Hz
FIDRES 0.126314 Hz
AQ 3.9584243 sec
RG 362
DW 60.400 usec
DE 6.00 usec
TE 293.2 K
D1 1.00000000 sec
TDO 1
CHANNEL fl
NUCI 1H
P1 15.07 usec
PL1 0.00 dB
SFO1 400.1324710 MHz
F2 - Processing parameters
SI 65536
SF 400.1300052 MHz
WDW EM
SSB 0
LB 0.30 Hz
GB 0
PC 1.00
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Table 1. Crystal data and structure refinement for
Identification code
Empirical formula
Formula weight
Temperature
Wavelength
Crystal system
Space group
Unit cell dimensions
Volume
07054.
07054
C22 H18 Br N 03
424.28
90(2) K
0.71073 A
Monoclinic
P2(1)
a = 11.299(2) A
b = 7.0747(15) A
c = 12.317(3) A
930.4(3) A3
a= 900 .
3= 109.089(3)0.
Y = 900.
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 29.570
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole
1.514 Mg/m3
2.231 mmnr
432
0.50 x 0.15 x 0.10 mm3
1.91 to 29.570.
-15<=h<=15, -9<=k<=9, -17<=1<=17
19192
5157 [R(int) = 0.0469]
99.9 %
Semi-empirical from equivalents
0.8077 and 0.4016
Full-matrix least-squares on F2
5157/1 /246
1.046
R1 = 0.0320, wR2 = 0.0798
R1 = 0.0348, wR2 = 0.0808
0.022(6)
0.839 and -0.517 e.A -3
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Figure 3.6. A portion of the unit cell, focusing on the insertion product (Table 3.3, entry 4).
Figure 3.7. The entire unit cell (identification code d08020).
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Table 1. Crystal data and structure refinement for d08020.
Identification code d08020
Empirical formula C24 H21 N 03
Formula weight 371.42
Temperature 100(2) K
Wavelength 1.54178 A
Crystal system Orthorhombic
Space group P2(1)2(1)2(1)
Unit cell dimensions a = 6.8367(2) A
b = 12.3571(4) A
c = 22.1285(7) A,
Volume 1869.46(10) A3
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 67.680
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole
1.320 Mg/m3
0.697 mmn1
784
0.49 x 0.11 x 0.09 mm3
4.00 to 67.680.
-8<=h<=8, -14<=k<=14, -26<=1<=26
34755
3383 [R(int) = 0.0301]
99.7 %
Semi-empirical from equivalents
0.9399 and 0.7265
Full-matrix least-squares on F2
3383 / 0 / 255
1.036
R1 = 0.0268, wR2 = 0.0694
R1 = 0.0273, wR2 = 0.0697
0.01(16)
0.197 and -0.139 e.A-3
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a= 900 .
13= 900.
y = 90 0.
i-Pr i-Pr
Ph Ph
3.1 U
Figure 3.8. A Portion of the unit cell, focusing on Cu'(3.10) 2.
The corresponding triflate counterions are shown in Figure 3.9.
S2t
3t
I - 1
Sit
Figure 3.9. The entire unit cell: 3 x Cu'(3.10) 2, 3 x OTf, and 2 x CH 2C12
(identification code 08081).
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Table 1. Crystal data and structure refinement for 08081.
Identification code 08081
Empirical formula C52 H62 C12 Cu F3 N4 07 S
Formula weight 1078.56
Temperature 100(2) K
Wavelength 0.71073 A
Crystal system Triclinic
Snace grnun P1
Unit cell dimensions a = 12.1014(12) A
b = 12.1428(12) A
c = 30.373(3) A
3856.7(7) A3
a= 78.616(2)o.
p= 85.976(2)0.
y = 61.855(2).
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 29.570
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole
1.393 Mg/m3
0.635 mm-1
1692
0.47 x 0.36 x 0.07 mm3
1.37 to 29.570.
-16<=h<=16, -16<=k<=l16, -42<=1<=42
85656
41010 [R(int) = 0.0463]
99.5 %
Semi-empirical from equivalents
0.9569 and 0.7545
Full-matrix least-squares on F2
41010 / 943 / 1973
1.039
R1 = 0.0753, wR2 = 0.1900
R1 = 0.0909, wR2 = 0.1994
0.045(9)
1.723 and -1.240 e.A-3
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